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Abstract 
The work in this dissertation provides structural and kinetic insight into the mechanism of 
action of quinoline antimalarial drugs which may aid rational drug design. Quinoline 
antimalarial drug-ferrihaem (Fe(III)PPIX) complexes were investigated. Single crystal X-
ray diffraction (SCD) structures of the complexes formed between Fe(III)PPIX and the 
quinoline methanol antimalarials quinine, quinidine and mefloquine have been determined, 
and are the first observed structures of complexes formed between free Fe(III)PPIX and 
quinoline antimalarial compounds. Quinine, quinidine and mefloquine are shown to have a 
three-point binding mode to Fe(III)PPIX, which comprises direct coordination of the drug 
to the Fe(III) centre through its benzylic alcohol functionality, π-stacking between the drug 
and porphyrin aromatic systems, and intramolecular hydrogen bond formation between the 
porphyrin propionate group and the protonated quinuclidine nitrogen atom of the drug in 
the case of quinine and quinidine, and formation of an intramolecular hydrogen bonding 
network in the case of mefloquine. Extended X-ray absorption fine structure spectroscopy 
(EXAFS) was use to elucidate structural information of Fe(III)PPIX-drug complexes in 
solution, and indicates that coordination persists in solution.  
The protocol for lipid-mediated formation of β-haematin, where monopalmitic glycerol 
was used as a model lipid, was successfully modified to incorporate antimalarial drugs into 
the aqueous layer in order to investigate drug activity under biologically-relevant 
conditions. Four compounds were chosen, namely chloroquine and amodiaquine, both 4-
aminoquinolines and quinine and quinidine. IC50 values for the inhibition of β-haematin 
formation show good correlation with biological activities determined against a 
chloroquine-sensitive Plasmodium falciparum strain. The lipid-water interface system was 
further used to investigate the effects of quinine, quinidine chloroquine and amodiaquine 
on the kinetics of β-haematin formation. The results led to the development of a kinetic 
model based on the Avrami equation and the Langmuir isotherm. The data strongly support 
a mechanism of antimalarial drug action by adsorption to the growing face of haemozoin, 
with precipitation of Fe(III)PPIX at high drug concentrations accounting for decreased 
yields. Adsorptions constants (log Kads) determined for each drug show a strong correlation 
with biological activity. Finally, the first SCD structure of the µ-propionato dimer of 
Fe(III)PPIX, the structural unit of haemozoin, has been determined as its DMSO solvate. 
EXAFS suggests that this species is only formed upon nucleation, with the π-π dimer 
species being favoured in solution. 
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Opsomming 
Die werk in die dissertasie verleen struktuur en kinetiese insig in the meganisme van 
aktiwiteit vir kinolien antimalariamiddels wat kan bydra tot die ontwikkeling van nuwe 
medisyne. Kinolien antimalariamiddel-ferriheem (Fe(III)PPIX) komplekse was ondersoek. 
Navorsing is gedoen op die enkelkristal X-straaldiffraksie strukture van die komplekse 
gevorm tussen Fe(III)PPIX en die kinolien metanol antimalaria middels kinien, kinidien en 
mefloquine. Die strukture is die eerste komplekse wat waargeneem is tussen vrye 
Fe(III)PPIX en kinolien antimalariamiddels. Kinien, kinidien en mefloquine het ŉ drie-
punt bindingsvorm, direkte koördinasie met die Fe(III) deur die bensielalkohol groep, ŉ π-
stapel tussen die middel en die porfirien aromatiese sisteem, ŉ intramolekulêre 
waterstofbinding tussen the porfirienpropionaat funksie en die geprotoneerde kinuklidien 
stikstofatoom (kinien en kinidien) en ŉ netwerk van intramolekulêre waterstof bindings 
(mefloquine) insluit. Uitgebreide X-straal absorpsie fyn struktuur spektroskopie (EXAFS) 
is gebruik om inligting oor Fe(III)PPIX-middel komplekse in oplossing te verkry en het 
aangedui dat die koördinasie in oplossing voorkom.  
Deur gebruik te maak van monopalmitiengliserol as die lipid in the lipid-water interfase 
sisteem, waar antimalariamiddels suksesvol in die buffer geïnkorporeer was, was die 
middel se aktiwiteit onder biologiese kondisies geondersoek. Vier middels was gekies 
naamlik, chloroquine en amodiaquine, albei 4-aminokinoliene en kinien en kinidien om die 
IC50-waarde vir inhibisie van β-hematien vorming te bepaal. Die IC50 waardes het ŉ goeie 
korrelasie met biologiese aktiwiteite teen die chloroquine-sensitiewe Plasmodium 
falciparum stam gewys. Die lipid-water interfase-sisteem was ook gebruik om die effek 
van kinien, kinidien, chloroquine en amodiaquine op die kineties effek op die vorming van 
β-hematien te ondersoek. Die resultate het gelei to die ontwikkeling van die kinetiese 
model gebaseer op die Avrami vergelyking en die Langmuir isoterm. Die data ondersteun 
ŉ meganisme van middel aksie waar die middel teen die groeiende vlak van hemosoïen 
kristal adsorbeer. Die neerslag van Fe(III)PPIX wat vorm by hoë konsentrasies, het gelei 
tot laer opbrengste. Die adsorpsiekonstante (log Kads) bepaal vir elke middel, het goeie 
korrelasie met biologiese aktiwiteit getoon. Enkelkristal X-straaldiffraksie strukture van µ-
propionatodimeer van Fe(III)PPIX, die struktuur eenheid van hemosoïen, was bepaal as ŉ 
DMSO solvaat. EXAFS het aangedui dat die spesie slegs by kernvorming ontstaan en dat 
die π-π dimeerspesie in oplossing voorkom. 
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1 Literature Review 
1.1 Introduction 
 
Malaria, a mosquito-borne infectious disease, has cursed humanity from its primate 
ancestry until the present, affecting the daily lives of millions of people around the globe.
1
 
Based on data presented in the World Malaria Report (2011), it is clear that malaria has no 
boundaries. Half of the world’s population remains at risk, and the disease is having 
dramatic effects, cutting economic growth rates and taking the lives of 0.5 - 1 million 
people annually - young children and pregnant women living in sub-Saharan Africa are 
most at risk.
2
 Malaria is a significant global health problem, and the reality is that parasitic 
resistance towards the majority of quinoline - containing antimalarial drugs - most notably 
chloroquine (CQ), is increasing.
2
 This means that there is an urgent need to develop new, 
effective, and inexpensive antimalarial drugs. In order to achieve this goal, a better 
understanding of the molecular mechanisms of action of current antimalarial drugs is 
imperative.
3
 
 
1.2 Malaria History and Discovery 
 
The word malaria arises from the Italian translation of bad air, “mal’aria”, due to the 
believed connection between the disease and marshes. Writings corresponding to malaria 
symptoms date back 4000 years, thus it is evident that this disease has influenced the lives 
of human populations for centuries.
4
 Today the symptoms of chills, headaches and periodic 
fever are recognised and connected to malaria infection. 
The characteristic brown-black pigment observed in the blood of victims suffering from 
malaria was first reported in 1717 by the noted Italian physician Giovanni Maria Lancisi.
5
 
In 1880, with the research done by French army doctor Charles Louis Alphones Laveran, 
the parasite itself was observed within the red blood cells of soldiers suffering from 
malaria.
6
 Seventeen years later, in 1897, Sir Ronald Ross made the connection that the 
vector for the malaria parasite was the mosquito.
7
 In the same year, the Italian physician 
Giovanni Battista Grassi proved that the Anopheles mosquito was the vector for human 
malaria, and Robert Koch showed that quinine could be used effectively against the 
malaria parasite.
1
 A cure for malaria, quinine, was discovered more than 300 years ago, up 
in the mountains of the Andes in South America, where it was extracted from the bark of 
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the Cinchona tree.
1
 In addition, the antifever properties of the Qinghao plants were 
described in 340 BC, and the antimalarial endoperoxide drug artemisinin was isolated from 
this plant in 1971.
8
  
 
1.3 Lifecycle of the Malaria Parasite 
 
Malaria in humans is caused by parasites of the genus Plasmodium, of which 5 species (P. 
falciparum, P. malariae, P. ovale, P. vivax and P. knowlesi) are known. P. falciparum is 
the most virulent species, and is responsible for 90% of malaria deaths.
1
 
The lifecycle of the malaria parasite is complex (Figure 1.1).
9
 When the female Anopheles 
mosquito (primary host) takes a blood meal from an infected human (secondary host), it 
ingests gametocytes, which undergo sexual reproduction in the mosquito gut to mature sex 
cells called gametes. Fused male and female gametes (zygotes) develop further to form 
ookinetes, and later oocysts in the midgut wall. The oocysts grow and burst releasing 
sporozoites into the body cavity of the mosquito, which then travel and invade the 
mosquito salivary glands. Transmission occurs when the infected female mosquito injects 
the parasite, in the form of sporozoites, into the uninfected human host while taking a 
blood meal in order to develop her eggs. 
10
 
As the sporozoites enter the blood stream, they travel to and invade the liver cells first; 
here they may remain dormant for an extended period of time, and often this is the cause of 
relapses months and even years after initial infection. The time spent in the liver allows the 
sporozoites to multiply into merozoites.
10
 The merozoites then re-enter the host’s red blood 
cells (RBCs) upon exiting the liver cells, beginning the erythrocytic cycle. This stage of 
the parasite’s development is associated with the symptoms of malaria infection. While 
resident inside RBCs, merozoites undergo asexual reproduction, developing through the 
ring stage, and later the trophozoite stage, which is the most active period in terms of 
parasite growth. During the latter stage the parasite also develops the digestive vacuole 
(DV) where host haemoglobin is digested. The schizont stage follows, releasing 
merozoites back into the host’s bloodstream. This erythrocytic cycle repeats every 48 
hours in the case of P. falciparum, and the rupture of merozoites causes the periodic fevers 
and chills associated with malaria infection. Some of the merozoites develop into the 
sexual form of the parasite, called the male and female gametocytes (Figure 1.1). These 
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gametocytes circulate in the blood stream, and when the mosquito takes another blood 
meal, the cycle of infection begins afresh (Figure 1.1).
11,12,13
 
 
Figure 1.1 The life cycle of the malaria parasite. Reproduced from reference.
9
 
 
Following infection, an incubation period of 7-30 days can pass before any symptoms of 
malaria are observed. A malaria attack is exemplified by a cold stage, a hot stage and a 
sweating stage that comes and goes periodically. Symptoms include fever, chills, 
headaches, nausea and in severe cases kidney failure and cerebral malaria. The female 
mosquito, unlike humans, does not suffer from the presence of the parasite.
1
 
 
1.4 The Blood Stage 
 
During the residency of the malaria parasite inside red blood cells of the human host, large 
quantities of haemoglobin are digested by a series of protease enzymes, which include the 
aspartic, cysteine and zinc metallo-proteases,
14-16
 providing a source of amino acids as well 
as space for the growing parasite.
15
 The haemoglobin is being efficiently transported to the 
parasite’s acidic DV, also known as the food vacuole (FV), in endocytotic vesicles which 
are pinched off from the cytostome formed by invagination of the parasite plasma 
membrane.
17
 The acidic environment of the DV has an estimated pH of 4.8.
18
 The four 
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equivalents of haem iron(II) protoporphyrin IX (Fe(II)PPIX) released per unit of 
haemoglobin during digestion are readily oxidized to Fe(III)PPIX (Figure 1.2), which is 
potentially toxic to the parasite owing to the redox-active iron centre which may be 
involved in generating reactive oxygen species, and thus catalysing membrane damage via 
lipid peroxidation.
19
 The features of the Fe(III)PPIX molecule include a five-coordinate 
Fe(III) centre with the axial ligand being either hydroxide (HO
-
) or aqua (H2O) depending 
on pH, and an aromatic tetrapyrrole macrocycle with two propionic acid, two vinyl and 
four methyl groups as side chains.  
 
Figure 1.2 The molecular structure of iron(III) protoporphyrin IX (Fe(III)PPIX). Features include a 
five-coordinate Fe(III) centre with either HO
-
 or H2O as the axial ligand, and an aromatic 
tetrapyrrole macrocycle. Substituents include two propionic acid, two vinyl, and four methyl side 
chains. 
 
The parasite circumvents this imminent threat by detoxifying Fe(III)PPIX via 
biocrystallisation, whereby the potentially harmful Fe(III)PPIX is converted into an 
insoluble, inert crystal of Fe(III)PPIX called haemozoin (Figure 1.3).
20,21
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Figure 1.3 Schematic representation of the pathway for haemozoin formation. Haemoglobin (Hb) 
is efficiently ingested and transported to the parasite’s acidic digestive vacuole by transport 
vesicles, after which Hb undergoes degradation into amino acids and haem, (Fe(II)PPIX). 
Subsequent oxidation ([ox]) of haem yields haematin (Fe(III)PPIX) which is detoxified into 
malaria pigment (haemozoin).  
 
An electron microscopy study by Egan et al.
20
 has shown that at least 95% of all 
Fe(III)PPIX released during haemoglobin digestion is incorporated into haemozoin. 
Transmission electron microscopy (TEM) and electron spectroscopic imaging (ESI) of the 
parasite were used, showing for the first time that haemozoin formation is the 
overwhelming fate of Fe(III)PPIX iron released in the malaria parasite (Figure 1.4).  
 
Figure 1.4 The TEM image (left) and ESI (right) of an infected red blood cell, showing that iron 
distribution coincides with haemozoin crystals. Reproduced from reference.
20
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Amino
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The erythrocytic stage of the malaria parasite’s lifecycle is very important from a 
chemotherapy perspective, since quinoline containing antimalarials exhibit their 
antiplasmodial activity at this stage. During its residency inside host RBCs, the parasite is 
vulnerable at various points to drug action, however, interruption of haemoglobin 
degradation or Fe(III)PPPIX detoxification, have been widely considered.
22
 Understanding 
haemozoin formation in particular has been a focus in the literature during the last three 
decades given its important implications for the design of new therapeutic agents.  
 
1.5 Haemozoin 
 
It is known today that haemozoin is the pigment observed and reported by Lancisi.
5
 With 
the discovery of haemozoin in other blood-feeding organisms such as the insect Rhodnius 
prolixus,
23
 helmith worms including Schistosoma mansoni,
24,25
 Echinostoma trivolvis,
26
 
and Haemoproteus columbae,
24
 (Figure 1.5) research interest in haemozoin has increased 
significantly in recent years. Though unrelated to the malaria parasite, these organisms also 
detoxify Fe(III)PPIX by converting it into haemozoin. 
 
Figure 1.5 Samples of haemozoin purified from (a) P. falciparum, (b) S. mansoni and (c) H. 
columbea. The scale bar in each represents 200 nm. Reproduced from reference.
24
 
 
1.5.1 Structure of Haemozoin  
 
The discovery of a synthetic aggregate of Fe(III)PPIX called β-haematin, first described by 
Hamsik in 1936,
27
 opened the door to the study of the unique formation of haemozoin in 
vitro. Since then, it has been show that β-haematin is chemically and spectroscopically 
identical to haemozoin.
28,29,30
 Haemozoin and β-haematin give rise to identical Fourier 
transform infrared (FT-IR) spectra, powder X-ray diffraction patterns (PXRD), 
synchrotron PXRD patterns and Raman spectra.
28,30,31
  
(a) (b) (c)
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1.5.1.1 Interpretation from Haemozoin and β-Haematin 
 
Malaria pigment was first described as a melanotic pigment, due to its presumed 
association with melanins.
1
 This idea was contested in 1911 by Brown on the basis of 
comparison studies between well-known melanins and malaria pigment. Through bleach 
reactions and solubility studies he showed that there was marked dissimilarity between 
them. Using spectroscopic examination, Brown also showed that the chromophore 
(precursor) of malaria pigment is haematin.
32
 
Early characterisations of haemozoin suggested it to be a haemoprotein complex,
33
 
however the pioneering work of Fitch and Kanjananggulpan dismissed this notion. By 
using P. berghei infected erythrocytes, the material extracted was washed to remove 
protein by proteolytic digestion as well as lipid by chloroform/methanol extraction to yield 
high purity material. They showed for the first time that purified haemozoin consists only 
of ferriprotoporphyrin IX (Fe(III)PPIX) and suggested that haemozoin and β-haematin 
(synthetic haemozoin) are most likely identical.
29
  
Early structural interpretations by Slater et al.
28,30
 led to the conclusion that haemozoin was 
a bio-polymer comprising Fe(III)PPIX units sequentially linked via propionate 
coordination to the Fe(III) centre between adjacent monomers (Figure 1.6 (a)). They 
assigned the strong absorbance bands at 1211 cm
-1 
and 1664 cm
-1
 in the FT-IR spectrum of 
haemozoin to the C-O and C=O stretching frequencies of the coordinated propionate group 
to the Fe(III) centre (Figure 1.6 (b and c)). It was also Slater et al.
30
 who showed that 
haemozoin and its synthetic counterpart β-haematin give rise to identical PXRD patterns 
and FT-IR spectra. 
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Figure 1.6 The structure of haemozoin proposed by Slater et al.
30
 (a) They suggested that 
haemozoin was a linear polymer linked via Fe(III)-propionate coordination bonds. (b) A schematic 
representation of the then-believed structure of haemozoin viewed side on. C-O and C=O 
stretching frequencies responsible for the strong absorbance bands at 1211 cm
-1
 and 1664 cm
-1
 in 
the UV-visible spectrum are indicated. The thicker black lines represent the mean porphyrin plane. 
(c) The FT-IR spectrum of haemozoin (─) and Fe(III)PPIX (---). Characteristic peaks at 1211 cm-1 
and 1664 cm
-1
 in the spectrum of haemozoin are indicated with arrows, and are absent in the 
spectrum of Fe(III)PPIX. Reproduced from reference.
30
 
 
Making use of synchrotron powder X-ray diffraction (PXRD), Bohle et al.
34
 conclusively 
demonstrated that β-haematin is identical to haemozoin. Furthermore, their results revealed 
that the structure comprised a centrosymmetric unit cell, and they therefore proposed a 
revised structure for haemozoin (β-haematin) consisting of antiparallel polymer chains, as 
shown in Figure 1.7.  
(c)
(a) (b)
Fe
Fe
O
O
~ 1664 cm -1
~ 1211 cm -1
O
O
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Figure 1.7 The proposed structure of haemozoin/β-haematin by Bohle et al.34 consists of 
antiparallel polymer chains stabilised via intermolecular hydrogen bonding. Reproduced from 
reference.
34
  
 
The true structure of β-haematin was only determined by Pagola et al.35 in 2000. After 
careful analysis of synchrotron powder X-ray diffraction data, the authors were able to 
determine that the repeating unit in the crystal structure of β-haematin is a cyclic dimer of 
Fe(III)PPIX in which a deprotonated propionic acid group (propionate side chain) of one 
protoporphyrin unit coordinates to the Fe(III) centre of the second and vice versa to form a 
discrete centrosymmetric unit, and not a polymer as predicted years before.
28,30
 Hydrogen 
bonding between dimers occurs via the second propionic acid group of each 
protoporphyrin unit, and serves to link these dimers together, forming chains in the crystal 
structure (Figure 1.8).
35
  
 
Figure 1.8 The structure of β-haematin. Formation of the cyclic dimers occurs through Fe(III)-
propionate coordination bonds, with dimers linked by intermolecular hydrogen bonds between 
propionic acid groups (represented as pink dashed lines). Reproduced from reference.
35
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The centrosymmetric haemozoin dimer comes about as a result of the coordination of one 
propionate side chain of one Fe(III)PPIX coordinating to the Fe(III) centre of a second 
Fe(III)PPIX and vice versa (Figure 1.9). In agreement with early structural interpretations 
put forward by Slater et al.,
30
 the strong absorbance bands at 1211 cm
-1 
and 1664 cm
-1
 in 
the FT-IR spectrum of haemozoin are attributed to the C-O and C=O stretching frequencies 
of the coordinated propionate ligand (Figure 1.6 (c)). Today haemozoin or β-haematin can 
be readily characterised by their FT-IR spectra. Having solved the structure of β-haematin, 
and confirmed the same for haemozoin, had great implications for probing the mechanism 
of the biomineralisation process, whereby potentially harmful Fe(III)PPIX is converted 
into haemozoin.  
 
 
 
Figure 1.9 A schematic representation of the haemozoin centrosymmetric dimer (µ-propionato 
dimer) viewed side on. C-O and C=O stretching frequencies responsible for the strong absorbance 
bands at 1211 cm
-1
 and 1664 cm
-1
 in the UV-visible spectrum are indicated. The thicker black lines 
represent the mean porphyrin plane.  
 
One theory recently put forward by Klonis et al.
36
 suggested that the structure of 
haemozoin is composed of π-π dimers stabilised by µ-propionate coordination (Figure 
1.10). This conclusion was based on their solution of the structure of haemozoin by 
synchrotron PXRD, using maximum entropy-based pattern fitting.
36
 They proposed that 
nucleation of haemozoin crystals is initiated by π-π dimers, contradicting the idea that 
haemozoin and β-haematin nucleation is initiated from cyclic dimers of Fe(III)PPIX.37 The 
latter interpretation was based on the original structure determination of β-haematin. 
However, and it must be pointed out that the crystal structure is not sufficient to infer the 
nucleating species. 
Fe
Fe
O
O
~ 1664 cm-1
~ 1211 cm-1
O
O ~ 1664 cm-1
~ 1211 cm-1
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Figure 1.10 A proposed model for the formation of haemozoin: π-π dimers form columns which 
are extended in length via antiparallel non-covalent polymer (P-type) interactions and linked to 
adjacent columns via µ-propionate (µ-Pr) coordination. Reproduced from reference.
36
 
 
1.5.1.2 Local Fe(III) Environment of Haemozoin and β-Haematin 
 
To fortify the similarities, Walczak et al.
38
 set out to investigate haemozoin and its 
synthetic homologue, β-haematin, utilizing extended X-ray absorption fine structure 
(EXAFS) spectroscopy. They showed the usefulness of EXAFS to analyse and compare 
the distributions of atoms surrounding the absorbing Fe atom in β-haematin and 
haemozoin. Using the PXRD structure of β-haematin as a model, the scattering properties 
 ( ) and  ( ) were calculated for EXAFS analysis.35 Due to the fact that Fe(III)PPIX is a 
complex system, and scattering of photo-electrons is possible from many atoms 
surrounding the Fe centre, atoms were grouped into four coordination shells (Figure 1.11). 
The first shell contains the oxygen atom of the axial ligand, while the four nitrogen atoms 
of the porphyrin macrocycle, which coordinate to Fe in the equatorial plane, comprise the 
second shell. The third and fourth shells contain the eight α carbon and the four meso 
carbon atoms, respectively. 
  
µ-Pr
µ-Pr
PP
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Figure 1.11 A model of Fe(III)PPIX showing the four coordination shells surrounding the 
absorbing Fe centre. (a) The first shell contains the oxygen atom of the axial ligand. (b) The four 
nitrogen atoms of the porphyrin macrocycle, which coordinate to Fe in the equatorial plane, 
comprise the second shell. (c) The third shell contains the eight α carbon atoms, and (d) the four 
meso carbon atoms make up the fourth shell. These shells were used as a starting model for 
EXAFS analysis to investigate the distribution of atoms around the Fe centre in haemozoin and β-
haematin. Redrawn based on reference.
38 
 
The model was refined to include multi-scattering paths. There was very good agreement 
between the experimental data and the model, with R-factors of 0.005 and 0.007 obtained 
for β-haematin and haemozoin respectively (Figure 1.12). 
 
(a) (b)
(c) (d)
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Figure 1.12 Fe Kα-edge X-ray absorption spectra. The best fit of experimental data (labelled Exp) 
for (a) β-haematin and (b) haemozoin to a model generated from the coordinates of β-haematin 
determined by PXRD.
35
 R-factors are 0.005 and 0.007 respectively. Reproduced from reference.
38
 
 
Comparison of the EXAFS data for β-haematin and haemozoin highlighted a difference in 
the position of the axial oxygen atom. In the case of haemozoin, the Fe─O bond length 
was found to have a larger statistical error compared to the same parameter in β-haematin. 
The authors reasoned that not all of the oxygen bridges that bond Fe(III)PPIX can be 
formed in the natural pigment, due to the large error and large value of the Debye-Waller 
factor, indicating large disorder in the position and occupancy of the oxygen site. The X-
ray absorption near edge structure (XANES) results for β-haematin and haemozoin 
confirmed that the oxidation state of Fe is close to three.
38
 
 
1.5.1.3 Crystal Morphology of Haemozoin 
 
Crystal morphology is unique to every crystal structure and is sculptured by the relative 
growth rate of the various faces of the crystal. According to Hartman and Perdok,
39
 the 
morphology of a crystal is dependent on the growth rates of its various faces, which in turn 
depend on the layer energy, E1 (a measures of the stability of the layer), and the attachment 
energy, Eatt (which controls the growth rate perpendicular to the layer). These energies can 
be calculated for various low-index faces of a crystal, and can in turn be used to determine 
the theoretical crystal form.
35
 Using this approach, the theoretical growth form of β-
haematin has been investigated (Figure 1.13 A and B).
40
 Buller et al.
40
 determined a 
needle-like crystal morphology which is extended along the c-axis. Expressed in the 
(a) (b)
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morphology are the dominant (100) and (010) faces, a lesser developed (011) face and a 
minor (001) face. The theoretical morphology of haemozoin shows a strong resemblance to 
purified haemozoin crystals (Figure 1.13 C, D and E).
40
 An average crystal width-to-
thickness ratio of w/t = 1.3 ±0.5 was determined, and most of the crystals were seen to lie 
on their wide (100) face. 
 
Figure 1.13 The theoretical growth form of β-haematin (A and B) indicating the dominant (100) 
and (010) faces, a lesser developed (011) face and a minor (011) face. The external morphology of 
haemozoin (C, D and E) purified from P. falciparum, S. mansoni and H. columbae respectively. 
Reproduced from reference.
40
 
 
The authors identified the fastest growing crystal face, (001), of β-haematin, and showed 
that quinoline antimalarial drugs are able to bind remarkably well into the crevices created 
at this face. They reasoned that this could represent a possible mode of inhibition by 
quinoline antimalarial drugs. As such, their proposal is discussed in more detail later 
(section 1.6.4). 
A
D
E
C
B
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1.5.1.3.1 Stereoisomers of β-Haematin 
 
The molecule of Fe(III)PPIX has enantio-facial symmetry, therefore isomers of the dimer 
of β-haematin can form. Straaso et al.41 identified four possible stereoisomers in the dimer 
structure of β-haematin crystals after analysing the powder X-ray diffraction data of β-
haematin crystals.  These possible isomers consisted of two centrosymmetric and two 
chiral enantiomers, which they named cd ̅1, cd ̅2 and cd2(+), cd2(-) respectively (Figure 
1.14). Only the cd ̅1 centrosymmetric cyclic dimer was described in the initial elucidation 
of the β-haematin structure.35  
 
Figure 1.14 A schematic representation of the four isomers of the β-haematin µ-propionato 
dimer.
41 
The two achiral centrosymmetric dimers, (a) and (b), have been termed cd ̅1, and cd ̅2, 
respectively, while the two chiral non-centrosymmetric dimers, (c) and (d), have been termed 
cd2(+) and cd2(-), respectively. The vinyl substituents shown in green occupy α (top porphyrin) 
and γ (bottom porphyrin) sites, while those shown in orange occupy the β (top porphyrin) and δ 
(bottom porphyrin) sites. Atom colour coding: C – grey; N – blue; O – red; Fe – cyan and vinyl 
groups – green and orange. Redrawn based on reference.41 
 
In these four isomers, the vinyl substituents are located at the α/γ, β/γ, α/δ and β/γ 
positions, respectively. The authors proposed that β-haematin consists of a major (cd ̅1,) 
and a minor (cd ̅2) phase, and reasoned that adsorption of the chiral stereoisomers onto 
various faces of the growing crystal could result in blocking further growth. They 
suggested that this could be the reason why only micrometre-sized crystals are observed in 
β-haematin formation, and could explain why a suitable crystal for single crystal X-ray 
diffraction has not been obtained. Alternative interpretations propose that there is only a 
single phase, and that disorder in the structure, particularly with regard to the methyl and 
(a) (b) (c) (d)
11cd 21cd )(2 cd )(2 cd
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vinyl substituents is caused by the presence of all four isomers.
42
 The authors acknowledge 
that powder X-ray diffraction is limited, and that it cannot distinguish between the 
observed vinyl/methyl disorder. They explained that SCD would provide insight into 
resolving the problem. Besides the reference system for the four stereoisomers used above, 
different nomenclature systems are also referred to in the literature; these are outlined in 
Table 1.1. 
Table 1.1 The different nomenclature systems used to describe the stereoisomers of the µ-
propionato dimer
.# 
Straaso
a
 CPI
b
 IUPAC
c
 Vinyl sites
d
 
cd ̅  (R/S) 2,2 α/γ 
cd ̅  (S/R) 18,18 β/δ 
cd2(-) (S/S) 2,18 α/δ 
cd2(+) (R/R) 18,2 β/γ 
#
 Reproduced from reference.
42
 
a 
Straaso et al.
41
 
b 
Cahn, Prelog, and Ingold system for Fe-O coordination to Re or Si face of Fe(III)PPIX. 
c
 IUPAC 
43
 The numbering (2 and 18) refer to the propanoate bearing C-atoms from which the Fe-O bond. 
d
 Reproduced from reference.
42
 
 
 
In order to understand the mechanism of haemozoin crystallisation and the involvement of 
the different stereoisomers, Marom et al.
44
 conducted van der Waals-corrected density 
functional theory (DFT) studies of β-haematin. Based on computational modelling of the 
different stereoisomers, they proposed a mechanism whereby the formation of cyclic 
dimers of Fe(III)PPIX is the first stage of nucleation. 
 
1.5.1.3.2 β-Haematin Crystal Properties 
 
In 2003 Bohle et al.
45
 showed that β-haematin is able to absorb up to 14% of its mass in 
water, corresponding to a mol ratio of 4.78 water molecules per molecule of Fe(III)PPIX. 
Samples of hydrated β-haematin were heated to temperatures exceeding 150 oC, after 
which reabsorption of water took place at room temperature. Depending on the 
experimental method used to make β-haematin, more crystalline samples have been shown 
to have a greater capacity for reabsorbing water when compared to more amorphous 
samples. They also showed, by comparing synchrotron PXRD patterns, that samples 
become more ordered as they are allowed to rehydrate. The authors could not account for 
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where the water is adsorbing and simply stated that it may be possible for the water to 
either intercalate between layers or attach to the surface of crystals. 
 
1.5.1.3.3 Single Crystal Analoque of β-Haematin 
 
Due to the essential role that β-haematin studies have contributed to our understanding of 
haemozoin, much effort has gone into growing a malaria pigment analogue large enough 
for single crystal X-ray diffraction. The structure of β-haematin was solved using Rietveld 
refinement of data collected from synchrotron X-ray powder diffraction.
35
 Only as recently 
as 2012, Bohle and Dodd
46
 presented the first single crystal X-ray diffraction structure of a 
propionate-linked dimer similar to that found in haemozoin. The haemozoin model 
compound, [gallium(III) protoporphyrin IX]2 (Figure 1.15), was crystallised from a 
solution of Ga(PPIX)-OH in 2,6-lutidine in the presence of one equivalent of pyridine.  
 
 
Figure 1.15 The crystal structure of [gallium(III) protoporphyrin IX]2. The dimeric propionate-
bridged dimer has a six-coordinated metal atom with a pyridine ligand bound trans to the 
propionate group. An intraporphyrin hydrogen bond is observed between the gallium-bound 
propionate and the free propionic acid group from the same porphyrin unit. Reproduced from 
reference.
46
 
 
The crystal structure shows a cyclic dimer of Ga(III)PPIX, in which the propionate side 
chain of one protoporphyrin unit coordinates to the Ga(III) centre of the second and vice 
versa to form a centrosymmetric cyclic dimer, as observed in β-haematin and haemozoin 
structures. However, the Ga(III) centre is six-coordinate with a pyridine ligand bound trans 
to the coordinated propionate group, therefore the Ga(III) centre resides in the plane of the 
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phorphyrin. Furthermore, the free propionic acid forms an intramolecular hydrogen bond 
with the propionate group of the same porphyrin molecule. Owing to the coordination of 
the pyridine and the absence of intermolecular hydrogen bonding, [gallium(III) 
protoporphyrin IX]2 is more soluble in methanol (MeOH) and other organic solvents 
compared to β-haematin, therefore allowing for the characterisation of solution structures 
using 
1
H NMR spectroscopy. Solution 
1
H NMR spectra of [gallium(III) protoporphyrin 
IX]2 in methanol-d4 by 1D NOESY indicates that pyridine promotes dimerisation: an 
increase in intensity of the methane-20-propionate 2β, 18β NOE peak is observed as 
pyridine is added (Figure 1.16). Comparatively, in the haemozoin dimer, the Fe centre is 
five-coordinate such that the Fe(III) centre resides outside of the porphyrin plane and no 
intramolecular hydrogen bonding is observed. 
 
Figure 1.16 The 
1
D NOESY 
1
H NMR spectra of [gallium(III) protoporphyrin IX]2 in methanol-d4 
indicate that pyridine promotes dimerisation, due to the increase in intensity observed for the 
methane-20-propionate 2β, 18β NOE peak (indicated with blue arrow) as (a) 0 equiv, (b) 3 equiv, 
(c) 14 equiv, and (d) 27 equiv of pyridine are added. Reproduced from reference.
46
 
 
1.5.1.4  Analogues of β-Haematin 
 
In 2011 Bohle et al.
47
 published the structure of the µ-propionate coordination dimer of 
Fe(III) mesoporphyrin IX, a species which is isostructural to the β-haematin dimer and 
which they referred to as mesohaematin anhydride. In the mesoporphyrin, the vinyl groups 
are substituted for ethyl groups, leading to a compound more soluble in dichloromethane 
(DCM). Solved by X-ray powder diffraction, the structure of this dimer was shown to be 
(a)
(b)
(c)
(d)
ppm
Stellenbosch University  http://scholar.sun.ac.za
Chapter 1 – Literature Review 
19 
 
similar to the Fe(III)PPIX dimer observed in malaria pigment, however unlike β-haematin 
in which dimers hydrogen bond to one another through their free propionic acid groups, 
the free propionic acid side chains of the mesohaematin anhydride dimer are hydrogen 
bonded to solvent dimethyl sulfoxide (DMSO) molecules. (Figure 1.17 (a)).
47
 The authors 
subsequently investigated the interaction between chloroquine (CQ) and deuterohaematin 
anhydride (where the vinyl groups are substituted for hydrogen atoms) in solution (DCM) 
using UV-visible spectroscopy. Following the addition of up to 37 equivalents of CQ, only 
very small shifts in the soret band (1-2 nm) were observed, with no change in the Q band 
region, (Figure 1.17 (b)). The authors suggested that the UV spectrum shows direct 
evidence for noncovalent interactions between CQ and deuterohaematin anhydride, since 
there are no changes in the Q bands.
48
 Furthermore they reasoned that there is minimal 
self-aggregation at low concentration of deuterohaematin anhydride due to no broadening 
observed in the Soret band. They also state that π-π complex formation between CQ and 
deuterohaematin anhydride would be expected to lead to hypochromism in the Soret 
band.
49
 
 
Figure 1.17 (a) The mesohaematin anhydride dimer, showing the hydrogen bond between the free 
propionic acid side chain of the porphyrin dimer, O37, and the DMSO solvent molecule O(45).   
(b) The UV-visible spectrum of CQ and deuterohaematin anhydride in solution (DCM) shows the 
changes observed on addition of CQ (up to 37 equivalents) in DCM to deuterohaematin anhydride. 
Reproduced from reference.
47
 
 
EXAFS spectroscopy was used to compare the similarities between haemozoin and the 
newly synthesised synthetic analogues, namely mesohaematin- and deuterohaematin 
anhydrides.
37
 Using crystallographic powder diffraction data for mesohaematin anhydride 
and β-haematin, scattering properties  ( )  and  ( )  could be calculated as a starting 
(a) (b)
Q bands
Soret
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model for the EXAFS analysis to model the structure around the Fe atom of these 
structures. Following careful analysis of the experimental EXAFS spectra of haematin, β-
haematin, mesohaematin anhydride and deuterohaematin anhydride, and the refined 
EXAFS parameters, the authors concluded that there was a greater similarity between the 
synthetic anhydrides and β-haematin compared to haematin (Figure 1.18). 
 
Figure 1.18 The experimental EXAFS spectra of (1) haematin, (2) β-haematin (haematin 
anhydride) and (3) deuterohaematin anhydride compared to the EXAFS spectrum of mesohaematin 
anhydride (solid line) in each case. Reproduced from reference.
37
 
 
This study also showed that it is possible to distinguish between the dimer in β-haematin 
(µ-propionato) and the monomer conformation of haematin using EXAFS. 
In a subsequent study, EXAFS spectroscopy was again used to study the iron environment 
of mesohaematin anhydride dissolved in DMSO. Using the mesohaematin anhydride 
PXRD structure as a starting model for the analysis, the study showed that in the presence 
or absence of freebase CQ, the dimer character of the mesohaematin anhydride persists in 
the aprotic solvent system (Figure 1.19).
50
 This conclusion was reached based on the fact 
that the oxygen coordinating to the Fe centre remained in position within structural 
disorder parameters in the different environments. Interestingly, EXAFS analysis of CQ in 
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the presence of the dissolution of mesohaematin anhydride showed a strong influence at a 
distance of 2.5 and 3.8 Å from the absorbing Fe (Figure 1.19, green circles). Based on the 
EXAFS refinement, the authors proposed that a CQ-ferrimesoporphyrin IX complex may 
be present, however, none of the atoms form ionic or covalent bonds to the central Fe(III) 
atom. 
 
Figure 1.19 The experimental EXAFS spectra of mesohaematin anhydride microcrystalline 
powder phase (solid line), mesohaematin anhydride dissolved in DMSO (MDDMSO, open circles) 
and mesohaematin anhydride and free base CQ dissolved in DMSO (MDDMSOQ, black squares). 
The additional features in the EXAFS spectrum of MDDMSOQ due to the CQ are circled in green. 
Reproduced from reference.
50
 
 
In a related study, changing the solvent conditions from aprotic (DMSO) to protic (acetic 
acid) in the absence or presence of water, and with or without the addition of free base CQ, 
was investigated. The EXAFS spectra indicate disruption of the µ-propionate dimer, 
resulting in the propionate groups dissociating from the iron centre.
51
 When comparing the 
Fourier transformed spectra of crystalline mesohaematin anhydride to mesohaematin 
anhydride dissolved in acetic acid and water (15:1 v/v, MDAA15), there is a narrowing and 
shift in the first peak (at 1.5-2.5 Å) and a reduction in the amplitude and change in the 
shape of the second peak (at 2.7-3.8 Å), Figure 1.20 (1). Similar changes are observed in 
the remainder of the spectra for mesohaematin anhydride in the presence or absence of free 
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base CQ, shown in Figure 1.20. Between the distances from 2.85 to 3.75 Å, oxygen and 
carbon atoms were detected, most probably from the acetic acid. The different results 
obtained from these related studies emphasise that the solution conditions may 
significantly influence Fe(III)PPIX speciation. 
 
Figure 1.20 Experimental EXAFS spectra of mesohaematin anhydride dissolved in acetic acid, 
MDAA. The inclusion of CQ in a solution is indicated by a Q in the species key, while the 
inclusion of water is indicated numerically, the percentage ranging from 15-30 % (v/v). (1) EXAFS 
spectra of mesohaematin anhydride microcrystalline powder phase (solid line) and compared to 
MDAAQ30. (2) EXAFS spectrum of MDAA compared to that of MDAAQ. (3) EXAFS spectrum 
of MDAA30 compared to that of MDAAQ30. (4) EXAFS spectrum of MDAA15 compared to that 
of MDAAQ15. Reproduced from reference.
51
 
  
(1)
(2)
(3)
(4)
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1.5.2 Haemozoin Formation In Vivo 
 
It is suspected that haemozoin is formed via biocrystallisation, a process in which living 
organisms form crystalline materials from organic macromolecules.
52
 While not 
completely understood, the formation of haemozoin is a highly efficient manner of 
detoxifying the Fe(III)PPIX released during haemoglobin degradation inside the host’s red 
blood cell, and involves transformation between different Fe(III)PPIX species. 
 
1.5.2.1 The Role of Proteins in Haemozoin Formation 
 
The role that different proteins may play in haemozoin nucleation and formation has been 
studied for some time. Sullivan et al.
53
 put forward the idea that histidine-rich proteins 
(HRP), especially HRP-2 and HRP-3, are capable of catalysing haemozoin formation. 
Papalexis et al.
54
 showed that the concentration of HRP-2 in the parasite’s food vacuole 
(FV) is too low to support catalytic activity. The idea that HRP are required to catalyse 
haemozoin formation was eventually dismissed when it was shown that haemozoin crystals 
are still able to form in the absence of HRP-2 and HRP-3.
55
 The involvement of a haem 
detoxification protein (HDP) has been questioned more recently.
56
 This protein was shown 
to be extremely potent in converting haem into haemozoin, and is transported to the FV via 
endocytosis of host cytosol in the same way in which haemoglobin is deliverd to the FV. It 
was hypothesised that HDP can mediate the formation of haemozoin dimers and then 
deliver these dimers to lipid nonospheres where stacking can lead to haemozoin crystal 
growth.
56 
 
1.5.2.2 The Role of Lipids in Haemozoin Formation 
 
When Fitch et al.
57
 investigated purified lipids, they found that arachidonic, linoleic, oleic, 
palmitoleic acids, mono- and di-oleoylglycerol were able to promote β-haematin 
formation. Tri-oleoylglycerol, cholesterol, di-oleoylphosphatidylethanolamin, and both 
stearic and palmitic acids were inactive in promoting β-haematin formation. Based on the 
results the authors suggested that lipids co-precipitate with monomeric Fe(III)PPIX in the 
acidic FV, allowing Fe(III)PPIX to dissolve in the lipid and be converted into haemozoin. 
Recent studies have shown that the formation of haemozoin most likely takes place inside 
neutral lipid bodies. Jackson et al.
58
 first characterised the lipid environment using Nile 
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Red (a fluorescent hydrophobic probe), electron microscopy and spectral imaging confocal 
microscopy. A population of neutral lipids closely associated with the DV of the parasite 
was identified, and analysis of these lipids indicated that these neutral lipid bodies are 
composed predominantly of mono- and di-acylglycerols. Mono-, di- and triacylglycerol 
were subsequently found to promote β-haematin formation.58 In a subsequent review 
published by Coppens and Vielemeyer,
59
 haemozoin crystals were observed within a lipid 
body for the first time (Figure 1.21 (a)). Pisciotta et al.
60
 set out to investigate the role of 
neutral lipid nanospheres in haem crystallisation by P. falciparum, and demonstrated that 
neutral lipid nanospheres present within the digestive vacuole are the most likely in vivo 
site of haemozoin formation (Figure 1.21 (b)). Upon analysis, significant amounts of the 
saturated lipids monostearic glycerol (MSG) and monopalmitic glycerol (MPG) were 
found in association with haemozoin.  
 
Figure 1.21 (a) Within a parasitised red blood cell (RBC), haemozoin crystals are observed in 
association with neutral lipid bodies (LB) inside the digestive vacuole (DV). The arrows indicate a 
close association of haemozoin crystals within the lipid body. N indicates the parasite nucleus. 
Scale bar 0.5 µm. Reproduced from reference.
59
 (b) TEM image of an early trophozoite stage 
during the life cycle of P. falciparum. Haemozoin crystals are surrounded by the neutral lipid 
sphere inside the digestive vacuole of the malaria parasite. The inset shows no sign of a bilayer 
membrane surrounding the lipid. Scale bare 1.0 µm. Reproduced from reference.
60
 
 
Oliveira et al.
61
 have also shown that haemozoin formation occurs inside lipid droplet-like 
particles in both Schistosoma mansoni and Rhodnius prolixus. These two organisms also 
detoxify Fe(III)PPIX in the same manner as the malaria parasite, and TEM images of these 
organisms show haemozoin crystals inside lipid droplets and membrane bound vesicles 
respectively (Figure 1.22). 
(b)(a)
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Figure 1.22 TEM images of haemozoin crystals (C) in (a) S. Mansoni inside lipid droplets (L) and 
(b) R. Prolixus inside membrane-bound vesicles. Inset shows higher magnification with scale bar 
25 nm. Reproduced from reference.
61 
 
More recently an alternatively proposal has been put forward that haemozoin nucleation 
may occur at the DV inner membrane, rather than at the surface of lipid droplets. 
Kapishnikov et al.
62,63
 set out to investigate the location and orientation of haemozoin 
using cryogenic soft X-ray tomography and 3D electron microscopy, to better understand 
the nucleation process involved in haemozoin formation. They proposed that a thin layer of 
lipid is coating the DV membrane from within, possibly serving as the active site for 
haemozoin nucleation, and that crystal growth take place in the aqueous environment in 
the DV. The role that membrane fragments may play in the formation of haemozoin was 
put forward by Hempelmann et al.,
64
 after they showed TEM images of a membrane 
fragment in close association with haemozoin crystals.  
During the parasite’s residency inside host RBCs (Figure 1.23), the formation of 
haemozoin in the parasite’s DV is supposed to take place at various locations, including 
the bulk aqueous phase (1), the bulk lipid phase (2), or at any of the three interfaces: (3) 
aqueous-lipid, (4) lipid-membrane and (5) aqueous-membrane. 
(a) (b)
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Figure 1.23 Schematic indicating the possible location for haemozoin nucleation inside the DV. 1 
– The bulk aqueous phase. 2 – Inside lipid nanospheres. 3 – At the lipid-water interface. 4 – At the 
interface between the DV membrane and lipid phase, and 5 – at the interface between the DV 
membrane and the aqueous phase. Redrawn from reference.
65
 
 
Although there are ongoing efforts to firmly establish where the haemozoin crystals are 
located once formed and what direction crystal growth takes place in, the overall body of 
data emanating from recent studies support the involvement of lipids and strongly suggest 
that crystal nucleation is associated with a lipid-water interface. This cumulative body of 
evidence shifts the intracellular microenvironment of Fe(III)PPIX crystallisation from a 
polar aqueous environment to a non-polar neutral lipid environment. 
 
1.5.3 Formation of Synthethic Haemozoin (β-Haematin) 
 
1.5.3.1 Non-Biological Methods for β-Haematin Synthesis  
 
The process of β-haematin formation can be followed in the laboratory, however, the 
majority of methods used to date have relied on non-biological conditions.
66,67
 Bohle and 
Helms described the synthesis of β-haematin by dehydrohalogenation of haemin, where β-
haematin was formed in 12 hours at 22 
o
C from a solution of haemin (Cl-Fe(III)PPIX) 
dissolved in methanol and 2,6-lutidine under anhydrous conditions.
66
 Slater et al.
30
 
synthesised β-haematin from haematin dissolved in 0.1 M NaOH and precipitated 
Fe(III)PPIX by adding acetic acid; the reaction was run over night at 70 
o
C, and the 
precipitate was washed multiple times with water.  
Red Blood Cell
Parasite
Digestive 
Vacuole
1
5
Lipid
Lipid
Lipid
2
3
4
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Egan et al.
68
 reported a method by which β-haematin was formed in just one hour in 
acetate buffer (4.5 mM), although the procedure still called for elevated temperatures (60 
o
C). The authors went on to study the kinetics of β-haematin formation under these 
conditions and showed that the time dependence could be accounted for by fitting the data 
to the Avrami equation. The Avrami equation (eq. 1.1) describes how solids transform 
from one phase into another at a constant temperature, and it specifically describes the 
kinetics involved in crystallisation processes.
69,70
 
  
  
     
 
 (1.1) 
In the above equation,   is the mass of Fe(III)PPIX remaining at time t compared to the 
initial mass  , z is an empirical rate constant, and n is a constant known as the Avrami 
constant, which is usually an integer ranging between 1 and 4. The best fit of the data to 
the Avrami model was when n = 4 (Figure 1.24).
68
 An Avrami constant equal to 4 
indicates spontaneous nucleation and crystal growth in three dimensions. On the other 
hand, when n = 1, the model assumes random nucleation and that crystal growth takes 
place in one dimension, that is crystal growth is linear. When the constant takes on 
intermediate values 2 or 3, random or instantaneous nucleation occur and crystal growth is 
rod-like or disc-like. The sigmoidal dose response curve was explained on the basis of the 
reaction process (β-haematin formation) taking place in three stages: induction, during 
which β-haematin crystal nucleation takes place, growth/propagation, during which 
Fe(III)PPIX is readily converted to β-haematin and termination, where available 
Fe(III)PPIX is fully converted to β-haematin.71  
  
Stellenbosch University  http://scholar.sun.ac.za
Chapter 1 – Literature Review 
28 
 
 
Figure 1.24 β-haematin formation in 4.5 M acetate buffer (60 oC) monitored by IR spectroscopy. 
The best fit through the experimental data (●) was attained when n = 4 (─) in the Avrami equation. 
The other lines are the best fit to the data when n = 1 (– ∙ –), 2 (– –) and 3 (∙∙∙∙) respectively in the 
Avrami equation. When the value of n is 4, this indicates spontaneous nucleation and three 
dimensional crystal growth. Reproduced from reference.
68
 
 
In 2006, Egan and Tshivhase
72
 described a method of β-haematin synthesis in 0.05 M 
benzoic acid (pH 4.5, 60 
o
C). This method was more active in promoting β-haematin 
formation with the reaction completed within 100 minutes, compared to acetic acid, which 
at the same temperature, but at a concentration of 2.0 M would take up to 4 h to reach 
completion.
68
 The kinetic data from this study was also fitted to the Avrami equation with 
n = 4, indicating that β-haematin formation involved sporadic nucleation and growth in 
three dimensions. It was proposed that the role of the carboxylic acid in mediating β-
haematin formation was to disrupt the hydrogen bonding network between the propionate 
groups, the axial water molecule ligated to the Fe(III) centre of Fe(III)PPIX, as well as 
solvent water molecules, assisting the reorganisation of new hydrogen bonds which would 
facilitate β-haematin formation. The greater activity of benzoic acid compared to acetic 
acid was explained on the basis of the ability of benzoic acid to form π-π interactions with 
haematin as a result of the benzene ring. It was suggested that these π-π interactions disrupt 
the π-stacking between porphyrins, therefore promoting the rearrangement of the haematin 
aggregate to form β-haematin.72 
  
n = 1
n = 4
n = 2
n = 3
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1.5.3.2 Lipid-Mediated β-Haematin Formation 
 
Given the close association of lipids with haemozoin in vivo, Egan et al.
73
 set out to 
investigate the role played by lipids in the formation of β-haematin. Their results showed 
that β-haematin forms rapidly under biomimetic conditions (pH 4.8, 37 oC) near 
octanol/water, pentanol/water and lipid/water interfaces. The half life of 5.3 min observed 
in the kinetics of β-haematin formation brought about at the monoglyceride lipid MMG-
water interface demonstrated that the lipid-water interface may play an important role 
during Fe(III)PPIX crystallisation, Figure 1.25.
73
 Notably, the observed kinetic profile 
differs from the sigmoidal profile observed in acetate, however, the data were not analysed 
according to the Avrami model. 
 
Figure 1.25 The kinetics of β-haematin formation brought about at the monoglyceride lipid MMG-
water interface. The data were fitted to a first–order equation with k = 0.13 ± 0.02 min-1, 
corresponding to a half-life of 5.3 min. Reproduced from reference.
73 
 
Studying the abilities of different lipids, including monoglycerides (rac-1-
monopalmitoylglycerol (MPG), rac-1-monostearoylglycerol (MSG) and rac-1-
monooleoylglycerol (MOG)); diglycerides (1,3-dioleoylglycerol (DOG), 1,3-
dipalmitoylglycerol (DPG) and 1,3-dilinoleoylglycerol (DLG)), triglycerides 
(trioleoylglycerol (TOG) and trimyristoylglycerol (TMG)) and cholesterol (CHL), to 
promote β-haematin formation under biologically relevant conditions (37 oC, pH 4.8), 
Hoang et al.
74
 showed that on average, the mono-acyl glycerols are 60-80% efficient in 
their conversion (Figure 1.26 (a)). Furthermore, they found that the rate at which β-
haematin formation occurs in this lipid-water interface system is physiologically relevant 
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and is able to account for haemozoin formation in vivo,
74
 with kinetic studies performed 
showing biologically relevant half-life values in the order of minutes for the formation of 
β-haematin. Using the lipid-water interface model system, they performed studies on the 
rate of β-haematin formation under biomimetic conditions. The reaction was shown to be 
complete within five minutes, with a significant amount of β-haematin formed in less than 
one min (Figure 1.26 (b)). 
 
Figure 1.26 (a) The efficiency of different lipids, monoglycerides MPG, MSG and MOG; 
diglycerides DOG, DPG, DLG, triglycerides TOG and TMG and cholesterol (CHL), in promoting 
the formation of β-haematin. The percentage yield of β-haematin formation was compared after 60 
minutes incubation time. The mono- and diglycerides show similar yields, while less product is 
formed using triglycerides. The control reaction in which Fe(III)PPIX was incubated in aqueous 
medium alone shows no yield. (b) The % β-haematin formed depending on the surface area of the 
vessel used during the reaction, demonstrates that the reaction is complete in less than 5 minutes. 
Reproduced from reference.
74
 
 
TEM and fluorescence imaging data of samples recovered from just beneath the interface 
indicate that lipids spontaneously organise into a lipid emulsion. Following 10 minutes of 
incubation, Fe(III)PPIX can be seen localised near the lipid-water interface. The presence 
of β-haematin crystals was confirmed by infrared spectroscopy and powder X-ray 
diffraction. TEM imaging of Fe(III)PPIX-lipid samples (using both MPG and MSG) 
indicates that β-haematin forms at the interface (Figure 1.27), in keeping with observations 
of haemozoin crystals in vivo. 
(a) (b)
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Figure 1.27 TEM images of β-haematin formed between the MPG-water (A-C) and MSG-water 
(D-F) interface. Samples were analysed following 10 min of incubation. In both cases β-haematin 
crystals were observed along the lipid-water interface (A and D) with clusters of β-haematin 
crystals oriented parallel to each other at the interface (B, C, E and F). Reproduced from 
reference.
74
 
 
More recently, Ketchum et al.
65
 investigated the crystallisation of β-haematin from 
aqueous buffer (pH 4.8) and water-saturated octanol to mimic the environment of the lipid 
nanosphere. Based on the observed crystal morphologies from the aqueous and water-
saturated octanol environments respectively (Figure 1.28), only the morphology of the β-
haematin crystals grown at the water-saturated octanol interface resembles the morphology 
of haemozoin crystals as they are formed in vivo. They also showed that haematin 
solubility in the pure aqueous solution (pH 4.8) is almost four times lower than at the 
water-saturated octanol interface, suggesting therefore that crystallisation from the water-
saturated octanol interface would be faster.  
 
C
A B
D E
F
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Figure 1.28 β-haematin crystal morphology. (a) AFM image of the crystalline material grown from 
aqueous solution at pH = 4.8 in 0.1 M acetate buffer. (b) SEM image of a cluster of crystals grown 
at the interface of aqueous citrate buffer (pH 4.8) and water-saturated octanol. The morphology of 
the crystals obtained from the aqueous solution is distinctly different to haemozoin crystal 
extracted from malaria-infected red blood cells. Reproduced from reference.
65
 
 
Huy et al.
75
 recently investigated the association of phospholipid with synthetic haemozoin 
(β-haematin), since the lipid membrane of the digestive vacuole has recently been 
implicated in haemozoin formation in vivo.
60
 β-haematin crystals grown from haem 
solutions incubated with phospholipid in an acetate buffer (pH 4.8) were investigated by 
cryo-TEM, and indeed showed evidence of being surrounded by a lipid membrane (Figure 
1.29). 
 
Figure 1.29 β-Haematin crystals grown from haem (Fe(III)PPIX) incubated with phospholipid in 
an acetate buffer (pH 4.8). The arrows indicate the monolayers of phospholipids that surround the 
β-haematin crystals. Reproduced from reference.75 
(a) (b)
100 nm
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1.5.3.3 Detergent-Mediated Formation of β-Haematin 
 
Owing to cost considerations, detergents have been investigated as substitutes for the lipid 
environment in which both haemozoin and β-haematin formation takes place. In 1999 
Fitch et al.
57
 showed that detergents such at Tween 80, n-octyl-glucopyranoside and 
sodium dodecyl sulfate (SDS) were active in promoting β-haematin formation, presumably 
by helping dissolve monomeric Fe(III)PPIX. Recently, the detergent nonyl 
phenoxypolyethoxylethanol (NP-40) has been found to be a good candidate to develop an 
assay to search for new inhibitors of β-haematin formation.76 Most recently, Sandlin et 
al.
77
 have made use of this lipophilic detergent NP-40 based assay to promote β-haematin 
formation as part of a screen to identify inhibitors of β-haematin formation.  
 
1.5.4 Theoretical Investigations of Haemozoin Formation 
 
1.5.4.1 Fe(III)PPIX in Aqueous Solution 
 
The varied speciation of Fe(III)PPIX in solution has made it difficult to rationalise which 
species is more relevant in haemozoin formation and which species is more relevant to 
drug action. Therefore, due consideration of this complexity is required before undertaking 
any investigation. On the basis of the IR spectrum of the green material precipitated from 
aqueous solution under basic conditions, Brown et al.
78
 put forward the idea that 
Fe(III)PPIX exists in aqueous solution as a µ-oxo dimer (whereby the iron centres are 
linked via an oxo (Fe–O–Fe) bridge). Having been widely accepted in the literature for 
more than 30 years, this idea was recently overturned. A model of aqueous Fe(III)PPIX 
whereby molecules interact through π-π or stacking interactions, more specifically via non 
covalent interaction of the unligated faces to form a π-π dimer with the axial ligands 
pointing outwards, was proposed.
79
 This conclusion was based on the UV-visible spectrum 
of aqueous Fe(III)PPIX, showing the typically broad and weak Soret band, which has been 
attributed to dimerisation. These observations were not consistent with the spectrum of the 
µ-oxo dimer, induced in 0.1 M NaOH containing 10% (v/v) pyridine (Figure 1.30).
80
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Figure 1.30 The speciation of Fe(III)PPIX in solution. (a) The UV-visible spectrum of 7 µM 
Fe(III)PPIX in aqueous solution at pH 6.029 (solid line) and at pH 9.669 (dotted line). The weak 
and broad Soret band has been attributed to dimerisation and does not reflect the characteristics of 
the µ-oxo dimer species. (b) The UV-visible spectrum of the µ-oxo dimer of Fe(III)PPIX, induced 
in 0.1 M NaOH containing 10% (v/v) pyridine. Reproduced from reference.
79 
 
The 
1
H NMR spectrum of aqueous Fe(III)PPIX was shown to be characteristic of a five-
coordinate, high-spin Fe(III)PPIX species, with broad peaks as far downfield as 50-60 ppm 
due to the paramagnetic iron centre. It is quite dissimilar to that of either the six-coordinate 
species formed spontaneously in DMSO or the µ-oxo dimer (Figure 1.31). Due to 
antiferromagnetic coupling via the oxo-bridge, the 
1
H NMR spectrum of the latter species 
falls within the normal 0-10 ppm range. Magnetic susceptibility measurements indicated 
that there is no antiferromagnetic coupling in the aqueous (π-π) dimer, with an average 
magnetic moment, µ, per Fe(III) centre of 4.21 compared to 1.04 for the µ-oxo dimer. 
(a) (b)
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Figure 1.31 (a) The 
1
H NMR spectrum of aqueous Fe(III)PPIX. The peaks were assigned based on 
the design by Budd et al:
81
 i methyl groups, ii vinyl α-CH and α-CH2 and iii cis and trans vinyl β-
CH2 and propionyl β-CH2 peaks. (b) The 
1
H NMR spectrum of µ-oxo dimer of Fe(III)PPIX, 
induced in 10% (v/v) aqueous pyridine-d6 in 0.1 M NaOD/D2O. Peaks are assigned as i propionyl 
α-CH2, ii methyl groups and iii propionyl β-CH2. (c) The 
1
H NMR spectrum of Fe(III)PPIX in 
DMSO-d6. Peaks are assigned as i methyl groups, ii vinyl α-CH, iii porphyrin meso H, iv propionic 
acid COOH group, v propionyl β-CH2 and vi cis and trans vinyl β-CH2. Asterisks indicate solvent 
signals. Reproduced from reference.
79 
 
The proposed π-π dimer structure was supported by X-ray crystal structures of haemin (Cl-
Fe(III)PPIX)
82
 and aqua-iron(III)octaethylporphyrin perchlorate [Fe(OEP)(H2O)]ClO4,
83
 
(Figure 1.32). 
(a)
(b) (c)
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Figure 1.32 A model of the aqueous π-π dimer is supported by the single crystal X-ray structures 
of (a) haemin (Cl-Fe(III)PPIX),
82
 and (b) aqua-iron(III)octaethylporphyrin perchlorate 
[Fe(OEP)(H2O)]ClO4,
83 
viewed from the side (top), and top (bottom) in each case. The structures 
were accessed from the Cambridge structural database,
84
 using reference codes CHEMIN and 
HECZUK respectively, and show significant lateral displacement between the two porphyrin 
molecules relative to one another. 
 
1.5.4.2 Theoretical Modelling of β-Haematin Formation 
 
The new insight into the speciation of aqueous Fe(III)PPIX, namely a π-π dimer, had direct 
implications for understanding the mechanism of haemozoin formation, since haemozoin 
formation from a µ-oxo dimer species, where the propionate coordination sites are 
blocked, is difficult to comprehend. The π-π dimer species provides a rational pathway to 
propose how aqueous Fe(III)PPIX may be incorporated into haemozoin. 
Using molecular dynamics simulations, Egan et al.
73
 provided insight into the mechanism 
by which haemozoin may form, and the role that lipids may play in the process (Figure 
1.33). The authors explain that the competitive hydrogen bonding of the water molecules 
weakens as the hydrophobic Fe(III)PPIX π-π dimer enters the lipid layer. The negatively 
charged propionate group is then attracted to the positively charged Fe(III) centre to form 
the β-haematin precursor (Figure 1.33 (b)). Subsequent bond formation between the Fe(III) 
(a) (b)
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centre and the propionate group, together with the release of the axial water ligands, is all 
that is needed in order for the precursor to convert to the β-haematin (haemozoin) dimer.73  
 
Figure 1.33 Molecular dynamics simulation of the interaction of two H2O-Fe(III)PPIX molecules. 
Solvent water molecules are not shown for clarity. (a) The simulation was started with the 
molecules placed in a back-to-back arrangement (as expected for a π-π dimer), with the propionate 
and propionic acid groups extended from the porphyrin core and far away from each other (i). The 
β-haematin precursor is rapidly formed in vacuo (ii). In a simulated aqueous environment, the β-
haematin precursor very quickly breaks down, and the propionate groups again interact with the 
solvent molecules (iii). Enlarged in (b), the simulation suggests the coordination of the propionate 
groups with the Fe(III) centre and loss of axial H2O ligand that needs to take place in order for the 
precursor dimer to convert over to the β-haematin dimer. Reproduced from reference.73  
 
Hempelmann explained that in order to form the iron-propionate bond under aqueous 
conditions, non-physiological temperatures or ionic strength would be required to grow β-
haematin crystals in vitro.
64
 In the lipid environment, however, the iron-propionate bond is 
likely to be more stable owing to a low water concentration. Furthermore, hydrogen 
(a)
(b)
β-haematin
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bonding between propionic acid side chains is more likely, whereas in aqueous solutions, 
the high concentration of water would have a higher probability of interacting with the 
propionic acid group. 
 
1.5.4.3 Fe(III)PPIX in Non-Aqueous Solution 
 
The π-π dimer species provides a rational pathway to propose how aqueous Fe(III)PPIX 
may be incorporated into haemozoin (Figure 1.34, 1). Molecular dynamics simulations in 
vacuo have shown that as Fe(III)PPIX enters a low dielectric medium such as a lipid 
environment,
73
 it most likely forms an intermolecular precursor to haemozoin (Figure 1.34, 
2) which then converts to the haemozoin dimer by coordination of the propionate groups 
with the Fe(III) and displacement of H2O ligands (Figure 1.34, 3). The haemozoin crystal 
is formed upon hydrogen bonding between these dimers (Figure 1.34, 4).
85
 
 
Figure 1.34 A schematic representation showing the proposed route of haemozoin formation (1-4). 
(1) As the aqueous π-π dimer enters the lipid environment (2) the haemozoin precursor dimer is 
formed. (3) Coordination of the propionate groups with the Fe(III) centre and displacement of H2O 
ligands forms the haemozoin dimer. (4) The haemozoin crystal is formed upon hydrogen bonding 
between these dimers. Redrawn from reference.
85
 
 
In a recent publication by Asher et al.,
86
 the speciation of Fe(III)PPIX in aqueous and 
mixed aqueous solutions was investigated. In different solvent environments, and 
depending on temperature, concentration, pH, the presence of salts and the solvent used, 
Fe(III)PPIX was shown to exist as a monomer, π-π dimer, µ-oxo dimer or π-stacked 
aggregate of µ-oxo dimers (Figure 1.35). It was also shown that conversion between the µ-
oxo dimer and π-π dimer is fully reversible in mixed aqueous solution. A 10-fold dilution 
=  Fe(III)PPIX= H2O
H2O Lipid
π-πDimer Haemozoin precursor 
dimer
Haemozoin dimer Haemozoin
+
+ -
-
+
+- -
1. 2. 3. 4.
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of a 3 × 10
-4
 M solution of the µ-oxo dimer of Fe(III)PPIX in aqueous DMSO (5.64 M, pH 
10) into the same concentration of aqueous methanol gave rise to spectral changes which 
were consistent with the π-π dimer (Figure 1.35 II and III) and visa versa. Furthermore, 
aprotic solvents such as 5.64 M DMSO, acetone, dimethylformamide (DMF), 
tetrahydrofuran (THF) and 2,6 lutidine at pH 10 were shown to promote µ-oxo dimer 
formation while protic solvents such as methanol, ethanol, propanol, ethylene glycol, 
diethylene glycol and formamide, at the same concentration and under the same 
conditions, gave rise to π-π dimer formation. 
 
Figure 1.35 The speciation of Fe(III)PPIX species in aqueous and mixed aqueous solution. The 
following species are shown in equilibrium: (I) monomer, (II) π-π dimer, (III) µ-oxo dimer and 
(IV) larger aggregate of µ-oxo dimers. Redrawn from reference.
86
 
 
Despite the structure of β-haematin (haemozoin) having been determined from powder X-
ray diffraction, the mechanism by which the parasite crystallises Fe(III)PPIX remains 
poorly understood. 
  
Low concentration or 
high % organic solvent
Aqueous or protic solvent mixtures, 
higher concentration, any pH
Aqueous or aprotic solvent mixtures, 
higher concentration, high pH
Aqueous solution with high salt 
concentrations and higher pH
I
IVIII
II
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All these methods for synthesising β-haematin have come a far way in order to improve 
our understanding of haemozoin formation in vitro. The recent studies in particular 
indicate the significant role of lipid involvement in haemozoin formation. The kinetic 
studies performed in lipid-water interface model systems have returned biologically-
relevant half-life values in the order of minutes for the formation of β-haematin.73, 74,87 
Interestingly, the activity of drugs has not been studied in detail in this system; given that 
biologically-relevant kinetics of β-haematin formation have been demonstrated, it would 
seem an ideal system to investigate in order to probe Fe(III)PPIX-drug interactions, which 
may aid in understanding the antimalarial mechanism of action. 
 
  
Stellenbosch University  http://scholar.sun.ac.za
Chapter 1 – Literature Review 
41 
 
1.6 Quinoline Antimalarial Drugs 
 
1.6.1 History of Discovery  
 
Extracted from the bark of the South American Cinchona tree, quinine was the first 
antimalarial drug used in western medicine and has since been in use for more than 300 
years.
1
 Quinine and related quinoline antimalarial drugs (Figure 1.36) have been the most 
successful class of antimalarial drugs to date.  
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Figure 1.36 Molecular structures of a selection of important quinoline (CQ, AQ, QN, QD and MQ) 
and phenanthrene (Hf) antimalarial drugs. 
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1.6.1.1 Quinoline Methanol Antimalarial Drugs 
 
Medicinal properties of the Chinchona bark date back to the 1560s. The Cinchona 
alkaloids (Figure 1.37 (a)) are a group of naturally occurring quinoline methanol 
stereoisomers. Quinine (QN, 8S, 9R) and quinidine (QD 8R, 9S) are active antimalarials 
with a erythro orientation (diastereomers with identical substituents on the same side), 
while 9-epiquinine (EQN, 8S, 9S) and 9-epiquinidine (EQD, 8R, 9R) are inactive with a 
threo orientation (diastereomers with identical substituents on opposite sides).
88
 This 
difference in activity between the alkaloids is also reflected in their abilities to inhibit the 
formation of β-haematin (Figure 1.37 (b)).89,90  
 
Figure 1.37 The Cinchona alkaloids. (a) Molecular structures of the Cinchona alkaloids quinine 
(QN, 8S, 9R), quinidine (QD, 8R, 9S), 9-epiquinine (EQN, 8S, 9S) and 9-epiquinidine (EQD, 8R, 
9R). (b) Table of relative strengths of association in solution (Log K),
91,92
 biological activity (IC50) 
values against the CQ-sensitive strain (D-6),
88
 and β-haematin inhibitory activity (BHIA).89 
 
Compounds shown to inhibit β-haematin formation are able to form association complexes 
in solution,
90,92-94
 however, not all compounds that form complexes with Fe(III)PPIX in 
solution are able to inhibit β-haematin formation.95,96 As shown in Figure 1.37 (b), all the 
Cinchona alkaloids have comparable association constants, but when comparing the IC50 
and β-haematin inhibitory activity (BHIA) values, it is apparent that only QN and QD are 
active antimalarials and are able to inhibit β-haematin formation effectively. 
Mefloquine (MQ), a synthetic analogue of QN, was synthesised in the 1970’s and sold 
under the trade name Lariam. The drug had a promising future, due to it having a longer 
half-life and being safe to use during pregnancy.
97
 However, MQ is now known for its 
neuropsychiatric side effects, and resistance to this drug has limited its accessibility. 
Today, MQ is most commonly prescribed in combination with artesunate, an example of 
Log Kassociation IC50 (nM) BHIA/%
QN 4.10 29.3 84  1
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an artemisinin-based combination therapy (ACT), and is recommended by the World 
Health Organisation for the treatment of malaria in areas of low transmission.
2,98
 
 
1.6.1.2 4-Aminoquinoline Antimalarial Drugs 
 
Chloroquine (Resochin), a synthetic analogue of the oldest known antimalarial quinine, has 
been the drug of choice since its development towards the end of World War II.
1
 The 
development of CQ was motivated due to the high demand for QN which could not be met 
during World War II owing to the Japanese invasion of Java where Cinchona plantations 
which supplied 90% of the world’s demand were located. CQ is considered the most 
successful antimalarial drug to date as a result of its relatively low toxicity, its ability to be 
used during pregnancy, and its affordability. However, with widespread chloroquine-
resistant P. falciparum, novel antimalarial drugs are urgently needed as replacements for 
this and other mainstay chemotherapeutics.
3,99
 Amodiaquine (AQ), similar to chloroquine 
was used since the 1970’s and is still in use today for treatment of uncomplicated malaria.2 
 
1.6.2 Site of Action  
 
As mentioned before, the parasite is vulnerable to drug action at several points during its 
residency inside host RBCs.
22
 Currently it is known that CQ and other quinoline 
anitmalarial drugs are active against the growing (trophozoite) stage of the parasite life 
cycle during which haemoglobin is actively digested.
100
 Yayon et al.
101
 demonstrated using 
fluoromicroscopic examination that antimalarial drugs accumulate in malaria infected 
erythrocytes. This site of action is further supported by the fact that CQ-resistant (CQR) 
strains show a decrease in CQ accumulation compared to CQ-sensitive (CQS) parasite.
102
  
The quinoline antimalarial drugs are diprotic weak bases.
103
 They find their way into the 
FV by a mechanism known as pH trapping.
55
 In the form of a neutral weak base, CQ is 
able to cross membranes and enter into the FV. In the acidic environment of the FV 
however, the drug becomes protonated and therefore membrane-impermeable, leading to a 
20 000 fold higher concentration inside the FV compared to the outside, based on the 
Henderson-Hasselbach equation.
104
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During the parasite’s residency inside host RBCs, the parasite is vulnerable at various 
points to drug action, however interruption of haemoglobin degradation or Fe(III)PPPIX 
detoxification, have been widely considered.
22
 
 
1.6.3 Resistance to Quinoline Antimalarial Drugs 
 
Antimalarial drug resistance has been defined as the “ability of a parasite strain to survive 
and/or multiply despite the administration and absorption of drugs given in doses equal to 
or higher than those usually recommended but in tolerance of the subject”.105 Since the 
appearance of drug resistance to historically successful antimalarials, research has focused 
on the development of new and effective antimalarials.
106
  
Chloroquine, a diprotic weak base with two proton-binding groups, the quinoline nitrogen 
atom (pKa1 = 8.1) and the side chain terminal amine (pKa2 = 10.2), can be driven by the pH 
gradient across the parasite’s food vacuole membranes in its unprotonated form, to 
accumulate in the acidic food vacuole (FV). Resistance occurs due to an overall reduced 
uptake of the drug, most probably as a result of efflux out of the FV.
107
 Krogstad and co-
workers have shown that CQR parasites release CQ 40- to 50-fold faster than CQS 
parasites,
107
 which leads to lower accumulation of CQ in the FV, such that the 
concentration is no longer sufficient to inhibit Fe(III)PPIX crystallisation. Since the pH of 
the FV shows no significant difference between CQS and CQR parasites,
18
 the rapid efflux 
of CQ out of the FV of CQR parasites suggests that they have an elevated permeation 
pathway for CQ across the FV membrane. 
It has been established that CQ resistance is associated with mutation in the pfcrt gene on 
chromosome 7, which encodes the P. falciparum CQ-resistance transporter (PfCRT). 
PfCRT is a 424-amino acid transmembrane protein on the surface of the food vacuole, and 
a mutation at position 76 in the amino acid sequence of this protein (K76T), in which the 
neutral, hydrophilic threonine α-amino acid (T) replace the positively charge lysine α-
amino acid (K), is associated with the resistant strain.
108
 A second food vacuole transporter 
protein associated with drug resistance, namely P. falciparum multidrug resistance gene 1 
(Pfmdr1), is located on chromosome 5 and encodes P-glycoprotein homologue (Pgh1).
109
 
An over-expression of Pgh1 is associated with resistance to QN, MQ and Hf.
110
 QN 
resistance is also connected to P. falciparum sodium proton exchanger (pfnhe-1),
111
 
however the mechanism for QN resistance is not altogether clear. 
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To date the mechanism by which mutated PfCRT brings about CQ resistance has not been 
solved. Two schools of thought exist, however, the first being that PfCRT can act as a 
channel (enabling protonated CQ to flow out of the FV via an electrochemical gradient). 
An alternative explanation is that PfCRT can act as a transporter (where CQ are displaced 
out of the FV via an active efflux transporter) of CQ.
104
 In both of these mechanisms, the 
accumulation of CQ in the food vacuole is reduced below the amount needed for inhibition 
of haemozoin formation.  
Since resistance to quinoline antimalarials does not appear to influence the formation of 
haemozoin, and since this crucial survival process is not under the genetic control of the 
parasite, haemozoin still remains a valid drug target. Furthermore, there is no equivalent 
process in the human host. Thus understanding the process of haemozoin formation, as 
well as the mechanism of action at the molecular level of the antimalarial drugs which 
have been and remain clinically relevant today, are important research foci if we intend to 
develop novel antimalarial haemozoin inhibitors. 
 
1.6.4 Mechanisms of Action of Quinoline Antimalarial Drugs 
 
The quinoline antimalarial drugs CQ, AQ, QN, QD and MQ are known to inhibit the 
formation of β-haematin under different conditions.53,90,93,112,113 With knowledge of the 
crystal morphology of β-haematin, the possible role played by antimalarials in inhibiting 
crystal nucleation and crystal growth could be addressed. To date, the lack of any crystal 
structures of either Fe(III)PPIX or haemozoin/β-haematin complexed to a quinoline 
antimalarial has meant that Fe(III)PPIX-drug interactions have only been studied through 
the use of spectroscopic methods and computational analyses. 
 
1.6.4.1 Haemozoin Crystal Capping 
 
Regarding the inhibition of β-haematin formation, it has been hypothesised that drug 
compounds adhere directly to the growing surface of β-haematin crystals, thus preventing 
further crystal growth.
35,40,114
 At the time when haemozoin was still believed to be a 
polymer, Sullivan et al.
114,115
 suggested that Fe(III)PPIX-quinoline complexes were 
directly responsible for termination. By capping onto the growing polymer at its elongated 
site, the Fe(III)PPIX-drug complex would inhibit further polymer growth (Figure 1.38). 
Stellenbosch University  http://scholar.sun.ac.za
Chapter 1 – Literature Review 
46 
 
 
Figure 1.38 Proposed model for quinoline inhibition of haemozoin formation. The Fe(III)PPIX-
drug complex at the end of the elongation site of the growing polymer prevents further addition of 
Fe(III)PPIX. Reproduced from reference.
114 
 
In a later study, and first having identified the fastest growing (001) crystal face, Buller et 
al.
40
 used computational approaches to show that quinoline antimalarial drugs are able to 
bind remarkably well into crevices created at this face, being stabilised by exposed 
functional groups of Fe(III)PPIX (Figure 1.39 (a)), which include the propionic acid, 
methyl and vinyl groups, as well as aromatic surfaces which run parallel to the a-axis. In 
the case of CQ (monoprotonated) bound to the (001) face of the β-haematin crystal, the 
energetically-favourable hydrogen bonding interactions include (1) Ndrug···HC=Cporphyrin 
2.4 Å, (2) Cldrug···H3Cporphyrin 3.0 Å, (3) NHdrug···O2porphyrin 2.7 Å and (4) 
NHdrug···C=Cporphyrin 2.7 Å (Figure 1.39 (b)). Due to the exocyclic amine chain of CQ 
being longer and more flexibile compared to the quinuclidine side chain of QN, it was 
reasoned that this allows for a stronger intercalation of the quinoline, such that CQ is more 
tightly bound within the crevices. Interestingly, the authors were able to demonstrate a 
correlation between the antimalarial activity of various quinolines and their theoretical 
binding characteristics to the (001) face of β-haematin. However, they were not able to 
support their results by experiment. It is important to point out that CQ, AQ, QN and MQ 
were only shown to be able to cap onto the (001) surface of β-haematin when only the 
nonprimary exocyclic amine is protonated. The authors reasoned that if CQ was also 
protonated at the aromatic nitrogen atom, the drug would not be able to dock effectively 
into the crevice. This is interesting since the drug is expected to be doubly protonated in 
the FV.  
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Figure 1.39 β-haematin crystal capping. (a) β-haematin, viewed along the a-axis, showing exposed 
propionic acid, methyl and vinyl groups as well as aromatic surfaces at the (001) side face, with the 
available crevices outlined in green. (b) Chloroquine bound to the (001) face of the β-haematin 
crystal, highlighting the energetically favourable hydrogen bonding interactions: (1) 
Ndrug···HC=Cporphyrin 2.4 Å, (2) Cldrug···H3Cporphyrin 3.0 Å, (3) NHdrug···O2porphyrin 2.7 Å and (4) 
NHdrug···C=Cporphyrin 2.7 Å. Also shown is the intercalation of the quinoline rings in between the 
surface of the aromatic groups of β-haematin. Reproduced from reference.40 
 
1.6.4.2 Fe(III)PPIX-Drug Complexes in Solution 
 
An alternative hypothesis is that drug compounds form complexes with free Fe(III)PPIX in 
the aqueous medium of the FV, either through π-stacking or coordination, therefore 
preventing its incorporation into β-haematin.116,117,118 As mentioned before, with the ability 
of Fe(III)PPIX to exist as a precursor in the form of monomer, π-π dimer, µ-oxo dimer or 
even the cyclic dimer required for formation of haemozoin, there are multiple Fe(III)PPIX-
drug interactions which could be of relevance in antimalarial drug activity, and 
investigating these would be valuable in furthering our understanding of the mode of 
action of quinoline antimalarials. 
Using NMR inversion recovery experiments, and exploiting the paramagnetic influence of 
the Fe centre on drug proton resonances to map the geometries of Fe(III)PPIX-drug 
complexes, Leed et al.
119
 showed that depending on the protonation state of the drug, 
(a) (b)
1
2
3
4
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significant differences are observed for the Fe – H distances. Using these distances as 
constraints in molecular modelling, it was shown that CQ, QN and QD form non-covalent 
complexes in solution, irrespective of whether they are neutral, mono- or diprotonated. At 
the time, the µ-oxo dimer form of Fe(III)PPIX was considered to be present under aqueous 
conditions, and thus was modelled in the calculated structures. Interestingly, there is no 
evidence of QN or QD complexing directly with Fe(III)PPIX in the predicted structures. In 
the case of CQ, π-π interactions between the aromatic rings of the drug and the tetrapyrrole 
region of Fe(III)PPIX played an important role in stabilising the CQ-Fe(III)PPIX complex. 
In subsequent NMR experiments, de Dios et al.
120
 proposed that CQ forms a covalent 
complex with monomeric Fe(III)PPIX in the solid state via coordination between the Fe 
centre of Fe(III)PPIX and the quinolinyl N atom of the drug. Using a similar method, AQ 
has also been shown to form π-π complex with the µ-oxo dimer form of Fe(III)PPIX, with 
the complex being significantly stabilised by the aromatic side chains of AQ.
121
 The 
stoichiometry for the CQ, QN, QD and the AQ complex was determined to be 1:2 
drug:Fe(III)PPIX. 
By re-examining the nature of Fe(III)PPIX in aqueous solution, Casabianca et al.
122,123
 
have shown that the way in which CQ interacts with Fe(III)PPIX monomer–µ-oxo dimer 
equilibrium is quite distinct from that of QN. Their data suggests that CQ is more likely to 
promote µ-oxo dimer formation, indicating a preference to bind to the dimeric form of 
Fe(III)PPIX. On the other hand, QN prefers binding to the monomeric form of 
Fe(III)PPIX. Given that the Fe(III) centre of the µ-oxo dimer is five-coordinate, Behere 
and Goff further suggested the unlikelihood for QN to be able to coordinate to the metal of 
a µ-oxo dimeric Fe(III)PPIX.
48
 In the five-coordinate Fe(III) centres in the µ-oxo dimer 
structure the Fe–O–Fe bonds are stronger than the monomeric five-coordinated 
Fe(III)PPIX species, therefore QN would not be able to coordinate to the metal of the µ-
oxo dimeric Fe(III)PPIX. 
In the 1980’s, Warhurst124 conducted spectrophotometric studies to examine the complexes 
of QN, QD, EQN and MQ with haemin in benzene. The results indicated direct 
coordination of the drug to the Fe centre of Fe(III)PPIX via the nitrogen atom of the 
quinuclidine (QN and QD) and piperidine (MQ) rings. Interestingly, no evidence of 
coordination was observed for the inactive drug EQN. Later on, Behere et al.
48
 showed that 
QN forms a complex with Fe(III)PPIX, facilitated by coordination of the Fe centre to the 
deprotonated benzylic alcohol functional group of the drug in non-aqueous solutions, 
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generating a neutral complex in a low-dielectric medium. The hyperfine-shifted porphyrin 
signals in the 
1
H NMR were distinctive for alkoxide complexes, and the authors reasoned 
that the strong Lewis acid and oxophilic character of the Fe(III) centre promotes alkoxide 
formation. The results indicated a Fe(III)PPIX-drug stoichiometry of 1:1 and no binding of 
QN to the µ-oxo dimer form of Fe(III)PPIX was detected. 
As recently as 2011, Alumasa et al.
125
 studied the biological activity of QN analogues 
lacking various functional groups. The loss of either of the quinuclidine ring or hydroxyl 
functional group was found to almost completely destroy activity, indicating that these 
groups are essential in the inhibition of haemozoin formation. They also investigated the 
QN-Fe(III)PPIX adduct formed under aqueous conditions (pH 6-8.5), where 2 mM haemin 
in 0.1 M NaOH was slowly titrated with increasing volumes of 100 mM QN stock, while 
monitoring the pH. After analysing the adduct by mass spectrometry and fluorescence, as 
well as vibrational and solid-state NMR spectroscopy, they reasoned that the resulting 
adduct consists of QN free base complexed with Fe(III)PPIX (Figure 1.40 (a)). It was 
argued that both propionic acid side chains of Fe(III)PPIX are deprotonated, given the 
absence of a carboxylic acid stretch in the IR spectrum of the material (Figure 1.40 (b)). 
Furthermore, it was proposed that a strong hydrogen bond between the quinuclidyl 
nitrogen and the QN hydroxyl (–OH) proton, is essential in stabilising such a complex. 
 
 
Figure 1.40 (a) The structure of the proposed QN-Fe(III)PPIX adduct. (b) IR spectra of the QN-
Fe(III)PPIX adduct precipitated from aqueous solution (W, dotted line), QN free base (X, dashed 
line), Fe(III)PPIX (Y, continuous line), and QN hydrochloride salt (Z, dash-dot line). The strong 
peak at 1702 cm
-1
 in the spectrum of Fe(III)PPIX represents the carbonyl stretch of the Fe(III)PPIX 
propionic acid groups and is absent in the spectrum of the Fe(III)PPIX-drug adduct, reportedly 
indicating that the Fe(III)PPIX species has two propionate groups. Reproduced from reference.
125
 
(a) (b)
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Making use of IR and Raman spectroscopy, Asghari-Khiavi et al.
126
 provided evidence 
that in the solid state, CQ does not form a complex with the µ-oxo dimer. This was based 
on the presence of the absorption band at 878 cm
-1
 (assigned to the asymmetric stretching 
frequency (νas) Fe–O–Fe in the IR spectra of air dried samples of aqueous haematin and 
the µ-oxo dimer. The results suggest that Fe(III)PPIX samples dried from aqueous solution 
convert to the µ-oxo dimer form, however the basic conditions used in preparing both 
samples may also play a role. Nevertheless, this absorption band was absent in the case of 
CQ-haematin and CQ-µ-oxo dimer mixed samples (Figure 1.41).  
 
Figure 1.41 The ATR-IR spectra of (a) haematin, (b) µ-oxo dimer, (c) CQ-haematin mix and (d) 
CQ-µ-oxo dimer mix. Samples were air dried from aqueous solutions. The absorption band at 878 
cm
-1
 observed in haematin and µ-oxo dimer is dramatically decreased in the spectra of drug-
Fe(III)PPIX complexes. Reproduced from reference.
126
 
 
Based on their Raman spectroscopy results, the band at 397 cm
-1
 in the Raman spectra of 
CQ-haematin mix (Figure 1.42 (c)) was attributed to the formation of an hydrogen bond 
between a propionate group of Fe(III)PPIX and the tertiary amino nitrogen atom of CQ.
126
 
No evidence was found to support the formation of hydrogen bonding between the 
carboxylate group and the quinuclidine (QN) or piperidine (MQ) nitrogen atom of drug 
compounds QN and MQ, since there was no band present at 397 cm
-1
 in the Raman 
spectra.
126 
 
(a)
(b)
(c)
(d)
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Figure 1.42 The Raman spectra of (a) CQ, (b) haematin, (c) CQ-haematin mix, (d) β-haematin and 
(e) crystalline haematin. The band at 397 cm
-1
 was attributed to the vibrational mode of the drug 
which is sensitive to hydrogen bonding around N1 and enhances due to coupling to a strong 
propionate band. 
 
Reproduced from reference.
126
 
 
1.6.4.3 Structure-Activity Studies of 4-Aminoquinolines 
 
In order to understand the inhibition activity of drug compounds, the influence of the 
functional groups needs to be appreciated. Egan et al.
95
 proposed a detailed model of the 
structure-function relationships for chloroquine. They showed that the 4-aminoquinoline 
nucleus is efficient for complexing Fe(III)PPIX, but not sufficient for inhibiting haemozoin 
formation. The weakly basic quinoline and terminal amine nitrogen atoms are necessary 
for drug accumulation via pH trapping. Introduction of the 7-chloro group has proven to be 
most effective for the inhibition of haemozoin formation (Figure 1.43). 
(a)
(b)
(c)
(d)
(e)
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Figure 1.43 The proposed structure-activity relationships in 4-aminoquinoline antimalarials 
(chloroquine). Reproduced from reference.
95
 
 
1.6.4.4 The Crystal Structure of Halofantrine-Fe(III)PPIX 
 
The first crystal structure of a complex formed between an antimalarial drug and 
Fe(III)PPIX was only recently published. Using single crystal X-ray diffraction (SCD), the 
structure of the coordination complex formed between halofantrine (Hf) and Fe(III)PPIX 
was determined (Figure 1.44).
85
 Haematin and Hf had been incubated together at a 
monomyristoylglycerol (MMG) – aqueous (citrate, pH 4.8) interface. Following 
centrifugation, the pellet was redissolved in a small volume of a solution containing 
acetone and pyridine. The resultant solution was left to stand at room temperature, and 
crystals were observed after 10 days.
85
 
The 4-aminoquinoline nucleus is 
responsible for complexing 
Fe(III)PPIX
The 7-chloro group is 
required for inhibition of β-
haematin formation
The weak bases are 
required for vacuolar 
accumulation via pH 
trapping
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Figure 1.44 The crystal structure of Hf-Fe(III)PPIX. Thermal ellipsoids are drawn at 50% 
probability. Solvent molecules acetone and water are included. Atom colour labelling: grey ─ C, 
white ─ H, lime green ─ Cl, prussian blue ─ F, cyan ─ Fe, dark blue ─ N and red ─ O. Reproduced 
from reference.
85
 
 
The structure shows that the drug interacts with Fe(III)PPIX as a monomer and not a µ-oxo 
dimer. Furthermore, Hf forms a 5-coordinate complex with Fe(III)PPIX via its 
deprotonated hydroxyl group. The Fe-O bond length (1.840(4) Å) was shown to be in 
agreement with the coordination of an alkoxide (1.816 – 1.867 Å),127,128,129,130 rather than 
an alcohol (2.112 – 2.160 Å).131,132 Intermolecular hydrogen bonding between the 
protonated N atom of Hf and the propionate of Fe(III)PPIX was observed as well as 
hydrogen bonding between the propionic acid and propionate group of adjacent 
Fe(III)PPIX molecules.  
 
1.6.4.5 Rationalising Activities of the Cinchona Alkaloids 
 
In the past, various hypotheses have been put forward in an attempt to relate the structural 
features of the active and inactive Cinchona alkaloids to their observed biological and β-
haematin inhibitory activities. By comparing the crystal structures of QN and QD to those 
of their inactive epimers, EQN and EQD, Karle et al.
88
 showed that the formation of an 
intermolecular hydrogen bond between the hydroxyl and amine groups was possible for all 
four compounds. However, there was a distinct difference in the “torsion angle” in the case 
Water
Acetone
Stellenbosch University  http://scholar.sun.ac.za
Chapter 1 – Literature Review 
54 
 
of QN and QD, compared to EQN and EQD, upon formation of these intermolecular 
hydrogen bonds (Figure 1.45). The N─H and the O─H bonds are positioned 13o relative to 
each other in the QN structure, in comparison to 67
o 
in the case of EQN. The authors 
proposed that these structural differences may account for the difference in antimalarial 
activity profile of the alkaloid compounds. 
 
Figure 1.45 (a) The numbering scheme for EQD adopted by Karle et al. (b) 9-epiquinidine 
hydrochloride monohydrate and (c) quinidine sulfate dihydrate, both viewed down the right angles 
of the HN1–N1–C8–C9–O12–HO12 segment. Reproduced from reference.88 
 
Warhurst et al.
89
 reported that active erythro alkaloids can be transferred into the lipid 
phase with a distribution ratio of 55:1, compared to the decreased ratio of 4.5:1 for the 
inactive threo alkaloids. The authors examined the possible influence of the dipole 
orientation of the protonated quinuclidine nitrogen atom when modelling solvated 
structures of the complexes of QN and EQN with Fe(III)PPIX, and showed that the 
positive electric field of the protonated quinuclidine nitrogen atom in EQN is directed to 
the solvent, therefore increasing solvation, but in the case of QN it is directed towards the 
quinoline ring (Figure 1.46).
89
 They therefore reasoned that the cumulative effect of lipid-
water distribution and Fe(III)PPIX-drug interaction could contribute to the difference in 
antiplasmodial activity of the active and inactive alkaloids.  
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Figure 1.46 The space filling models of (a) quinine (QN) and (b) 9-epiquinine (EQN) complexing 
with Fe(III)PPIX (haematin) respectively. The black arrow indicates the electric field of the 
alkaloid N1-H1, which is towards the quinoline ring in QN and towards solvent in EQN. 
Reproduced from reference.
89 
 
All attempts by de Villiers et al.
85
 to crystallise Fe(III)PPIX in complex with any other 
antimalarial compounds having the benzylic hydroxyl group were unsuccessful. However, 
due to structural resemblances between the Cinchona alkaloids and Hf, they undertook an 
in vacuo molecular mechanics investigation of the complexes of QN, QD, EQN and EQD 
with Fe(III)PPIX.
85
 Their reasoning to do so was supported by comparable changes 
observed in the UV-visible spectra of Fe(III)PPIX following spectrophotometric titration 
with both Hf and QD free bases in acetonitrile.  
In vacuo conditions were chosen as a model of a low dielectric lipid environment in order 
to explore the relationship between the structures of the four alkaloids (QN, QD, EQN and 
EQD), which differ only in their stereochemistry at two centres, and their notable 
differences in antimalarial and β-haematin inhibitory activities.85 Aside from the methyl, 
vinyl and propionate groups on the porphyrin and the methoxy and vinyl groups on the 
alkaloid periphery, only two torsion angles were identified as being significantly flexible, 
namely N2-Fe(III)-O10-C9 (φ) and C4-C9-C8-N1 (ψ), (Figure 1.47). When considering 
rotation about these bonds in the strain free complexes (i.e. when no constraints are put on 
the complexes and they are free to adopt their lowest energy conformation), no significant 
Haematin
QN
Haematin
EQN
(a) (b)
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difference between the four Fe(III)PPIX-drug complexes was observed (Figure 1.48, white 
circles).
85
 
  
Figure 1.47 Model structure of Fe(III)PPIX-alkaloid complex showing the two dihedral angles N2-
Fe(III)-O10-C9 (φ) and C4-C9-C8-N1 (ψ) about which the most free rotation is expected in the 
strain free complexes. Reproduced from reference.
85
 
 
The hydrogen bonds in the Hf-Fe(III)PPIX crystal structure exist between neighbouring 
complexes. However, in the aprotic lipid environment where haemozoin formation is 
thought to occur, this hydrogen bonding potential is more likely to be satisfied by forming 
intramolecular hydrogen bonds. It was concluded that an intramolecular hydrogen bond 
(salt bridge) between the protonated quinuclidine N-atom of the alkaloid and the 
negatively charged Fe(III)PPIX propionate side chain could be formed. A notable effect of 
the intramolecular hydrogen bond within each complex is the reduction in free rotation 
about the Fe(III)―O10 and C9―C8 bonds compared to the strain free complexes. The 
relative strain energy surfaces, generated by rotating ψ and φ relative to one another and 
determining the free energy at each step are shown in Figure 1.48. The position of the 
global energy minimum is indicated with a white circle and the conformation required for 
the salt-bridge formation is indicated with a black circle, for each complex. It is evident 
that the active alkaloids (QN and QD) are able to form the intramolecular hydrogen bond 
relatively easily compared to the inactive epimers. 
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Figure 1.48 The relative strain energy surface for the rotation around the torsion angles φ and ψ for 
(a) QD- , (b) QN- , (c) EQD- and (d) EQN-Fe(III)PPIX. The positions of the global energy 
minimum (white circle) and the conformation required for salt-bridge formation (black circle) are 
indicated for each complex. The low energy furrow observed in the QD-Fe(III)PPIX complex is 
indicated in the red box at the point where ψ is fixed at 210o. Reproduced from reference.85 
 
A feature of the calculated relative strain energy surface for QD-Fe(III)PPIX is the low 
energy furrow at the point that ψ is fixed at   210o (Figure 1.48 (a)). It would seem that 
the barrier to rotation about the Fe(III)-O10 bond is minimal in this region, and that φ 
could therefore adopt any value. A direct correlation was observed between the difference 
in strain energy required for salt bridge formation and the minimum energy obtained from 
the strain-free complex and the biological activity of the four stereoisomers (Figure 1.49). 
(a) (b)
(c) (d)
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Figure 1.49 (a) Modelled complex of Fe(III)PPIX and the Cinchona alkaloid QN. The strain free 
complex is shown on the left together with the conformation induced by the formation of an 
intramolecular salt bridge at the right. (b) Correlation between the biological activity and the strain 
energy required for salt-bridge formation (∆E) are shown for each complex. Reproduced from 
reference.
85
 
 
Based on the theoretical studies, it was proposed that the formation of the haemozoin 
precursor dimer may be inhibited by salt bridge formation, thus accounting for the strong 
activity of the two active isomers QN and QD.
85
 In aqueous medium, Fe(III)PPIX has been 
shown to exist as a π-π dimer in which the unligated faces of the two porphyrins interact 
with each other while the axial ligands are directed outwards.
79
 Both the active and 
inactive Cinchona alkaloids have been shown to associate with Fe(III)PPIX to a similar 
degree in an aqueous environment (Figure 1.50, 1 and 5),
118
 still allowing Fe(III)PPIX to 
exist as a  -  dimer. As the complexes of the inactive isomers enter the lipid environment, 
formation of the haemozoin precursor dimer dominates complex formation (Figure 1.50, 
2), allowing the formation of haemozoin to proceed as normal.
85
 However, when 
complexes of the active isomers enter the lipid environment, it was hypothesised that the 
strong salt bridge formed makes the propionate group unavailable for the formation of the 
haemozoin precursor dimer and subsequently haemozoin formation does not proceed 
(Figure 1.50, 6). According to this model, the Cinchona alkaloids inhibit the formation of 
haemozoin through interaction with monomeric Fe(III)PPIX, which is in agreement with 
the findings of Casabianca et al.
122,123
  
(a) (b)
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QD
EQN
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Figure 1.50 Proposed rationalisation of activity profile of the Cinchona alkaloids. The inactive 
Cinchona alkaloids (EQD and EQN) associate with Fe(III)PPIX in aqueous solution (1), but are not 
able to inhibit haemozoin formation (2, 4) Following association with Fe(III)PPIX in aqueous 
solution (5), the active compounds, QN and QD, are able to form stabilised coordination complexes 
with Fe(III)PPIX (6), which do not allow haemozoin formation to proceed. Redrawn from 
reference.
85
 
 
It was observed that the active alkaloids (QN and QD) were able to form the 
intramolecular hydrogen bonds more easily in comparison to the inactive alkaloids, and 
suggested that MQ and lumefantrine (Lf) could interact with Fe(III)PPIX in a similar 
manner through coordination to the Fe centre of Fe(III)PPIX.
85
 However, the authors were 
unable to demonstrate coordination of any further compound, particularly the quinolines, 
to the Fe centre of Fe(III)PPIX experimentally.  
The three-point binding mode observed theoretically between Fe(III)PPIX and the 
Cinchona alkaloids, namely π-stacking, coordination, and intramolecular hydrogen bond 
formation, could be exploited in the rational design of novel haemozoin inhibitors. 
However, while this model addressed certain questions in the literature, for example the 
disparate activity profiles of the four alkaloids given their very similar association 
constants in aqueous DMSO solutions,
118
 the absence of crystal structure data has limited 
the support for this model. Furthermore, since the only crystal structure of a Fe(III)PPIX-
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drug complex is that of the phenanthrene compound halofantrine,
85
 the pharmacophore for 
quinoline antimalarials is for the most part unknown and the reason for why certain 
compounds inhibit haemozoin formation while others do not still requires explanation. 
Single crystal X-ray diffraction structures of Fe(III)PPIX complexing to quinoline 
antimalarial drugs will aid in the understanding of whether these compounds coordinate to 
the Fe(III) centre of Fe(III)PPIX via the quinoline, quinuclidine or piperidine nitrogen 
atoms or the hydroxyl oxygen atom of the drug. Furthermore, the complexes of active and 
inactive Cinchona alkaloids could help to explain the differences in activity. Obviously 
correct interpretation of Fe(III)PPIX-drug complexes in solution is also critical, since the 
solid state is not representative of the biological environment of the FV. 
 
1.6.4.6 Inhibition of β-Haematin Formation 
 
1.6.4.6.1 Pyridine Hemichrome Inhibition of β-Haematin (Phiβ) Assay 
 
The quest to find a novel antimalarial compound is of wide interest given resistance, and 
two approaches can be followed in order to accomplish this goal.
22
 The first approach is to 
screen libraries of compounds, both natural and combinatorial, for activity against a 
validated drug target. The formation of haemozoin is unique to the parasite and represents 
an attractive drug target for antimalarials,
133
 though this unique crystallisation process still 
remains not fully understood. Nevertheless, compound screening may be of importance in 
the discovery of new antimalarials. Most recently, Sandlin et al.
77
 have made use of a 
lipophilic detergent NP-40 based assay to screen and identify inhibitors of β-haematin 
formation. A second approach, namely rational drug design, relies upon a sound 
understanding of the biological target (haemozoin) as well as the mechanism by which 
drug activity is brought about. In the case of chloroquine (CQ), quinine (QN), quinidine 
(QD), amodiaquine (AQ) and mefloquine (MQ), these aspects have not been unequivocally 
established to date.  
The inhibition of β-haematin formation has been studied using different methods. In 1994, 
Egan et al.
90
 made use of acidic acetate solutions (4.5 M, pH 4.5 at 60 
o
C) to promote the 
formation of β-haematin, and infrared spectroscopy to characterise the products obtained in 
the absence and presence of antimalarial drugs. It was observed  that quinoline antimalarial 
drugs inhibit the spontaneous formation of β-haematin, while inactive compounds such as 
EQN had no effect on the reaction.
90
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The pyridine hemichrome inhibition of β-haematin (Phiβ) assay developed by Ncokazi et 
al. exploits the ability of 5% (v/v) aqueous pyridine pH 7.4 to solubilise free Fe(III)PPIX in 
the presence of β-haematin, resulting in a characteristic orange-pink bis-pyridyl complex in 
solution, which has a distinctive absorbance maximum at 405 nm.
134
 With increasing 
pyridine concentration, the broad and relatively low intensity soret band attributed to the 
aqueous Fe(III)PPIX π-π dimer species exhibits a red shift (transitions are shifted to longer 
wavelengths) from 389 to 404 nm, with a sharper and more intense peak indicating the 
monomerisation of the iron porphyrin (Figure 1.51).
134
 The changes in the spectra are 
consistent with the coordination of two pyridine ligands to the Fe(III) centre of the 
porphyrin.
135
  
 
Figure 1.51 The effect of increasing pyridine concentration on the spectrum of Fe(III)PPIX in 
aqueous solution. The changes in the spectra are consistent with coordination of two pyridine 
ligands to the Fe(III) centre of Fe(III)PPIX. Arrows indicate the direction of change as the 
concentration of pyridine is increased. Reproduced from reference.
134
 
 
In order for the assay to be useful, conditions under which the pyridine reacts exclusively 
with Fe(III)PPIX and not β-haematin were investigated. Under pH conditions close to 
neutral, the axial ligand of Fe(III)PPIX is likely to be water, which being a weak field 
ligand is easily replaced by the strong field pyridine ligand. β-Haematin, however, is a 
cyclic dimer of Fe(III)PPIX in which the propionate side chain of one protoporphyrin 
coordinates to the Fe(III) centre of the other.
35
 Thus, the coordination of pyridine to the 
Fe(III) centre of this microcrystalline solid would be much more difficult, requiring the 
breakage of the Fe-O (propionate) bond and disruption of the crystal. Ncokazi et al. 
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explained that under basic conditions where β-haematin is less stable, and at high enough 
concentration of the pyridine to compete with the propionate groups, β-haematin 
decomposes to form Fe(III)PPIX-pyridine complexes. However, in aqueous solutions 
containing only 5-10% (v/v) pyridine, buffered at a pH value that is neutral or only mildly 
basic, the pyridine does not react with β-haematin (Figure 1.52).134  
 
Figure 1.52 Interaction of aqueous pyridine with Fe(III)PPIX species. (a) Schematic of the bis-
pyridyl complex formed after reacting 5% (v/v) aqueous pyridine with Fe(III)PPIX in solution. The 
orange-pink bis-pyridyl complex has a distinctive absorbance maximum, measurable at 405 nm. (b) 
The bis-pyridyl complex will not form in the presence of β-haematin. The thicker black lines 
represent the mean porphyrin plane, which is viewed from the side. 
 
In 5-10% aqueous pyridine solutions, Ncokazi et al. showed that absorbance data can be 
used to directly quantify the percentage Fe(III)PPIX in a Fe(III)PPIX/β-haematin mixture 
(Figure 1.53).
134
  
 
Figure 1.53 Linear dependence of Soret band intensity (A405) on Fe(III)PPIX concentration. 
Reproduced from reference.
134
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In the so-called Phiβ assay, β-haematin formation was studied under the conditions used by 
Egan et al. in 1994,
90
 specifically 4.5 M acetate solution (pH 4.5, 60 
oC). The Phiβ assay 
provided a means of quantifying the amount of Fe(III)PPIX remaining following the 
formation of β-haematin in the presence of potential inhibitors.136 An example of the visual 
effect of pyridine can be seen in Figure 1.54, where the pyridine-based assay was 
conducted in a 96-well plate. β-Haematin inhibitors are readily identifiable, owing to the 
formation of the orange-pink colour in the well. The greater the activity of the test 
compounds, resulting in greater quantities of unreacted Fe(III)PPIX, the more intense the 
orange-pink colour. 
 
Figure 1.54 Example of the Phiβ assay used in a 96-well plate where 47 compounds were screened 
for their ability to inhibit β-haematin formation. After the reaction was completed, 5% (v/v) 
aqueous pyridine (pH 7.5) was added and inhibitors of β-haematin could be identified by direct 
visual inspection. Reproduced from reference.
134
 
 
Overall, it was demonstrated that the Phiβ assay is an easy to use and reproducible method 
to study the inhibition of β-haematin formation.134 Furthermore, absorbance data can be 
easily manipulated in order to reflect the % β-haematin formed.  
 
1.6.4.6.2 Effect of Quinoline Antimalarial Drugs on Kinetics of β-Haematin Formation. 
 
Chong and Sullivan
137
 made used of a high throughput crystal growth determination assay 
to investigate the effect of quinoline antimalarials on the kinetics of crystal growth. They 
found that the 50% inhibitory concentration (IC50) value is dependent on incubation time 
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and they further recognised that β-haematin formation eventually occurs in the presence of 
CQ and QD.
137
 Subsequent studies by Egan et al.
71
 supported these previous findings. An 
investigation of β-haematin formation, mediated by 4.5 M acetate, pH 4.5 at 60 oC, in the 
presence of quinoline antimalarials showed a sigmoidal dependence of β-haematin 
formation on drug concentration (Figure 1.55).
71
 A decrease in the rate of β-haematin 
formation in the presence of CQ and QN was also observed. However, a much slower 
decrease in the rate for β-haematin formation was seen for QN, Figure 1.55 (b).71 The 
reaction was monitored spectroscopically at 405 nm, employing 5% (v/v) aqueous pyridine 
(pH 7.5) for the reasons discussed above. 
 
Figure 1.55 The effect of quinoline antimalarial drugs on β-haematin formation. Increasing molar 
equivalents of (a) CQ and (b) QN were observed to decrease the rate of β-haematin formation. The 
different incubation times in hours are 1(■), 2 (▲), 3 (▼), 4 (turned black square), 5 (○), 6, (∆) 7, 
(upside down triangle), 8 (◊) and 24 h (□). Reproduced from reference.71 
 
As discussed earlier, the sigmoidal dose response curve is based on the reaction process (β-
haematin formation) taking place in three stages: induction, growth/propagation and 
termination.
71
 At low drug equivalents, the reaction would be expected to reach its 
termination stage and little unreacted Fe(III)PPIX would remain to react with the pyridine, 
thus giving rise to a low absorbance value. Upon increasing the drug equivalents, the 
reaction only reaches its growth stage, resulting in increasing concentrations of unreacted 
Fe(III)PPIX to react with the pyridine. When the drug equivalents are sufficiently high, the 
reaction remains in the induction stage, (very little Fe(III)PPIX is converted into β-
haematin) and the absorbance value is high.  
(b)(a)
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The IC50 values of the 4-aminoquinolines for the inhibition of β-haematin formation were 
shown to depend strongly on incubation time (Figure 1.56). The authors showed that at 1 
hour incubation time, CQ was a stronger inhibitor than QN, but at 2 hours the IC50 data 
indicate that QN was a stronger inhibitor than CQ, therefore incubation times must be 
considered carefully when investigating inhibitory activity. The authors demonstrated that 
the IC50 data following an incubation time of one hour correlate well with biological 
activity, suggesting that drug action may be more relevant at the early part of the inhibitory 
process. 
 
Figure 1.56 The effect of increasing incubation time on the IC50 values for inhibition of β-haematin 
formation by (a) CQ and (b) QN. Reproduced from reference.
71
 
 
The mechanisms of action of antimalarial drugs were unknown for a long time, and there is 
still a long way to go to understanding how these drugs provide chemotherapy against the 
malaria parasite. In spite of the important role that CQ has played over the years, little is 
known about the molecular interaction of CQ and related antimalarials with the proposed 
drug target(s), haemozoin and its precursor Fe(III)PPIX. At the present we do not 
understand enough about the mode of action of these existing drugs; however, we need to 
focus on understanding their mode of action first in order to be able to design novel and 
more efficient drug candidates. 
 
  
(a) (b)
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1.7 Aim and Objectives 
 
After thoroughly reviewing the literature on Fe(III)PPIX, malaria pigment and the current 
understanding on the mechanisms of action of quinoline antimalarial drugs, three questions 
not fully answered in this field were identified. For this reason, the following aims were set 
as targets:  
1. Determine the structural features of Fe(III)PPIX-quinoline drug complexes which 
could account for their activity. In doing so, probe the relationship between the 
solid-state structures and the structures present in solution. 
2. Investigate the effect of quinoline antimalarial drugs on lipid-mediated β-haematin 
formation.  
3. Gain deeper insight into the mechanism of formation of β-haematin (haemozoin) 
through structural analysis. 
 
To achieve the aforementioned aims, the specific objectives of this research project were 
to: 
 
1. Use various crystal growing techniques to grow single crystals of Fe(III)PPIX-drug 
complexes and study their molecular features using X-ray diffraction techniques 
and infrared spectroscopy.  
2. Compare UV-visible spectra to rationalise species existing in solution. 
3. Validate the biomimetic lipid-water interface system as a means of assaying 
antimalarial drug activity. 
4. Investigate the effect of quinoline antimalarial drugs on the kinetics of β-haematin 
formation, making use of the lipid-water interface system. 
5. Investigate crystals of β-haematin using single crystal X-ray diffraction. 
6. Use extended X-ray absorption fine structure (EXAFS) spectroscopy to gain 
understanding about Fe(III)PPIX-drug complexes and Fe(III)PPIX in solution. 
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2 Experimental Techniques 
 
The work presented in this dissertation has involved the use of several instrumental 
techniques. These techniques are briefly described in this chapter to outline their use in the 
field of antimalarial drug research.  
 
2.1  X-ray Crystallography 
 
X-ray crystallography is a technique used by crystallographers in which the closely spaced 
lattice of atoms in a crystal is recorded from the pattern produced by the diffraction of X-
rays through the crystal. Analysing these results reveal the nature of the lattice. A crystal 
by definition is a solid containing an internal lattice of atoms, molecules, or ions that is 
regular, repeating and geometrically arranged.
138
 
This non-destructive technique uses X-ray radiation to gain information about the internal 
lattice of a crystalline material. Each single crystal has a characteristic diffraction pattern. 
Using Miller indices (hkl) assigned to each reflection by measuring the directions of the 
diffraction and the corresponding intensities, refinements are performed in order to obtain 
the three-dimensional crystal structure. From this determination, information about bond 
lengths, angles and chemical formula can be ascertained for the crystal structure 
responsible for diffraction. 
 
2.1.1  Single-Crystal X-Ray Diffraction 
 
Single crystal X-ray diffraction (SCD) is currently the most accurate characterisation 
technique available by which to analyse crystalline materials.  
The interaction of X-rays with a sample produces constructive interference when Bragg’s 
Law is satisfied (eq. 2.1). Bragg considered crystals to be made up of parallel lattice planes 
of atoms. When X-rays are in-phase with one another they will leave the crystal at an angle 
equal to that of the incident beam. Bragg’s law identifies the angles of the incident 
radiation relative to the lattice planes for which diffraction peaks occur. Constructive 
interference occurs when the path difference is an integral number of wavelengths (nλ). 
This is known as Bragg’s law (eq. 2.1). 
           (2.1) 
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This describes the relationship between the wavelength of the incident X-ray, λ, angle of 
incidence θ, and the interplanar spacing d, between lattice planes with n the order of 
reflections.
139
 The wavelength, λ, of the X-ray is typically 1 Å, comparable to the 
interatomic spacing. No diffraction occurs when the above condition is not satisfied. 
 
Figure 2.1 Bragg considered crystals to be made up of parallel planes of atoms (●). The incident 
waves are reflected specularly from the parallel planes. Bragg’s law is satisfied when the distance 
between the two incident waves and the two diffracted waves differ by an integer d, the interplanar 
spacing. Reproduced from reference.
140
 
 
To label the reflections, Miller indices of the planes are used (hkl). The diffracted X-rays 
are then detected by the CCD (Charge-Coupled Device) area-detector. By changing the 
position of the detector, sample and X-ray source, all possible diffractions of the lattice 
should be achieved and the detected data can be processed. 
 
2.1.1.1 Data Collection 
 
Data collections for the five SCD structures presented in this dissertation were carried out 
using a Bruker Apex Duo diffractometer fitted with either a cupper, Co-Kα (λ = 1.5418 Å) 
or molybdenum, Mo-Kα (λ= 0.71073 Å) incoatec IµS microsource and an Oxford 
Cryosystems Cryostat (700 Series Cryostream Plus). Data were captured with a CCD area-
detector. Crystals were mounted on the MiTeGen mount in paratone oil, and data were 
collected at 100K. It should be noted that most crystals were found to be unstable, most 
likely the result of rapid desolvation when the crystals were removed from mother liquor. 
Therefore, it was necessary to mount the crystals and place the gonionmeter head directly 
in the cold stream as quickly as possible to avoid decomposition. APEX II software
141
 was 
λ
Diffracted 
wavesIncident 
waves
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used to determine a reliable unit cell and implement a suitable data collection strategy, as 
well as for subsequent data reduction and absorption corrections. 
 
2.1.1.2 Structure Solution and Refinement 
 
All structures were solved by direct methods and refined using the SHELX-97
142
 package 
implemented through XSeed.
143
 All diagrams were generated using POVRay
144
, 
implemented through XSeed.
143
 PLATON/SQUEEZE implemented in WinGX,
145
 was 
used to analyse residual electron density present in the structure due to disordered solvent 
molecules, which could not be modelled during structure refinement. SQUEEZE 
calculations generate values for the void volume and the total number of electrons in the 
void.
146
 
 
2.1.1.3 Application to Fe(III)PPIX Studies 
 
SCD studies in the field of antimalarial drug research have been limited to date by the fact 
that one requires a single crystal which is stable and with dimensions in the order of 0.1 – 
0.5 mm for this method. To grow single crystals of Fe(III)PPIX-drug complexes, in order 
to study the interactions of antimalarials with Fe(III)PPIX, is very difficult, as evidenced 
by the limited number of structures published in the literature. On the other hand, if one is 
able to acquire such a crystal, this technique is the most precise method for structure 
determination, as was shown in the case of the first crystal structure of a Fe(III)PPIX-drug 
complex, the Fe(III)PPIX-halofantrine crystal structure.
85
 
 
2.2 Powder X-ray Diffraction  
 
Powder X-ray diffraction (PXRD) is a non-destructive technique and is mainly used to 
characterise solid materials. Homogeneity of crystal samples can be determined by 
comparing the PXRD data with the corresponding calculated powder pattern generated 
from a known structure. 
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2.2.1.1 Data Collection 
 
Powder X-ray diffraction data were recorded on a PANalytical X’Pert PRO X-ray Powder 
Diffractometer from PANalytical, Netherlands with Bragg-Brentano geometry, and using a 
Cu-Kα radiation (λ = 1.5418 Å) source. Samples were ground to fine powders before being 
placed on a zero-background sample holder. Intensity data were collected using a 
X’Celerato detector and 2θ scans in the range of 5 – 30o. 
 
2.2.1.2 Application to Fe(III)PPIX Studies 
 
PXRD was used to confirm the formation of β-haematin as well as the extent of 
crystallinity of the samples, since it was not possible to obtain suitable crystals for analysis 
by SCD. Notably, this method has been used previously to solve the structure of synthetic 
malaria pigment, however, the high-resolution data was collected using a synchrotron light 
source rather than a standard laboratory diffractometer.
35
  
 
2.3 Infrared Spectroscopy 
 
Infrared Spectroscopy (IR) exploits the fact that molecules vibrate and rotate when the 
energy which they absorb is sufficient to excite them from the ground state into an excited 
state.
147
 The specific frequencies which molecules absorb are characteristic of the chemical 
functional groups in the sample, and therefore IR spectroscopy can be used to identify 
structural features in compounds.  
In order for a molecule to be IR active, at least one vibrational mode must be associated 
with a change in the dipole. The number of ways a molecule can vibrate is related to the 
number of atoms, therefore the number of bonds in molecule. If a molecule has n-atoms, 
the molecules has 3n-6 degrees of vibrational freedom (3n-5 if molecule is linear).
147
 
Vibrational modes include stretching, bending, scissoring, rocking and twisting. IR 
absorption data is presented in the form of a spectrum with wavenumber ( ̃) on the x-axis, 
and percent transmission on the y-axis. The IR region is divided into three smaller areas, 
near IR (13 000-4 000 cm
-1
), mid IR (4000-200 cm
-1
) and far IR (200-10 cm
-1
). 
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2.3.1 Detection Modes 
 
2.3.1.1 Attenuated Total Reflectance-Infrared Spectroscopy  
 
One advantage of using the attenuated total reflectance-infrared spectroscopy (ATR-IR) 
technique is that no sample preparation is required and both solid and liquid samples can 
be examined. The sample is placed in close contact with the ATR crystal normally zinc 
selenide (ZnSe) or germanium (Ge) crystal, which haves a high refractive index, by 
compressing it with a diamond tip (Figure 2.2). First, the IR light is directed to the ATR 
crystal at a specific angle so as to reflect the light several times within the ATR-crystal. 
These internal reflections generate an evanescent wave and in the regions where the 
sample absorbs energy, the wave will be attenuated (alter). Once the light exits the crystal, 
it passes through the detector which measures the absorbance by the sample from the 
damped signal of the output beam. The sample thickness will influence the quality of the 
transmission spectroscopy. 
 
Figure 2.2 A schematic representation of the ATR-IR system. The sample is pressed into very 
close contact with a ZnSe or Ge crystal by a diamond tip. As the beam of IR light passes through 
the ATR crystal multiple times, an evanescent wave (dashed blue arrow) is produced. The 
evanescent wave interacts with the sample and results in a damped signal to the output beam of the 
infrared radiation. Reproduced from reference.
148
 
 
2.3.1.2 Application to Haemozoin Studies 
 
Fourier transform infrared (FT-IR) spectroscopy was used to characterise samples of β-
haematin, prepared by various methods. As mentioned in the literature review, the strong 
absorbance bands at 1211 cm
-1 
and 1664 cm
-1
 in the FT-IR spectrum of β-haematin have 
been attributed to the C-O and C=O stretching frequencies, respectively of the coordinated 
propionate group. These strong bands are visible in the ATR-IR spectra of β-haematin and 
ATR Crystal
Sample in contact with 
the evanescent wave 
Diamond Tip
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haemozoin, but are absent in the spectrum of Fe(III)PPIX and are either absent or present 
to a lesser extent in samples of the material prepared in the presence of quinoline 
antimalarial drugs.
30
 
 
2.4 UV-Visible Spectroscopy 
 
UV-visible (UV-vis) spectroscopy involves the spectroscopy of photons in the UV-vis 
region (400-700 nM). When electromagnetic radiation of the correct frequency is absorbed 
by the material, molecules undergo electronic transitions from their normal ground state 
(where valence electrons can be found in σ, π or non-bonding orbitals (n)), to higher 
energy excited state (antibonding orbitals σ* or π*). Due to the fact that transitions from 
bonding orbitals require to high a frequency to be measured easily (too short a 
wavelength), allowed transitions include σ→ σ*, π →π*, n→ σ* and n→ π*.149 
 
2.4.1 Data Collection 
 
UV-vis single wavelength readings were recorded using a UNICAM Helios UV-vis 
spectrophotometer. UV-vis spectra readings were recorded using a SPECORD®210PLUS 
UV-vis spectrophotometer. Quartz cuvettes from SUPRASIL®, Hellma and 1 cm path 
lengths were used in the spectrophotometer.  
 
2.4.2 UV-Visible Spectrum of Fe(III)PPIX 
 
Due to the complexity of the speciation of Fe(III)PPIX in solution, UV-spectra have been 
studied in depth to characterise the species observed in solution.
86
 The porphyrin of 
Fe(III)PPIX is a highly-conjugate molecule containing 22 π electrons. Due to this 
conjugated π-electron system, solution of porphyrins are able to absorb UV-vis light and 
typically have an intense colour.
150
 The molecular orbital (MO) diagram for the Fe(III) 
centre and the conjugated porphyrin ring system of Fe(III)PPIX is shown in Figure 2.3. 
The Fe(III) centre in Fe(III)PPIX is high spin, therefore each of the five d-orbitals is singly 
occupied by an electron (spin state S = 5/2). The extensive aromatic porphyrin core is 
considered to have D4h symmetry (refer back to Figure 1.2, section 1.4).
151
 The absorption 
spectra of porphyrins were explaind by Gouterman during the 1960’s.152,153 The 
characteristic bands in the UV-vis spectra arise from transitions between the two highest 
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occupied molecular orbitals (HOMO), a1u and a2u orbital, and the lowest unoccupied 
molecular orbitals (LUMO), doubly degenerate eg orbitals. The nature of the metal centre 
of the porphyrin and the substituents on it affect the relative energies of these transitions. 
Due to orbital mixing these energy states are split creating a higher energy state giving rise 
to the Soret (or B) band, and a lower energy state creating the Q bands (Figure 2.4).  
 
Figure 2.3 The molecular orbital (MO) diagram for the Fe(III) centre and the conjugated porphyrin 
ring system of Fe(III)PPIX. The characteristic bands (Q and Soret) in the absorption spectra arise 
from transitions between the two highest occupied molecular orbitals (HOMO), a1u and a2u orbital, 
and the lowest unoccupied molecular orbitals (LUMO), doubly degenerate eg orbitals, in the 
conjugate porphyrin ring system. 
 
The UV-vis spectrum of Fe(III)PPIX in methanol solution shows distinct bands due to the 
major electronic transition of the porphyrin core at the Soret band and the Q and Charge-
Transfer (CT) bands (Figure 2.4 (a)). Comparing this spectra to the spectra of Fe(III)PPIX 
as µ-oxo dimer species where the Fe(III) centre is in a low spin state (Figure 2.4 (b)), there 
is clearly a difference in appearance. Therefore UV-vis can also be used to distinguish 
between different Fe(III)PPIX species.  
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Figure 2.4 The UV spectra of haemin in (a) methanol solution and (b) Fe(III)PPIX dissolved in 0.1 
M NaOH containing 10% (v/v) pyridine. Showing the absorption Soret (or B), Q and CT bands. 
Reproduced from reference.
154
 
 
It has previously been shown in the pyridine hemichrome inhibition of β-haematin (Phiβ) 
assay that 5% (v/v) aqueous pyridine solution (pH 7.5), can selectively react with free 
Fe(III)PPIX, resulting in a characteristic orange-pink bis-pyridyl complex in solution with 
a distinctive absorbance maximum at 405 nm.
134
 In the current work, we applied the 
principles of the Phiβ assay to the lipid-water interface model system (refer back to Figure 
1.51, section 1.6). 
Spectrophotometric titration of quinoline drugs against Fe(III)PPIX in solution has a 
hypochromic effect (absorbance band decreases) on the Soret band of Fe(III)PPIX, which 
quinoline drugs induce when binding to Fe(III)PPIX in solution. These binding isotherms 
is used to determine Fe(III)PPIX stoichiometries and association constants. The CT bands 
arise as a result of electronic transition from an ligand to the Fe centre of 
Fe(III)PPIX.
118,125,155
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2.5 Australian Synchrotron Light Source 
 
2.5.1 Background 
 
A synchrotron light source produces a high intensity beam of light as a result of 
accelerating electrons, which travel close to the speed of light in a ring-shaped chamber 
under ultra-high-vacuum conditions and have their path changed by powerful magnetic 
fields. A synchrotron light source includes 6 stages of operation (Figure 2.5). Starting with 
the electron gun (1), electrons are produced by thermionic emission from a heated tungsten 
matrix cathode. These electrons are then accelerated in the linear accelerator (2) to nearly 
the speed of light. The electrons then make their way into the booster synchrotron (3) 
where the energy stored in the electrons is increased to much higher energies. The storage 
ring (4) is the final destination for the accelerated electrons, where they circulate under 
ultra-high-vacuum conditions for many hours, before the electrons make their way into 
individual beamlines (5), positioned around the storage ring.  
The synchrotron light can be filtered and directed down several beamlines located around 
the storage ring to be used in a wide range of high-resolution, in situ, real-time imaging 
and analysis techniques to examine the atomic and molecular detail of a wide range of 
materials, Figure 2.5.
156
 At the beamlines, devices such as monochromators, filters and 
mirrors are used to select the appropriate wavelength of light for the experimental 
technique, and to focus the beam. The end station (6) is where the experiment is conducted, 
and the synchrotron light source is used to gather data in the form of images, chemical 
spectra, or scattered light.
156
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Figure 2.5 Schematic representation of synchrotron facility. Electrons emitted by an electron gun 
(1) are first accelerated in a linear accelerator (2), before entering a booster synchrotron (3), where 
they are further accelerated to higher energy levels. The electrons are then injected into the storage 
ring (4) where they travel close to the speed of light under ultra-high-vacuum conditions at a 
constant energy, having their paths changed by powerful magnetic fields. The light enter the 
different beamlines (5) located around the storage ring and make sure that the appropriate 
wavelengths is selected to utilise in the experiment at the end station (6). Redrawn based on 
reference.
156
 
 
X-ray absorption spectroscopy (XAS) is one of many experimental techniques that rely on 
the intense radiation produced by a synchrotron light source. The measurements in this 
dissertation were carried out at the Australian synchrotron light source, in collaboration 
with Dr. Victor Streltsov from the Commonwealth Scientific and Industrial Research 
Organisation (CSIRO). 
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2.5.2 X-ray Absorption Spectroscopy 
 
X-ray absorption spectroscopy (XAS) is a widely used method for investigating local 
atomic structure around an absorbing atom, for example Fe(III) in Fe(III)PPIX. The high 
energy X-rays generated by a synchrotron light source pass through the sample according 
to eq. 2.2. 
     
    (2.2) 
where    represents the intensity of the incident X-rays reaching the sample,   is the 
intensity of the X-rays that are transmitted through the sample,   is the sample thickness 
and µ is the absorption coefficient. The latter is a measure of the rate at which the intensity 
of an incident beam is reduced as it passes through a specific material. 
An XAS spectrum consists of three regions. The absorption edges, which are labelled K, L 
or M, corresponding to the excitation of an electron from the n = 1, 2, 3 quantum levels of 
electron energy states.
157
 The values for the absorption edge energies are well known and 
depend on the absorbing atom of interest. Therefore, K-edge chosen corresponds to the 
excitation of core level electrons (1s) in the K shell of the absorbing atom, and    and    
emission lines result from electrons transferring to the K (n = 1) shell from the n = 2 
orbitals (L shell) and n = 3 orbitals (M shell), respectively. 
In the XAS spectrum oscillations are visible above the edge. These oscillations take place 
at a specific value of photon energy, when the photons have sufficient energy to excite a 
photon from an atom’s core in the sample to create a photo-electron. This happens when 
the energy of the X-ray is higher than the energy level that is binding that electron to the 
core of the atom.
157
 XAS therefore deals with measuring the energy dependence of   at 
and above the binding energy of a known core level electron of a known atomic species 
(eq. 2.3).
157
 
  
   
   
 (2.3) 
According to the above equation, the value of µ depends on the sample density  , the 
atomic number Z, the atomic mass A, and the X-ray energy E. XAS is element-specific 
since the dependence on Z infers that µ for each absorbing atom is unique. Therefore, the 
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selected absorbing element can be examined by tuning the X-ray energy to an appropriate 
absorption edge corresponding to the binding energies of the electrons. 
The other twee regions of the XAS spectrum relative to the edge are the X-ray absorption 
near edge structure, XANES and extended X-ray absorption fine-structure, EXAFS. The 
XANES region refers to absorption energies near the edge (± 30-50 eV within the main 
absorption edge) and follows after the pre-edge and edge region in the spectrum (Figure 
2.6). On the other hand, the EXAFS region refers to the oscillatory behaviour of the 
absorption coefficient above the absorption edge. Typically the EXAFS region starts 
anywhere from 50 to 100 eV above the absorption edge and can extend as far as 1000 eV 
past the edge (Figure 2.6). 
 
Figure 2.6 The Fe Kα-edge X-ray absorption spectroscopy (XAS) spectrum of FeO. The X-ray 
adsorption near edge structure (XANES) and extended X-ray absorption fine-structure (EXAFS) 
regions are indicated near to and above the absorption edge, respectively. Reproduced from 
reference.
157
 
 
XANES and EXAFS contain related but different information about an element’s local 
coordination and chemical state. XANES is sensitive to the formal oxidation state and 
geometry of the absorbing atom, while EXAFS provides information about the local 
structure around the absorbing atom, which includes bond lengths, thermal disorder and 
coordination numbers to neighbouring atoms. EXAFS data can be analysed in a more 
quantitative way than is currently possible for XANES,
158
 therefore EXAFS was chosen in 
this work, since the local structure surrounding the absorbing Fe atom of Fe(III)PPIX are 
of interest.  
Pre-edge
Edge
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2.5.3 Extended X-ray Absorption Fine Structure  
 
2.5.3.1 Background 
 
The oscillations in an extended X-ray absorption fine structure spectrum (EXAFS) can be 
thought of in a quantum mechanical manner, if the wave characteristics of the photo-
electron are considered. As the spherical wave propagates away from the absorbing atom 
and interacts with the electronic potential of the neighbouring atoms (Figure 2.7), a part of 
this wave is back-scattered to the origin. The interference between the outgoing and 
scattered photo-electron waves gives rise to the oscillations visible in the EXAFS region.  
 
Figure 2.7 Consideration of the photo-electron as a spherical wave. Backscattering of the photo-
electron from neighbouring atom (S) surrounding an absorbing atom (Fe) causes interference and 
leads to the oscillations visible in the EXAFS region of the spectrum. If there was no interference 
from neighbouring atoms, no oscillations would be visible, and the absorption coefficient would 
decrease smoothly with increasing energy. Redrawn from reference.
158
 
 
The EXAFS function  ( ) is shown in eq. 2.4, 
 ( )  
 ( )   ( )
   ( )
  (2.4) 
where  ( )  is the measured absorption coefficient,   ( )  is the intrinsic absorption 
coefficient of an isolated atom which is expected to be a smooth function in the absence of 
interference from neighbouring atoms, and    ( )  is the measured oscillations in 
absorption coefficient  ( ) at a threshold energy    (Figure 2.8).
157
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Figure 2.8 The Fe Kα-edge XAS spectrum. The measured absorption coefficient, µ(E) is shown 
relative to a smooth background function µ0(E) and edge-step ∆µ0(Eo) for FeO. Reproduced from 
reference.
157
 
 
Since data collection is carried out on a 100-channel Ge detector, data reduction starts with 
merging of all the measured  ( ) spectra, using the AVERAGE program.159 The EXAFS 
signals, which contain the information about the local structure around the absorbing atom, 
can then be extracted. In EXAFS spectroscopy, it is practice to convert the X-ray energy 
into the wave vector of the photo-electron ( ) (Figure 2.9 (a)). In this form, the different 
frequencies of the oscillations of  ( )  are directly proportional to (bond) distances 
between the absorbing atom and its nearest neighbours. Therefore provides information 
about the location and distance between atoms within a molecule/material. The raw 
EXAFS spectrum is rapidly attenuated at high   values (Figure 2.9 (a)) and therefore, the 
oscillations of  ( ) are typically multiplied by a function of   (for example   or    ), to 
produce EXAFS data in which the intensity of the oscillations are similar over the entire   
range (Figure 2.9 (b)).
157
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Figure 2.9 EXAFS spectrum for FeO. (a) The EXAFS signal as a function of photo-electron wave 
vector, χ(k). (b) To emphasise the oscillations, χ(k) is multiplied by a function of k (in this case k2). 
Reproduced from reference.
157
 
 
The  -weighted EXAFS data are used in fitting of the experimental EXAFS to the 
calculated EXAFS.
157
 The next step is to Fourier transform the EXAFS signal  ( ) into 
 ( )-space (Figure 2.10) to obtain a radial distribution. In the Fourier transform spectrum, 
the different shells of atoms around the absorbing atom are represented as peaks. The 
interatomic distance does not automatically correspond to the  -axis since there is a phase 
shift in the peaks in | ( )| when compared to the actual distance.  
(a)
(b)
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Figure 2.10  The Fourier transformed radial function, χ(R) in R(Å) space. The different shells of 
atoms around the absorbing atom are represented by the peaks in the spectrum. The first shell is 
denoted with a red circle. Reproduced from reference.
157
 
 
The EXAFS equation is use to describe and model the relationship (distance and spatial 
coordinates) of neighbouring atoms to an absorbing atom using the different frequencies in 
the oscillations of  ( ), eq. 2.5: 
 ( )  ∑
    
   ( ) 
      
 
   
     [       ( )] (2.5) 
In the above equation,   is the number of neighbouring atoms around the absorbing atom 
in shell  ,   is the distance of these neighbouring atoms to the absorbing atom, and    (the 
Debye-Wallers factor) is the mean-square disorder in  . Scattering properties of the 
neighbouring atoms include the amplitude reduction factor   
 , scattering amplitude  ( ), 
and the phase shift  ( ). The values of  ,   and    can be determined, since structure 
determination is made on the basis of fitting the experimental data to a structural model 
which is known, and the values of  ( ) and  ( ) can be obtained to a good approximate 
by comparing the data to the known structure. EXAFS spectroscopy is sensitive to the 
chemical speciation of the neighbouring atoms, since  ( ) and  ( ) depend on atomic 
number (Z).
157
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2.5.3.2 EXAFS Analysis Programs  
 
With the development of efficient analysis algorithms such as ATHENA,160,161 EXAFS 
oscillations  ( ) can be extracted from the measured absorption coefficient function. The 
first step involves automated background subtraction; in ATHENA for example, the 
AUTOBK algorithm is implemented for this purpose. Using the data generated in 
ATHENA, the ARTEMIS program is later used to quantitatively analyse the EXAFS 
oscillations ( ( )).160,161 ARTEMIS interfaces with FEFF, an automated algorithm for ab 
initio multiple scattering calculations generated according to a proposed input list of atom 
coordinates and distances from the absorbing atom (Figure 2.11). Using a model structure 
that is close to the expected structure (in solution or solid), a list of the x, y, and z 
coordinates is generated for all neighbouring atoms relative to a selected central atom, as 
well as the interatomic distances. This information is contained in the input file for FEFF, 
where the scattering amplitude  ( ) and phase shifts  ( ) are calculated theoretically. 
 
Figure 2.11 EXAFS data processing overview. The ATHENA program processes the absorption 
data (1) and interfaces with the automated background subtraction algorithm AUTOBK to remove 
instrumental background and absorption from other edges (2). Data analysis using ARTEMIS 
begins with inputting a suitable model for the most likely structure; this is often informed by SCD 
data (3). Theoretical models are processed through FEFF (4), and fitting of the model structure to 
the experimental data is enabled by IFEFFIT (5). 
 
When considering the path that a photo-electron can travel, this path includes many atomic 
shells, from 1
st
 neighbour shells, 2
nd
 neighbour shells, 3
rd
 neighbour shells and so on. A 
photo-electron can scatter from more than one atom before returning to the absorbing 
atom. Therefore multiple-scattering (MS) analysis of EXAFS data is important where the 
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backscatter of the photo-electrons is due to the contribution of two or more atoms, compare 
to single scattering (SS) (Figure 2.12). When multiple-scattering occurs at an angle greater 
than 150
o
, the contribution is strong. Angles can be determined from the strong 
dependence of the scattering, which could be use to assign a three-dimensional structure 
for the first few coordination shells from the absorbing atom.
158
 ARTEMIS calculates 
these effects and includes them in the calculated  ( ) and  ( ) values in the EXAFS 
equation (eq. 2.4). The calculated  ( )  and  ( )  values can be used in the EXAFS 
equation to predict the structural parameters  ,   and   .  
 
Figure 2.12 Back scattering contributions from neighbouring atoms. By considering Fe as the 
absorbing atom and A and B as its neighbouring atoms in the first and second shell respectively, 
there are three possible multiple-scattering pathways to consider when looking at atoms in the 
second shell. (i) The outgoing photo-electron to B, is only back-scattered by atom B. (ii) The 
outgoing photo-electron passes through A and B, is only back scattered by B. (iii) The outgoing 
photo-electron passes through A and B, is back scattered from B via A. Redrawn from reference.
158 
 
ARTEMIS also interfaces with IFEFFIT, which is used for fitting the EXAFS 
experimental data to the theoretical model of  ( ) built with FEFF (Figure 2.11). A fit is 
considered good if the R-value is less than 0.2, with   
  equal to         and    between 
        and        .158 
One advantage of EXAFS is that the sample can be in powder or solution form, although 
homogeneity is required. The disadvantage is that the structure determination is made on 
the basis of fitting the experimental data to a structural model. Hence it is imperative that 
you have a reasonable idea of the expected structure in order to generate a suitable 
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model.
158
 Having SCD data is beneficial in order to generate a starting model together with 
theoretical parameters to be used in the EXAFS fitting. If the structure in solution is of 
interest while only the solid state structure is known by SCD, then the SCD structure 
provides a reasonable starting point to probe the solution speciation. 
 
2.5.4 EXAFS Applied to Haemozoin Studies 
 
EXAFS studies can be employed to investigate the local iron environment of Fe(III)PPIX, 
which allows both the type and the distance of each shell of atoms surrounding the 
absorbing metal atom to be identified.  
As mentioned in the introduction (section 1.5.1), Walczak et al.
38
 used EXAFS to 
confirmed that the oxidation state of Fe in haemozoin and β-haematin is the same for both 
structures, close to three, even though they found large disorder in the occupation and 
position of the oxygen site. In a subsequent study, EXAFS spectroscopy was used to 
compare the similarities between haemozoin and newly-synthesised synthetic substitutes 
for haemozoin, namely mesohaematin and deuterohaematin anhydrides (Figure 2.13).
37
 
The effect of CQ on the mesohaematin anhydride dimer when dissolved in DMSO and 
acetic acid respectively was also investigated.
162,163
 Together, the body of literature relating 
to speciation studies of Fe(III)PPIX using EXAFS demonstrates the usefulness of the 
technique and its applicability to solution studies in particular. 
 
Figure 2.13 (a) The different shells of atoms surrounding the absorbing Fe centre of Fe(III)PPIX. 
This includes the four equatorial nitrogen and axial oxygen atoms (blue rings), the α and meso 
carbon atoms (orange rings) and the β carbon atoms (green rings). (b) These atoms give rise to the 
peaks observed in the Fourier transformed EXAFS spectra of meso β-haematin (solid line) and β-
haematin (black squares). (b) was reproduced from reference.
37
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3 Materials, Instrumentation and General Methods 
3.1 Materials 
 
The materials used in this work were obtained from commercial suppliers and were 
analytical grade or of highest purity available commercially and used without further 
purification. The materials used are listed in Table 3.1. 
Table 3.1 Materials used and their commercial source. 
MATERIALS COMMERCIAL SOURCE 
Solids  
Bovin haematin (H2O/HO—Fe(III)PPIX) Sigma Aldrich 
Bovin haemin (Cl- Fe(III)PPIX) Sigma Aldrich 
Soduim hydroxide pellets (NaOH) Sigma Aldrich 
Citric acid monohydrate (Citrate) Sigma Aldrich 
N-2-[hydroxyethyl]piperizine-N’-[2-ethanesulfonic acid] (HEPES) Sigma Aldrich 
rac-1-Monopalmitoylglycerol (MPG) Sigma Aldrich 
Liquids and Solvents  
Acetonitrile Sigma Aldrich 
Nitric acid (HNO3) Kimix Chemicals 
Dimethyl Sulfoxide (DMSO) Sigma Aldrich 
Pyridine Sigma Aldrich 
Acetone Kimix Chemicals 
Methanol Kimix Chemicals 
Antimalarial drugs  
Chloroquine diphosphate (CQ) Sigma Aldrich 
Amodiaquine dihydrochloride dihydrate (AQ) Sigma Aldrich 
Quinine hemisulphate hydrate (QN) Sigma Aldrich 
Quinidine sulphate dihydrate (QD) Sigma Aldrich 
Mefloquine hydrochloride (MQ) Sigme Aldrich 
Halofantrine hydrochloride (Hf) Sigma Aldrich 
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3.2 Instrumentation 
 
3.2.1 pH Measurements 
 
All pH measurements were performed using a METTER TOLEDO FE20/EL20 pH meter. 
Buffer solutions (pH 7 and pH 4) were obtained from CRISON and were used to calibrate 
the electrode before use. 
 
3.2.2 Water Bath  
 
A MEMMERT waterbath WNB 7-45 was used in this study at the temperature required for 
each experiment. 
 
3.2.3 Centrifugation  
 
Volumes of 5 – 15 mL were centrifuged in Greiner Falcon centrifuge tubes making use of 
a HERMLE LABORTECHNIK small centrifuge Z 206 A, with a maximum speed of 6 000 
rpm. 
 
3.2.4 UV-Visible Spectroscopy 
 
UV-vis single wavelength readings were recorded using a UNICAM Helios UV-vis 
spectrophotometer. UV-vis spectra were recorded using a SPECORD®210PLUS UV-vis 
Spectrophotometer. Quartz cuvettes from SUPRASIL®, Hellma of 1 cm path length were 
used in the spectrophotometer. Cuvettes used over in the same experiments were washed 
according to the procedures described in section 3.4 and air dried. 
 
3.2.5 Infrared Spectroscopy  
 
ATR-IR spectra were recorded using the NEXUS
TM
 FT-IR spectrometer from THERMO 
NICOLET instruments fitted with a Golden Gate ATR accessory.  
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3.2.6 Electron Microscopy 
 
Scanning electron microscopy was carried out using ZEISS EVO MA15VP scanning 
electron microscope. 
 
3.2.7 Powder X-ray Diffraction  
 
Powder X-ray diffraction data were recorded using the PANalytical X-ray Powder 
Diffractometer (XRD) from PANalytical, Netherlands. 
 
3.2.8 Single Crystal X-ray Diffraction  
 
Single crystal X-ray diffraction data were obtained using the Bruker Apex Duo single-
crystal X-ray diffractometer from Bruker AXS, Germany.  
 
3.2.9 Australian Synchrotron 
 
Extended X-ray absorption fine structure (EXAFS) scans were recorded at the Australian 
synchrotron beamline for X-ray absorption spectroscopy.  
 
3.3 Computer Software 
 
The computer software used to analyse data is listed in Table 3.2. 
Table 3.2 The computer software used in this dissertation. 
PROGRAMME VERSION USE 
GraphPad Prism
164 
5 Analysis and graphing 
XSeed5
143 
2.05 Windows program for X-ray crystallography 
POVRay
144 
3.6 Generate high quality molecular graphics 
PLATON
165
/SQUEEZE
146
 - Calculate the electron contribution of guest molecules 
AVERAGE
159
 2.0 Merge EXAFS scans 
ATHENA
160,161
 1.2.11 Data processing and background removal for EXAFS data. 
ARTEMIS
160,161
 1.2.11 Model fitting to EXAFS experimental data  
Endnote
166 
X2 Bibliography 
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3.4 General Preparation and Washing of Glassware and Plasticware 
 
Where water was used to prepare solutions, glass distilled water was used unless otherwise 
stated. When small volumes needed to be used during preparation (100-500  L) Eppendorf 
micro pipettes was used, and for even smaller volumes, 10 and 25 µL Hamilton syringes 
was used. 
Fe(III)PPIX is known to adsorb onto glass and plastic surfaces and therefore precautions 
are required.
79,86
 All glassware and cuvettes used to store solutions of Fe(III)PPIX in or 
during experiments were left to stand in 0.1 M NaOH for one hour, followed by extensive 
rinsing with water. The glassware and cuvettes were then washed with 1 M HNO3 and 
again extensively washed with water. When washing the Greiner Falcon centrifuge tubes, 
the tubes were also left to stand in 0.1 M NaOH for one hour, followed by extensive 
rinsing with water to remove Fe(III)PPIX residues from the sides of the tubes.   
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4 Structural Characterisation of Fe(III)PPIX-Drug Complexes 
4.1 Introduction 
 
Due to mounting parasitic resistance towards current treatments, there is a need to develop 
new and effective antimalarials. In this regard, the lack of definitive structural evidence of 
antimalarial drug interactions with free Fe(III)PPIX, Fe(III)PPIX being the precursor to 
haemozoin formation, precludes rational design of new drug candidates. In particular, the 
lack of solid-state structures of Fe(III)PPIX complexes formed with both quinoline 
methanol and 4-aminoquinoline compounds has hindered our understanding of the mode of 
action of these clinically-relevant antimalarial drugs. The only known informative crystal 
structure of a Fe(III)PPIX-drug complex is that of Fe(III)PPIX-halofantrine (Hf), published 
in 2008.
85
 Hence, the pharmacophore for quinoline antimalarials remains unidentified, and 
why certain compounds inhibit haemozoin formation while others do not, still remains 
ambiguous. At the present, one hypothesis is that drug compounds form complexes with 
free Fe(III)PPIX in solution, either through  -stacking or coordination, preventing its 
incorporation into β-haematin.116,117,118 Questions regarding the nature of the interactions, 
for example whether they are covalent or non-covalent, and the structural features of 
quinolines that influence their binding to Fe(III)PPIX still remain unanswered. 
In this chapter, single crystal X-ray diffraction (SCD) was used to determine the solid-state 
structure of the coordination complexes formed between Fe(III)PPIX and each of the 
quinoline methanol antimalarials quinine (QN), quinidine (QD) and mefloquine (MQ). 
Association studies of Fe(III)PPIX in solution with these antimalarials were undertaken to 
rationalise the existence of Fe(III)PPIX-drug species in non-aqueous solutions. 
Additionally, extended X-ray absorption fine structure (EXAFS) spectroscopy was used to 
confirm whether the species observed in the solid state also exists in solution, this being 
the medium that is more biologically relevant.  
The Fe(III)PPIX-drug complexes determined in this study are the first known SCD 
examples of complexes formed between Fe(III)PPIX and quinoline antimalarial drugs. 
Specifically, analysis of the QD-Fe(III)PPIX, QN-Fe(III)PPIX and MQ-Fe(III)PPIX 
crystal structures has made known a pharmacophore which is central to our understanding 
the antimalarial activity of quinoline methanol antimalarial drugs. Since binding to free 
Fe(III)PPIX would certainly limit haemozoin formation, and given that these coordination 
complexes are also proposed to exist in solution, it seems reasonable to hypothesise that 
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the observed complexation may contribute to the antimalarial action of these compounds. 
Furthermore, through analysis of the crystal structures of the Cinchona alkaloid 
complexes, an explanation of the long-standing question regarding the greater activity of 
QD compared to QN is proposed. 
 
4.2 Experimental Methods 
 
This section describes the methods used to grow the single crystals of the Fe(III)PPIX-drug 
complexes and to fully characterise their structures. The materials used have been 
previously listed in Table 3.1. 
 
4.2.1 Rationale for Growing Single Crystals of Fe(III)PPIX-Drug Complexes 
 
Malariologists have been trying for decades to crystallise Fe(III)PPIX-drug complexes in 
order to better understand the mechanisms of action of antimalarial compounds. While the 
solid state is not representative of the biological environment in which inhibition of 
haemozoin formation takes place, X-ray crystallography can provide insight into structural 
features (inter- and intra-molecular interactions for example) which may be important for 
drug activity.  
Owing to the fact that the speciation of Fe(III)PPIX varies from monomer to π-π dimer and 
even µ-oxo dimer depending on the solvent system,
86
 crystallisation experiments in this 
field are not of a seemingly routine nature where an extensive variety of solvent systems 
can be investigated with little consideration. However, standard techniques for growing 
crystals, including solvothermal crystallisation, slow evaporation, slow cooling, vapour 
diffusion and solvent diffusion, could be used. Solvothermal crystallisation allows 
reactions to be performed in a closed vessel, where one has control over the reaction time 
as well as the temperature and pressure of the sample. Although all of these techniques 
were attempted, only slow evaporation yielded crystals suitable for SCD. 
As a starting point, the same approach that was used to grow the crystals of Hf-
Fe(III)PPIX was followed in order to try and grow crystals of other quinoline drug 
compounds complexing to Fe(III)PPIX.
85
 After numerous attempts, none of the samples 
yielded crystals. The next step was to try and grow crystals from an aqueous medium at the 
pH of the food vacuole (roughly 4.8).
18
 However, only amorphous material that 
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precipitated out of solution was recovered. With the discovery of haemozoin crystals in 
association with lipid droplets inside the parasite food vacuole,
60
 the likely environment of 
haemozoin formation shifted from a aqueous environment to a neutral lipid environment. 
Therefore, it was reasoned that drug action could also take place in this environment. The 
strategy for subsequent crystallisation experiments was to make use of solvents such as 
dimethyl sulfoxide (DMSO), methanol, ethanol, acetonitrile and 1-propanol, which have 
been used previously to either grow or extract β-haematin crystals.30,66,67,167  
The success in using the acetonitrile and DMSO-methanol solvent systems to grow 
suitable crystals for SCD is due to persistence in changing Fe(III)PPIX or drug 
concentration, crystal solution environment and utilising all of the crystallisation methods 
mentioned above, until suitable crystals were grown. The procedures that resulted in the 
complexes determined in this study are described in detail below. 
 
4.2.2 X-Ray Crystallography 
 
The Crystallographic Information Files (CIF) along with the final SHELX “.res” and 
“.hkl” files for all crystal structures presented in this chapter can be found on the attached 
CD. 
 
4.2.2.1 The Crystal Structure of QN-Fe(III)PPIX 
 
4.2.2.1.1 Crystallisation of QN-Fe(III)PPIX 
 
The free base form of QN was prepared from an aqueous solution of the salt, using 
concentrated NaOH in order to yield a precipitate of the neutral species. The free base 
form of QN was recovered by drying the precipitate in the presence of phosphorus 
pentoxide for 3 to 7 days. A 3.08 mM stock solution of QN free base was prepared by 
dissolving 10.0 mg (30.82 μmol) in 10.0 mL acetonitrile. A 3.07 mM stock solution of 
Fe(III)PPIX was prepared by mixing Fe(III)PPIX (12.0 mg, 18.4 μmol) in 6.0 mL 
acetonitrile. The crystallisation medium was then prepared by adding 1.00 mL of the QN 
stock solution to 0.40 mL of the Fe(III)PPIX stock solution. Fe(III)PPIX is only sparingly 
soluble in acetonitrile and therefore exists as a suspension, only dissolving upon addition 
of the QN free base. The mixture was stirred for 30 min after which it was filtered through 
a PTFE filter disk (0.45 μm pore size) to remove excess Fe(III)PPIX. The glass vial 
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containing the filtrate was covered with parafilm, which was punctured with 2 needle-sized 
holes to allow for slow evaporation of solvent. The sample was left to stand at room 
temperature, and small needle shaped crystals were observed on the sides of the vial after 3 
days. A crystal of dimensions                mm was selected for X-ray diffraction.  
 
4.2.2.1.2 Structure Solution and Refinement 
 
Apart from the disordered methyl and vinyl groups and the included acetonitrile solvent 
molecule, all non-hydrogen atoms of the complex were refined with anisotropic 
temperature factors. The absolute stereochemistry of the complex was confirmed by the 
value of the Flack parameter [0.024(7)].
168
 Using simple bond length constraints, the 
hydrogen atom located on the quinuclidine nitrogen atom was located in the difference 
map and refined independently with its own displacement parameters. The hydrogen atom 
located on one of the propionic acid groups was also located in the difference map and 
refined independently. There is disorder displayed on the porphyrin pyrrole rings by the 
vinyl and methyl substituents. The vinyl groups are disordered over 2 positions with site 
occupancy factors (s.o.f’s) of 0.50 in each position, and the methyl groups are located in 
the alternate positions, also with s.o.f’s of 0.50 in each position. The QN-Fe(III)PPIX 
moieties pack in layers in the bc plane with acetonitrile solvent molecules located within 
the layers. Located in pockets within and between the layers, the presence of additional 
solvent and/or water molecules is suspected, however, the electron density could not be 
unambiguously modelled. This structure was therefore analysed using SQUEEZE,
165
 
which showed a total void volume of 972 Å
3
 and an electron count of 268 electrons. 
 
4.2.2.2 The Crystal Structure of QD-Fe(III)PPIX  
 
4.2.2.2.1 Crystallisation of QD-Fe(III)PPIX 
 
A 1.53 mM stock solution of Fe(III)PPIX was prepared by dissolving Fe(III)PPIX (10.0 
mg, 15.3 μmol) in 10.0 mL dimethyl sulfoxide. A 25.5 mM stock solution of QD sulphate 
dihydrate was prepared by mixing 100.0 mg (0.255 mmol) in 10.0 mL methanol. The 
crystallisation medium was prepared by adding 0.50 mL of the QD stock solution to 0.20 
mL of the Fe(III)PPIX stock solution in a small 10 mL glass vial. The mixture was stirred 
for 30 min, after which the vial was covered with parafilm. The parafilm was punctured 
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with 2 needle-sized holes to allow for slow evaporation of solvent. The sample was left in 
the fridge for 4 to 5 weeks after which it was noted that small crystals had formed on the 
bottom of the vial. A single crystal of dimensions                mm was selected for 
X-ray diffraction.  
 
4.2.2.2.2 Structure Solution and Refinement 
 
All non-hydrogen atoms of the complex were refined with anisotropic temperature factors. 
The absolute stereochemistry of the complex was confirmed by the value of the Flack 
parameter [0.020(5)].
168
 As for QN-Fe(III)PPIX, the hydrogen atom located on the 
quinuclidine nitrogen atom was located in the difference map and refined independently 
with its own displacement parameters, using simple bond length constraints. The hydrogen 
atom located on one of the propionic acid groups was also located in the difference map 
and refined independently as before. There is disorder displayed on the porphyrin pyrrole 
rings by the vinyl and methyl substituents. As before, the vinyl groups are disordered over 
2 positions with s.o.f’s of 0.50 in each position and the methyl groups are located in the 
alternate position, also with s.o.f’s of 0.50 in each position. The QD-Fe(III)PPIX structure 
packs to form channels in which disordered solvent molecules are included. The highly 
disordered solvent molecules could not be successfy modelled and instead, the structure 
was analysed using SQUEEZE,
165
 the results of which showed a total void volume of 3696 
Å
3
 and an electron count of 1192 electrons. 
 
4.2.2.3 The Crystal Structure of MQ-Fe(III)PPIX 
 
4.2.2.3.1 Crystallisation of MQ-Fe(III)PPIX 
 
Using concentrated NaOH in order to yield a precipitate of the neutral species, the free 
base of CQ was prepared from an aqueous solution of the salt. The free base form of CQ is 
hygroscopic, and was recovered by freeze drying the “sticky” precipitate. A solution 
containing 3.13 mM CQ free base and 2.42 mM MQ hydrochloride was prepared by 
dissolving CQ free base (5.0 mg, 15.6 μmol) and MQ (5.0 mg, 0.012 mmol) in 5.0 mL 
acetonitrile. It is important to note that MQ is obtained from Sigma-Aldrich as a racemate. 
After stirring the solution until all species had completely dissolved, haemin (4.0 mg, 6.14 
μmol) was added. The resultant solution was stirred at 50 oC for a further 20 min, after 
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which it was filtered through a PTFE filter disc (0.45 μm pore size) to remove excess 
Fe(III)PPIX. The glass vial containing the filtrate was then capped and placed in a water 
bath at 37 
o
C for 24 hours. Small plate-shaped crystals were observed on the bottom of the 
vial after 24 hours. A single crystal of dimensions              mm was selected for 
X-ray diffraction.  
 
4.2.2.3.2 Structure Solution and Refinement  
 
Since two enantiomers of MQ were present in solution, it was not unexpected that two 
MQ-Fe(III)PPIX moieties were found in the asymmetric unit. For clarity, one is referred to 
as MQ-Fe(III)PPIX (I) and the other one as MQ-Fe(III)PPIX (II). Apart from some of the 
atoms on the disordered acetonitrile solvent molecules, all non-hydrogen atoms were 
refined with anisotropic temperature factors. The hydrogen atoms located on the propionic 
acid groups and the piperidine nitrogen atoms were located in the difference map and 
refined independently, with a simple bond length constraint for the H atoms on the 
nitrogens. There is disorder displayed on the porphyrin pyrrole rings by the vinyl and 
methyl substituents in both moieties. In MQ-Fe(III)PPIX (I), the vinyl groups are 
disordered over two positions with s.o.f’s of 0.74 and 0.26. The vinyl group with an 
occupancy of 0.74 is disordered further over two positions with s.o.f’s of 0.42 and 0.32. In 
MQ-Fe(III)PPIX (II), the vinyl groups are disordered over two positions with s.o.f’s of 
0.52 and 0.48, with the group with occupancy 0.52 being further disordered over two 
positions (s.o.f’s of 0.21 and 0.31). One of the trifluoromethyl groups on the MQ-
Fe(III)PPIX (II) moiety is disordered over two positions with s.o.f’s of 0.47 and 0.53 
respectively. Simple bond length constraints were applied to this disordered group. In the 
MQ-Fe(III)PPIX (I) propionate group, both oxygen atoms are disordered over two 
positions, with s.o.f’s. of 0.81 and 0.19. The disordered acetonitrile molecules were 
modelled isotropically and simple bond length constraints were applied. One of the 
acetonitrile solvent molecules is disordered over two positions, which were modeled with 
s.o.f’s of 0.65 and 0.35. The remaining disordered acetonitrile molecule was modeled with 
partial occupancy, and over two positions with s.o.f.’s of 0.30 and 0.52. The water 
molecule was also modeled with a partial occupancy of 0.29. 
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4.2.3 The Association of QD and QN with Fe(III)PPIX in Solution 
 
4.2.3.1 Preparation of Solutions 
 
4.2.3.1.1 Fe(III)PPIX Stock Solution 
 
A 1.23 mM solution of Fe(III)PPIX was prepared by dissolving haemin (8.00 mg, 12.27 
μmol) in 10.0 mL DMSO. 
 
4.2.3.1.2 QD Stock Solutions 
 
A: A 10.0 mM stock solution of QD sulphate dihydrate was prepared by dissolving the 
solid (6.10 mg, 15.0 μmol) in 1.50 mL methanol. 
B: A 10.0 mM stock solution of free base QD was prepared by dissolving the solid (4.80 
mg, 14.80 μmol) in 1.50 mL acetonitrile. The free base form of QD was prepared from an 
aqueous solution of the salt using concentrated NaOH in order to yield a precipitate of the 
neutral species. The free base form of QD was recovered by drying the precipitate in the 
presence of phosphorus pentoxide for 3 to 7 days. 
C: A 2.5 mM stock solution of QD sulphate dihydrate was prepared by dissolving the solid 
(1.5 mg, 3.8 μmol) in 1.50 mL 1-pentanol. 
D: A 10.0 mM stock solution of QD sulphate dihydrate was prepared by dissolving the 
solid (6.10 mg, 15.0 μmol) in 0.15 mL HEPES (2 M, pH 7.5) and 1.35 mL H2O.  
 
4.2.3.2 Experimental Procedures 
 
4.2.3.2.1 The Association of QD with Fe(III)PPIX in DMSO-Methanol 
 
The sample cuvette contained 20.0 μL Fe(III)PPIX stock solution, 580.0 μL DMSO and 
1400.0 μL methanol, while the reference cuvette contained 600.0 μL DMSO and 1400.0 
μL methanol. Spectrophotometric titrations of Fe(III)PPIX were performed by the addition 
(to both sample and reference) of 4 × 5.0 μL aliquots followed by 6 × 10.0 μL and 1 × 20.0 
μL aliquots of drug stock solution A. The UV-vis spectra of the solutions were recorded 
between 300-800 nm after each addition of the QD stock solution and corrected for 
Stellenbosch University  http://scholar.sun.ac.za
Chapter 4 – Fe(III)PPIX-Drug Complexes 
97 
 
dilution. The final drug concentration in the cuvette was approximately 0.476 mM, 
compared to 0.012 mM Fe(III)PPIX. 
 
4.2.3.2.2 The Association of QD with Fe(III)PPIX in Acetonitrile 
 
The sample cuvette contained 20.0 μL Fe(III)PPIX stock solution and 1980.0 μL 
acetonitrile, while the reference cuvette contained 20.0 μL DMSO and 1980.0 μL 
acetonitrile. Spectrophotometric titrations of Fe(III)PPIX were performed by the addition 
(to both sample and reference) of 4 × 5.0 μL aliquots followed by 6 × 10.0 μL and 1 × 20.0 
μL aliquots of drug stock solution B. The UV-vis spectra of the solutions were recorded 
between 300-800 nm after each addition of the QD stock solution and corrected for 
dilution. The final drug concentration in the cuvette was approximately 0.476 mM, 
compared to 0.012 mM Fe(III)PPIX. 
 
4.2.3.2.3 The Association of QD with Fe(III)PPIX in 1-Pentanol 
 
The sample cuvette contained 20.0 μL Fe(III)PPIX stock solution and 1980.0 μL 1-
pentanol, while the reference cuvette contained 20.0 μL DMSO and 1980.0 μL 1-pentanol. 
Spectrophotometric titrations of Fe(III)PPIX were performed by the addition (to both 
sample and reference) of 4 × 5.0 μL aliquots followed by 6 × 10.0 μL and 1 × 20.0 μL 
aliquots of drug stock solution C. The UV-vis spectra of the solutions were recorded 
between 300-800 nm after each addition of the QD stock solution and corrected for 
dilution. The final drug concentration in the cuvette was approximately 0.119 mM 
compared to 0.012 mM Fe(III)PPIX. 
 
4.2.3.2.4 The Association of QD with Fe(III)PPIX in Aqueous Solution 
 
The sample cuvette contained 40.0 μL Fe(III)PPIX stock solution, 200.0 μL HEPES (2 M,. 
pH 7.5) and 1760.0 μL H2O while the reference cuvette contained 40.0 μL DMSO, 200 μL 
HEPES (2 M, pH 7.5) and 1760.0 μL H2O. Spectrophotometric titrations of Fe(III)PPIX 
were performed by the addition (to both sample and reference) of 4 × 5.0 μL aliquots 
followed by 6 × 10.0 μL and 1 × 20.0 μL aliquots of drug stock solution D. The UV-vis 
spectra of the solutions were recorded between 300-800 nm after each addition of the QD 
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stock solution and corrected for dilution. The final drug concentration in the cuvette was 
approximately 0.476 mM compared to 0.024 mM Fe(III)PPIX. 
The association of QN with Fe(III)PPIX in the DMSO-methanol and acetonitrile solvent 
systems was investigated using the same experimental procedures as described above for 
QD except that QD was replaced with QN, either as a salt or free base as required.  
 
4.2.4 EXAFS Studies of Fe(III)PPIX-Drug Species 
 
4.2.4.1 Sample Preparation 
 
The Fe Kα-edge EXAFS spectra were collected at the X-ray absorption spectroscopy 
(XAS) beamline at the Australian synchrotron. The crystals investigated, namely those of 
QD-Fe(III)PPIX, QN-Fe(III)PPIX and MQ-Fe(III)PPIX were grown as described in 
section 4.2.2 above. The crystals were placed in the sample holder with as much of the 
mother liquor removed as physically possible. In the case of the crystallisation solutions, 
the amount of haemin and drug was increased to yield a final Fe(III)PPIX concentration of 
10 mM in order to obtain the best data possible. However, in the crystallisation solutions of 
QN-Fe(III)PPIX and MQ-Fe(III)PPIX, the actual concentration was lower owing to the 
poor solubility of haemin in acetonitrile. All liquid samples were filtered through a PTFE 
filter disk (0.45 μm pore size) to obtain homogeneous solutions and were prepared 
immediately before the EXAFS experiment was conducted.  
All samples were flash frozen in liquid nitrogen, and the cryogenic temperature of   18K 
was maintained for the duration of the measurement of the sample to limit thermal disorder 
and avoid sample degradation. Spectra were collected from several locations within the 
sample to ensure the sample was homogenous and to limit sample damage due to 
continuous exposure to the X-ray beam.  
 
4.2.4.2 Data Analyses 
 
The raw EXAFS scans collected by the 100-channel Ge detector were merged using the 
AVERAGE program.
159
 Data processing and background removal were achieved with 
ATHENA and AUTOBK respectively, while fitting of experimental data to the 
corresponding model was done with ARTEMIS.
160,161
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4.3 Results 
 
4.3.1 The Crystal Structure of QN-Fe(III)PPIX 
 
QN-Fe(III)PPIX was crystallised by slow evaporation from an acetonitrile solution of 
Fe(III)PPIX and QN in its free base form and small needle-like crystals were recovered 
from the side of the glass vial after three days. A single crystal of dimensions 0.26 × 0.13 × 
0.10 mm was selected for single crystal X-ray diffraction. Structural analysis revealed that 
QN-Fe(III)PPIX crystallises in the orthorhombic space group C2221. The asymmetric unit 
is show in Figure 4.1 and the crystal and structural refinement parameters are summarised 
in Table 4.1.  
 
Figure 4.1 The asymmetric unit of the QN-Fe(III)PPIX complex. An intramolecular hydrogen 
bond between the propionate side chain of Fe(III)PPIX and the protonated quinuclidine nitrogen 
atom of the drug is shown as a red dashed line, with atoms involved in hydrogen bonding and the 
Fe(III) centre labelled. Solvent molecules and non-relevant H atoms have been removed for clarity. 
Atom colour coding: grey – C, cyan – Fe, dark blue – N, red – O and white – H. 
 
  
O2 O4
O1
H4
H5N
N5
Fe
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Table 4.1 Crystal data, experimental and refinement parameters for QN-Fe(III)PPIX. 
Molecular formula  C54H55N6O6Fe1.C2H3N 
Stoichiometry 1:1 
Formula weight / g mol
-1
 985.98 
Crystal system  orthorhombic 
Space group  C2221 
Unit cell dimensions (Å, °) a = 22.4947(9)  α =  90.00 
 b = 24.785(1) β =  90.00 
 c = 18.0929(6) γ =  90.00 
Z  8 
Crystal size (mm
3
) 0.26 × 0.13 × 0.10 
Temperature (K)  100(2) 
µ (mm
-1
) 2.864 
Independent reflections 6918 
Rint 0.0751 
Goodness of fit, S 0.868 
Final R indices [I˃2σ(I)] R1 = 0.0754, wR2 = 0.2046 
 
 
An intramolecular hydrogen bond between the propionate side chain of Fe(III)PPIX and 
the protonated quinuclidine nitrogen atom of the drug is observed in the asymmetric unit, 
while intermolecular hydrogen bonding occurs between the Fe(III)PPIX propionate group 
of one complex and the propionic acid side chain of a neighbouring complex. The 
intermolecular hydrogen bond results in pairs of hydrogen bonded QN-Fe(III)PPIX 
moieties. The various hydrogen bonds in the crystal structure are shown in Figure 4.2, 
while the hydrogen bond geometries are reported in Table 4.2. 
 
Figure 4.2 Hydrogen bonds (red dashed lines) observed in the crystal packing of QN-Fe(III)PPIX 
are (i) N5―H5N∙∙∙∙O2 (intramolecular hydrogen bond) and (ii) O4―H4∙∙∙∙O1 (intermolecular 
hydrogen bond). Solvent molecules and non-relevant H atoms have been removed for clarity. Atom 
colour coding: grey – C, cyan – Fe, dark blue – N, red – O and white – H. 
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Table 4.2 Hydrogen bond geometry in the QN-Fe(III)PPIX crystal structure. 
Complex D―H∙∙∙∙A D―H (Å) H∙∙∙∙A (Å) D∙∙∙∙A (Å) D―H∙∙∙∙A (
 o
) 
QN-
Fe(III)PPIX 
N5―H5N∙∙∙∙O2 0.99(1) 1.69(1) 2.677(8) 174(14) 
O4―H4∙∙∙∙O1* 0.88(3) 1.74(2) 2.578(7) 159(4) 
*
Symmetry code: 
 –x+1, y, -z+2 
 
 
In the crystal packing, the spaces in between the QN-Fe(III)PPIX moieties result in voids 
(with a total volume of 972 Å
3
) which are filled with disordered solvent molecules. Figure 
4.3 shows the packing in the crystal structure viewed along the crystallographic a-axis, 
with the disordered solvent molecules shown in space-filled mode. 
 
 
Figure 4.3 Crystal packing of QN-Fe(III)PPIX viewed along the crystallographic a-axis as 
indicated by the unit cell. Disordered acetonitrile molecules are shown in light blue (space-filling). 
Atom colour coding: grey – C, cyan – Fe, dark blue – N, red – O and white – H. 
  
b
a
c
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4.3.2 The Crystal Structure of QD-Fe(III)PPIX  
 
Crystals of QD-Fe(III)PPIX were obtained by slow evaporation from a 3:7 (v/v) solution of 
DMSO-methanol, with drug added in excess in its acid form as a hemisulfate salt. Small 
crystals were recovered from the side of the glass vial after six weeks. A single crystal of 
dimensions 0.30 × 0.18 × 0.13 mm was selected for X-ray diffraction. Structural analysis 
revealed that QD-Fe(III)PPIX crystallises in the orthorhombic space group I222. The 
asymmetric unit is shown in Figure 4.4 and the crystal and structural refinement 
parameters are summarised in Table 4.3. 
  
Figure 4.4 The asymmetric unit of the QD-Fe(III)PPIX complex. An intramolecular hydrogen 
bond between the propionate side chain of Fe(III)PPIX and the protonated quinuclidine nitrogen 
atom of the drug is shown as a red dashed line, with atoms involved in hydrogen bonding and the 
Fe(III) centre labelled. Solvent molecules and non-relevant H atoms have been removed for clarity. 
Atom colour coding: grey – C, cyan – Fe, dark blue – N, red – O and white – H. 
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Table 4.3 Crystal data, experimental and refinement parameters for QD-Fe(III)PPIX. 
Molecular formula  C54H55N6O6Fe1 
Stoichiometry 1:1 
Formula weight / g mol
-1
  939.89 
Crystal system  orthorhombic 
Space group  I222 
Unit cell dimensions (Å, °) a = 16.9423(6)  α =  90.00 
 b = 20.4999(6) β =  90.00 
 c = 34.755(1) γ =  90.00 
Z  8 
Crystal size (mm
3
) 0.30 × 0.18 × 0.13 
Temperature (K)  100(2) 
µ (mm
-1
) 2.369 
Independent reflections 10073 
Rint 0.0508 
Goodness of fit, S 0.878 
Final R indices [I˃2σ(I)] R1 = 0.0605, wR2 = 0.1931 
 
 
An intramolecular hydrogen bond between the propionate side chain of Fe(III)PPIX and 
the protonated quinuclidine nitrogen atom of the drug is observed in the asymmetric unit, 
while the intermolecular hydrogen bonding between the Fe(III)PPIX propionate and 
propionic acid side chain of a neighbouring complex results in pairs of hydrogen bonded 
QD-Fe(III)PPIX moieties. The various hydrogen bonds in the crystal structure are shown 
in Figure 4.5, while specific details of hydrogen bond geometries are reported in Table 4.4.  
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Figure 4.5 Hydrogen bonds (red dashed lines) observed in the crystal packing of QD-Fe(III)PPIX 
are (i) N5―H5N∙∙∙∙O2 (intramolecular hydrogen bond) and (ii) O4―H4∙∙∙∙O1 (intermolecular 
hydrogen bond). Solvent molecules and non-relevant H atoms have been removed for clarity. The 
two hydrogen-bonded pairs of QD-Fe(III)PPIX moieties shown are coloured grey and green 
respectively. Atom colour coding: blue – N, red – O and white – H. 
 
Table 4.4 Hydrogen bond geometry in the QD-Fe(III)PPIX crystal structure. 
Complex D―H∙∙∙∙A D―H (Å) H∙∙∙∙A (Å) D∙∙∙∙A (Å) D―H∙∙∙∙A (
 o
) 
QD-
Fe(III)PPIX 
N5―H5N∙∙∙∙O2 0.99(1) 1.66(1) 2.669(4) 175(6) 
O4―H4∙∙∙∙O1* 0.84 1.76 2.525(5) 154(6) 
*
Symmetry code: 
 –x+1, y, -z+2 
 
 
The intermolecular hydrogen bonding between the Fe(III)PPIX propionate and propionic 
acid side chain of the neighbouring complex is supported by an observed vibration at 
approximately 1702 cm
-1
 in the infrared spectrum of QD-Fe(III)PPIX, shifted almost 10 
cm
-1
 relative to the starting material (Fe(III)PPIX), confirming the presence of at least one 
propionic acid group in the product (Figure 4.6).  
(ii)
(ii)
(ii)
(ii)
(i) (i)
(i)(i)
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Figure 4.6 Infrared spectra of the QD-Fe(III)PPIX complex (thick black line) as well as the 
starting materials QD.HSO4 (thin black line) and Fe(III)PPIX (thin grey line). The vertical dashed 
line indicates the carbonyl stretch assigned to a carboxylic acid functional group. This corresponds 
to the propionic acid side chain of Fe(III)PPIX.  
 
The QD-Fe(III)PPIX moieties pack in the crystal structure forming rather large channels 
filled with disordered solvent molecules: SQUEEZE analysis indicated a total void volume 
of 3696 Å
3
. The channels are best appreciated when viewing the unit cell along the 
crystallographic b-axis (Figure 4.7).  
 
Figure 4.7 Crystal packing of QD-Fe(III)PPIX viewed along the crystallographic b-axis, as 
indicated by the unit cell. Disordered DMSO and methanol molecules are shown in light blue 
(space-filling). Atom colour coding: grey – C, cyan – Fe, dark blue – N, red – O and white – H. 
1500160017001800
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4.3.3 Similarities Between QN-Fe(III)PPIX and QD-(III)PPIX  
 
In addition to the hydrogen bonding features described above, the crystal structures of the 
QN-Fe(III)PPIX and QD-Fe(III)PPIX complexes share a number of structural features 
which may be important for the interaction of the drug with its proposed target, 
Fe(III)PPIX. First, analysis of the crystal structures confirms that the benzylic alcohol 
functional group of the drug is deprotonated in both complexes, facilitating coordination to 
the Fe(III) centre of Fe(III)PPIX. Second, the Fe-O bond lengths of 1.866 and 1.862 Å 
respectively, are in agreement with the coordination of an alkoxide (1.816 – 1.867 
Å),
127,128,129,130
 rather than an alcohol (2.112 – 2.160 Å).131,132  
In the QN-Fe(III)PPIX and QD-Fe(III)PPIX complexes, we observed that the quinoline 
ring is tilted at an angle of approximately 12.7
o 
and 10.1
o
 relative to the mean porphyrin 
plane and furthermore is located towards the edge of the porphyrin. One of the aromatic 
porphyrin pyrrole rings and the drug quinoline ring make their closest contact with one 
another at a distance of approximate 3.3 Å in both structures. The mean interplanar 
distance between the two aromatic systems is approximately 3.3 Å, which is consistent 
with π-stacking (Figure 4.8).169 
 
Figure 4.8 The π-π interaction found between aromatic rings. Reproduced from reference.169  
 
An interesting feature observed in the crystal packing in both structures is that there is 
additional π-stacking between the unligated faces of Fe(III)PPIX of adjacent alkaloid-
Fe(III)PPIX moieties, which may be a direct consequence of the crystal packing (Figure 
4.9 (a) and (b)). However, the geometry of the porphyrins relative to one another is 
reminiscent of that reported for the so called π-π dimer.79,83 The Fe(III) centres are offset 
relative to one another with a distance of 3.4 Å between the mean porphyrin planes.  
Stacked Offset 
  Stacking 
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Figure 4.9 The offset π-π dimerisation observed between (a) QN-Fe(III)PPIX, and (b) QD-
Fe(III)PPIX moieties in the crystal packing. (c) This “dimer” resembles the π-π dimer predicted in 
aqueous solution which was supported by the SCD structure of Cheng et al.
83
 for aqua-iron(III) 
octaethylporphyrin perchlorate.
83
 Picture (c) is reproduced from reference.
83
 Hydrogen bonds are 
shown as red dashed lines.  
 
Due to the highly disordered solvent molecules, which could not be successfully modelled 
in either structure, the structures were analysed using SQUEEZE.
146
 The results showed a 
total void volume of 972 Å
3
 and 3696 Å
3
 and an electron count of 268 and 1192 electrons 
for QN-Fe(III)PPIX and QD-Fe(III)PPIX, respectively. It is clear that the packing in each 
crystal structure is unique. This interesting result is unexpected at first given that QN-
Fe(III)PPIX and QD-Fe(III)PPIX complexes share so many structural similarities. An 
interesting observation in the crystal packing of QD-Fe(III)PPIX is the presence of rather 
large channels filled with disordered solvent molecules. Since porous materials are of 
increasing interest for gas storage and other applications, preliminary attempts were made 
to exchange the solvent in the crystals with other solvents, however, all attempts were 
unsuccessful. We suspect that this may be due to the fact that these crystals are seemingly 
very fragile when removed from their mother liquor. 
 
  
(a) (b) (c)
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4.3.4 The Crystal Structure of MQ-Fe(III)PPIX 
 
Crystals of MQ-Fe(III)PPIX were obtained from an acetonitrile solution of Fe(III)PPIX, 
MQ hydrochloride and CQ free base. Small needle-like crystals were recovered from the 
side of the glass vial after one day. A single crystal of dimensions 0.05 × 0.1 × 0.2 mm was 
selected for X-ray diffraction and structural analysis revealed that the MQ-Fe(III)PPIX 
complex crystallises in the triclinic space group P ̅. The asymmetric unit is shown in 
Figure 4.10 and the crystal and structural refinement parameters are summarised in Table 
4.5. 
 
Figure 4.10 (a) The asymmetric unit of the MQ-Fe(III)PPIX complex contains both of the erythro 
enantiomers of MQ, labelled (I) and (II) respectively. (b) The display of I and II above does not 
reflect the asymmetric unit; rather the two moieties in the asymmetric unit of MQ-Fe(III)PPIX (I 
and II), determined by SCD, were separated to make viewing of the atoms more visible with the 
two MQ-Fe(III)PPIX moieties in the asymmetric unit having a (I) C46R, C47S configuration and (II) 
C97S, C98R configuration respectively. Intramolecular hydrogen bonds are shown with red dashed 
lines with chiral centres and the Fe(III) centres labelled. Solvent molecules and non-relevant H 
atoms have been removed for clarity. Atom colour labelling: grey – C, cyan – Fe, dark blue – N, 
light blue – F, red – O and white – H. 
C46
Fe1
Fe2
(I) (II)
C47
C97
C98
Fe1
Fe2
(I) (II)
(a)
(b)
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In chapter 6 it will be shown that in the presence of haemin and CQ free base, the 
formation of β-haematin (DMSO solvate) crystals occurs. Therefore, the rationale in 
adding CQ free base and MQ together with haemin in solution was to see if MQ would 
block the formation of β-haematin DMSO solvate crystals. Indeed, this was found to be the 
case, as the MQ-Fe(III)PPIX complex was formed preferentially. 
 
Table 4.5 Crystal data, experimental and refinement parameters for MQ-Fe(III)PPIX. 
Molecular formula  C108H101O11Fe2N15F12  
Stoichiometry 1:1 
Formula weight / g mol
-1
  2155.81 
Crystal system  Triclinic 
Space group  P ̅ 
Unit cell dimensions (Å, °) a = 13.655(1)  α =  90.523(1) 
 b = 18.596(2) β =  108.490(1) 
 c = 20.269(2) γ =  96.048(2) 
Z  2 
Crystal size (mm
3
) 0.20 × 0.10 × 0.05 
Temperature (K)  100(2) 
µ (mm
-1
) 0.395 
Independent reflections 24809 
Rint 0.0522 
Goodness of fit, S 1.029 
Final R indices [I˃2σ(I)] R1 = 0.0597, wR2 = 0.1479 
 
 
MQ exists as a mixture of four diastereomers, which are divided into (+)- and (-)-erythro 
enantiomers having (11R,12S) and (11S,12R) configurations respectively, and the (+)- and 
(-)-threo enantiomers having (11R,12R) and (11S,12S) configurations respectively (Figure 
4.11). The MQ used in this study was obtained from Sigma-Aldrich as a racemate. 
Therefore, the MQ-Fe(III)PPIX crystal structure contains a mixture of the erythro 
enantiomers of MQ with the two MQ-Fe(III)PPIX moieties in the asymmetric unit having 
C46R, C47S configuration (Figure 4.10 (I)) and C97S, C98R configuration (Figure 4.10 (II)) 
respectively, which is expected. A racemic mixture of erythro enantiomers is most 
commonly used in clinical practice. However, the neurological side effects of MQ seem to 
be associated with the (-)-erythro enantiomer of MQ and therefore, enantiopure MQ is 
ideal.
170
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Figure 4.11 Optical isomers of MQ include (a) erythro enantiomers and (b) the threo enantiomers. 
 
In the crystal structure of MQ-Fe(III)PPIX, coordination to the Fe(III) centre of 
Fe(III)PPIX via the deprotonated benzylic alcohol functional group of the drug is also 
observed. The Fe1-O5 and Fe2-O10 bond lengths are 1.899 and 1.891 Å respectively, 
which again is consistent with the coordination of an alkoxide species.
127,128,129,130 Three 
intramolecular hydrogen bonds are observed in each complex (I and II); the first occurs 
between the propionate and propionic acid side chains of Fe(III)PPIX, while the other two 
occur between each of these groups and the piperidinium nitrogen atom of the drug. This 
network of intramolecular hydrogen bonds is shown in Figure 4.12, while the hydrogen 
bond geometries are reported in Table 4.6. An interesting observation is the absence of the 
intermolecular hydrogen bonds through Fe(III)PPIX propionate and propionic acid side 
chains of neighbouring complexes that were present in the QN and QD complexes. 
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CF3
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Figure 4.12 The hydrogen bonding network in the MQ-Fe(III)PPIX structure for the two MQ-
Fe(III)PPIX moieties in the asymmetric unit having a (I) C46R, C47S and (II) C97S, C98R 
configuration respectively. The display of I and II above does not reflect the asymmetric unit; 
rather the two moieties in the asymmetric unit of MQ-Fe(III)PPIX (I and II), determined by SCD, 
were separated to make numbering of the atoms more visible. 
 
Table 4.6 Hydrogen bond geometry in the MQ-Fe(III)PPIX crystal structure. 
Complex D―H∙∙∙∙A D―H (Å) H∙∙∙∙A (Å) D∙∙∙∙A (Å) D―H∙∙∙∙A (
 o
) 
MQ-
Fe(III)PPIX 
(C46R, C47S)* 
MQ-
Fe(III)PPIX 
(C92S, C98R)* 
N6―H6A∙∙∙∙O2 
N6―H6B∙∙∙∙O4 
O1―H12∙∙∙∙O3 
0.99 
1.00 
0.95 
2.21 
1.75 
1.63 
3.003(4) 
2.712(5) 
2.577(4) 
136.0 
161.5 
170.6 
N12―H12A∙∙∙∙O7 
N12―H12B∙∙∙∙O9 
O8―H8∙∙∙∙O6 
1.00 
0.99 
0.84 
1.72 
2.30 
1.70 
2.698(3) 
3.083(3) 
2.536(3) 
162.8 
134.8 
173.8 
* Labelling as in the crystal structure of MQ-Fe(III)PPIX 
 
 
The crystal packing of MQ-Fe(III)PPIX is best appreciated when viewing the unit cell 
along the crystallographic b-axis as shown in Figure 4.13. The MQ-Fe(III)PPIX moieties 
pack in the crystal to form layers along the crystallographic c-axis. The empty spaces 
within the layers are filled with disordered acetonitrile solvent and water molecules. 
 
O1
O2
O3
O4
H12
H6AH6B
N6
Fe1
O7O9
O6
O8
H8
H12AH12B
N12
Fe2
(I) (II)
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As before, some π-π stacking between the unligated faces of Fe(III)PPIX of adjacent 
alkaloid-Fe(III)PPIX moieties is observed. The distance between the mean porphyrin 
planes are 3.38 and 3.69 Å, respectively with the Fe(III) centres offset relative to one 
another (Figure 4.13).  
 
Figure 4.13 Crystal packing of MQ-Fe(III)PPIX viewed along the crystallographic b-axis as 
indicated by the unit cell. The offset π-π dimerisation is also observed between adjacent MQ-
Fe(III)PPIX moieties in the crystal packing. Disordered solvent molecules have been removed for 
clarity. 
 
4.3.5 The Association of QD and QN with Fe(III)PPIX in Solution  
 
While the crystal structures of the quinoline methanols complexing with Fe(III)PPIX 
provide insight into the key interaction in the solid state, the question of whether the same 
interactions (effectively the same species) are observed in solution needed to be addressed. 
Asher et al.
86
 showed that Fe(III)PPIX exhibits complex speciation equilibria in mixed 
aqueous solutions. Comparing the UV-vis spectra of Fe(III)PPIX in various solvent 
systems, it was found that in 40% (v/v) aqueous DMSO, pH 7.5, Fe(III)PPIX exists as a 
a
c
0
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monomer, although in the same concentration of methanol, Fe(III)PPIX exists as a π-π 
dimer which is independent of pH.
86
 
In the present study, crystals of QD-Fe(III)PPIX and QN-Fe(III)PPIX were obtained under 
non-biological conditions: 3:7 (v/v) DMSO-methanol solution in the case of the QD-
Fe(III)PPIX, and acetonitrile in the case of the QN-Fe(III)PPIX. However, as neither of the 
solvents were anhydrous, trace amounts of water could therefore be expected.  
The speciation of Fe(III)PPIX in 3:7 (v/v) DMSO-methanol solution was determined 
before and after spectrophotometric titration with both QD and QN hemisulfate salts 
(Figure 4.14 (a) and Figure 4.15 (a)). Similarly, both QD free base and QN free base were 
titrated against Fe(III)PPIX in acetonitrile (Figure 4.14 (b) and Figure 4.15 (b)), since these 
solutions represent the crystallisation media of the QD-Fe(III)PPIX and QN-Fe(III)PPIX 
crystals respectively. The initial spectra are shown in red and the final spectra are shown 
with light blue dashed lines in Figure 4.14. In Figure 4.15 only the initial and final spectra 
after all the titrations are shown in the graphs for clarity.  
Since the proposed location of drug activity has shifted from an aqueous environment to a 
neutral lipid environment,
60
 the speciation of Fe(III)PPIX in 1-pentanol, which is used as a 
simple model for a lipid in β-haematin formation studies at the lipid-water interface 
system,
73
 was investigated before and after spectrophotometric titration with QD 
hemisulfate salt (Figure 4.14 (c)). For comparison, the titration was repeated in aqueous 
solution and the results are shown in Figure 4.14 (b). 
The UV-vis spectrum of monomeric Fe(III)PPIX in 40% aqueous DMSO shows a 
distinctive Soret band at approximately 400 nm due to the major electronic transition of the 
porphyrin core. In the absence of either of the Cinchona alkaloids, the speciation of 
Fe(III)PPIX in 3:7 (v/v) DMSO-methanol is consistent with a monomeric species. Little 
change is observed in the UV-vis spectrum in this medium upon titration of Fe(III)PPIX 
with QD or QN (Figure 4.14 (a) and Figure 4.15 (a)). Following titration with QD free 
base or QN free base in acetonitrile (Figure 4.14 (b) and Figure 4.15 (b)), a very similar 
final spectrum to that seen in 3:7 (v/v) DMSO-methanol solutions was observed, though 
this is quite different to the broadly domed Soret peak at 387 nm observed in the absence 
of either QN or QD. Direct observation of the Fe(III)PPIX speciation in a lipid solution 
was not possible due to light scattering. However, as 1-pentanol has been used as a simple 
model for a lipid, we investigated the speciation of Fe(III)PPIX in this alcohol (Figure 4.14 
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(c)). The final spectrum is again similar to the spectra recorded in both DMSO-methanol 
and acetonitrile solutions. However, compared to the spectrum recorded in aqueous 
solution, the final spectra recorded in organic solutions are different. In aqueous solution, 
the Soret band is broad and flat indicating a dimeric Fe(III)PPIX species. The charge-
transfer band observed at ~603 nm in the spectra of Fe(III)PPIX in organic solvents differ 
from that in aqueous solution, suggesting different ligand interactions at the Fe(III) centre. 
 
Figure 4.14 The UV-vis spectra of Fe(III)PPIX in solution before (―) and after 
spectrophotometric titration with QD hemisulphate (---). Conditions are (a) 3:7 (v/v) DMSO-
methanol, (b) acetonitrile (titration with QD free base for solubility reasons), (c) 1-pentanol and (d) 
aqueous solution (0.2 M HEPES, pH 7.4). The position of the charge transfer band at 603 nm is 
marked by dotted vertical lines shown in the inset. As shown in the inset, the dotted line at 603 nm 
coincides with the charge transfer band in spectra (a-c) but not in aqueous solution (d). 
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Figure 4.15 The UV-vis spectra of Fe(III)PPIX in solution before (―) and after 
spectrophotometric titration with QN hemisulphate (---). Conditions are (a) 3:7 (v/v) DMSO-
methanol and (b) titration with QN free base in acetonitrile. The position of the charge transfer 
band at 603 nm is marked by dotted vertical lines shown in the inset. 
 
4.3.6 EXAFS Studies 
 
To further investigate whether the drug-Fe(III)PPIX complexes persist in solution, EXAFS 
spectroscopy was carried out. Spectra of crystalline samples of QD-Fe(III)PPIX, QN-
Fe(III)PPIX and MQ-Fe(III)PPIX were collected together with spectra of the 
crystallisation medium of each.  
In order to analyse the EXAFS data, a reasonable starting model of the neighbouring atoms 
around the absorbing Fe atom was needed as these atoms could be involved in photo-
electron back scattering. In all three cases, having access to the single crystal diffraction 
data was particularly useful. This data was used to generate coordinates for all non-
hydrogen atoms in a sphere of ≤ 5.0 Å around the central Fe atom of the porphyrin. 
Contributions from the porphyrin include the four nitrogen atoms directly bonded to the Fe 
centre, the α and meso carbon atoms, and the β-carbon atoms (Figure 4.16). Atoms 
involved in coordination to the Fe centre, for example the oxygen atom of the deprotonated 
alcohol functional group of quinoline methanol antimalarial drugs and all drug atoms used 
in the refinement, are referred to as axial atoms (a.a.), while atoms from a second 
Fe(III)PPIX molecule that could attribute to the backscattering as a result of π-π 
interactions or stacking between Fe(III)PPIX-drug moieties in the crystal packing, are 
labelled as atoms outside the ring (a.o.). The positions of the above mentioned atoms in the 
model were compared to the corresponding atomic positions determined from the EXAFS 
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refinement. The resulting R-factor, which indicates the goodness of fit, as well as best fit 
values of bond lengths, were used to rationalize whether species observed in the solid-state 
persist in solution or not. 
 
Figure 4.16 The atoms of Fe(III)PPIX included in the model used in the EXAFS refinement.         
(a) This includes the four nitrogen atoms and axial oxygen atom in blue, the α carbon atoms in 
orange, the β carbon atoms in green and the meso carbon atoms coloured yellow. (b) When 
connecting the atoms of the same colour with a circle, the circle represents all the atoms that 
contribute to any one shell in the EXAFS refinement.  
 
In the fitting process, N(X) is the average number of atoms considered to be in a particular 
shell,   is the distance (Å) from the absorbing atom (Fe) to the atoms in a particular shell, 
and    (Å2) is the Debye-Waller factor accounting for the dynamic (and partial static) 
disorder of the atoms in any shell. Further refinement parameters for all spectra include 
E0 (in eV) which is the shift in the photo-electron energy threshold (from E0 ~ 7122eV for 
the Fe   -edge),   
  which is the amplitude reduction factor,      which is the number of 
independent points examined and      which is the number of refined parameters. Finally, 
R and    are the statistical parameters which give an indication of the quality of the fit.  
During the iterative fitting process, if an experimental spectrum is found to disagree with a 
proposed model, the model for the local environment around the Fe centre must be 
modified assuming the absence or existence of additional atoms.  
  
(a) (b)
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4.3.6.1 EXAFS Studies of QD-Fe(III)PPIX 
 
The EXAFS spectra recorded for the QD-Fe(III)PPIX crystallisation solution and the 
crystals of QD-Fe(III)PPIX were first fitted to a model which was based on the SCD 
structure of the QD-Fe(III)PPIX complex. Atoms involved in the EXAFS refinement are 
shown in Figure 4.17. The raw EXAFS oscillations χ(q) and the corresponding Fourier 
transforms (direct and phase corrected) that were obtained for the crystals of QD-
Fe(III)PPIX and their crystallisation solution are shown in Figure 4.18. When phase 
correction is applied, the distances of atoms to the central Fe atom, reported on the x-axis 
of the radial distribution function, increase by approximately 0.5 Å; this is due to the 
scattering phase-shift.
157
 Phase shift is only applied to get a better visual interpretation of 
the data, and even though it appears that there are slightly different corrections in the 
spectra, the distances are not significantly affected. 
 
Figure 4.17 The asymmetric unit of QD-Fe(III)PPIX determined by SCD. The atoms considered in 
the EXAFS model refinement are labelled, while the intramolecular hydrogen bond observed in the 
solid-state is shown with a red dashed line. Atom colour labelling: grey – C, cyan – Fe, dark blue – 
N, red – O and white – H. 
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Figure 4.18 Experimental EXAFS spectra of QD-Fe(III)PPIX crystals (a, b, c) and the 
corresponding crystallisation solution (d, e, f). (a, d) The Fe Kα-edge k
3
-weighted experimental 
(blue) and the best fit (red) EXAFS oscillations; (b, e) the corresponding Fourier transforms and (c, 
f) Fourier transforms with phase corrections applied.  
 
The raw EXAFS oscillations χ(q) show no significant differences between the EXAFS 
model and the experimental spectra. In the corresponding Fourier transforms shown in 
Figure 4.18, similarities between the crystal and corresponding crystallisation solution 
medium are observed with the only deviation from the model in the region after 4.0 Å in 
the phase corrected spectra. The slight deviations observed in both the crystals and the 
(a)
(c)
(d)
(e)(b)
(f)
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crystallisation solution EXAFS, when compared to the model, could be a result of the 
mother liquor present in the crystal data collection and, since the molecules are able to 
move more freely in solution, slight deviation from the model is expected in the spectra of 
the crystallisation solution.  
The results of the detailed EXAFS analysis are presented in Table 4.7. The atomic 
positions of the model obtained from SCD data are also shown. The results indicate, given 
R factors for the best fit to the model of 0.033 and 0.029 for the QD-Fe(III)PPIX crystals 
and crystallisation solution respectively, and a χ2 value of 1.37 for both, that there is a good 
fit between the crystal structure of QD-Fe(III)PPIX and crystallisation solution. There is a 
correlation between the distances of the atoms from the absorbing atom (Table 4.7, 
distance from Fe (Å)) and the observed peaks (coordination shell) in the phase corrected 
spectra in Figure 4.18. For example, the first broad peak in the spectra, observed at 1.7-2.4 
Å when phase correction is applied, corresponds to the axial oxygen coordinating to the Fe 
centre through the alcohol functional group of the drug and the four nitrogen atoms from 
the Fe(III)PPIX ring. The average distance of these atoms from Fe in the crystal structure 
is 2.03 Å. When comparing the distances from the Fe absorber of the individual atoms in 
the crystal EXAFS to the crystallisation solution EXAFS, the atoms refined to identical 
distances from the Fe absorber. Therefore the local Fe environment in the crystallisation 
solution and in the crystal structure are essentially the same and this strongly suggests that 
the species shown to exist in the solid state is represented in solution as well.  
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Table 4.7 Refined EXAFS parameters of the crystals of QD-Fe(III)PPIX and the QD-Fe(III)PPIX crystallisation solution.  
 QD-Fe(III)PPIX (SCD)
#
 QD-Fe(III)PPIX Crystals EXAFS QD-Fe(III)PPIX Crystallisation Medium 
EXAFS 
E0(eV) - -0.7(1.4) 0.85(1.3) 
So
2
 - 0.91(8) 0.91(8) 
nind - 45.03 45.03 
nvar - 19 19 
R - 0.033 0.029 
2 - 1.37 1.37 
    
EXAFS 
labelling
##
 
Atom in 
SCD 
Distance  
from Fe (Å) 
Average Atom (X) N(X) Distance 
from Fe (Å) 
   (Å2) Atom (X) N(X) Distance 
from Fe (Å) 
   (Å2) 
N1 N1 2.064  N1 1 2.03(2) 0.0004(9) N1 1 2.03(2) 0.0004(9) 
N2 N2 2.073  N2 1 2.07(2) 0.0004(9) N2 1 2.07(2) 0.0004(9) 
N3 N3 2.066  N3 1 2.06(2) 0.0004(9) N3 1 2.06(2) 0.0004(9) 
N4 N4 2.064  N4 1 2.05(2) 0.0004(9) N4 1 2.05(2) 0.0004(9) 
C2 C1α 3.088 3.089 C2 4 3.06(2) 0.001(1) C2 4 3.06(2) 0.001(1) 
C2 C4 α 3.092          
C2 C6 α 3.09          
C2 C9 α 3.087          
C3 C11 α 3.075 3.068 C3 4 3.02(2) 0.001(1) C3 4 3.02(2) 0.001(1) 
C3 C14 α 3.063          
C3 C16 α 3.070          
C3 C19 α 3.065          
C5 C2 β 4.328 4.320 C5 4 4.28(5) 0.004(2) C5 4 4.28(5) 0.004(2) 
C5 C3 β 4.323          
C5 C7 β 4.318          
C5 C8 β 4.312          
C4 C12 β 4.291 4.295 C4 4 4.27(5) 0.004(2) C4 4 4.27(5) 0.004(2) 
C4 C13 β 4.295          
C4 C17 β 4.291          
C4 C18 β 4.306          
C6 C5 meso 3.457 3.440 C6 4 3.4(1) 0.004(2) C6 4 3.4(1) 0.004(2) 
C6 C10 meso 3.444          
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Table 4.7 Continued from previous page. 
 
      
EXAFS 
labelling
##
 
Atom in 
SCD 
Distance  
from Fe (Å) 
Average Atom (X) N(X) Distance 
from Fe (Å) 
   (Å2) Atom (X) N(X) Distance 
from Fe (Å) 
   (Å2) 
C6 C15 meso 3.414          
C6 C20 meso 3.446          
O1 O2 a.a. 1.862  O1 1 1.86(-0.07) 0.0004(9) O1 1 1.86(-0.07) 0.0004(9) 
C7 C44 a.a. 2.928  C7 1 2.8(-0.2) 0.001(1) C7 1 2.8(-0.2) 0.001(1) 
O2 C40 a.a. 4.222  O2 1 4.3(3) 0.004(2) O2 1 4.3(3) 0.004(2) 
C8 C45 a.a. 3.603  C8 1 3.69(9) 0.004(2) C8 1 3.69(9) 0.004(2) 
Cp1 C46 a.a. 3.749 3.765 Cp1 3 3.9(5) 0.004(2) Cp1 3 3.9(5) 0.004(2) 
Cp2 C35 a.a. 4.378 4.394 Cp2 2 4.4(1) 0.004(2) Cp2 2 4.4(1) 0.004(2) 
Cp3 C47 a.a. 4.877 4.736 Cp3 9 4.57(-0.08) 0.004(2) Cp3 9 4.57(-0.08) 0.004(2) 
Cp3 C41 a.a. 4.68          
Cp3 C42 a.a. 4.667          
Cp3 C53 a.a. 4.68          
Cp3 N5 a.a. 4.72          
 Fe o.r. 4.796  Fe 1 4.76(7) 0.004(5) Fe 1 4.76(7) 0.004(5) 
Cp1 N3 o.r. 3.756          
Cp3 N2 o.r. 4.659          
Cp3 C15 o.r. 4.799          
Cn1 C14 o.r. 4.14 4.17 Cn1 3 3.8(-0.2) 0.004(2) Cn1 3 3.8(-0.22) 0.004(2) 
Cp2 C13 o.r. 4.41          
Cn1 C12 o.r. 4.209          
Cp1 C11 o.r. 3.792          
Cn1 C10 o.r. 4.161          
Cp3 C9 o.r. 4.564          
Cp3 C27 o.r. 4.981          
            
#
The model was built from the SCD data of QD-Fe(III)PPIX. The atoms uses to model distances from the Fe centre of the porphyrin are included to 
compare with the distances refined in the EXAFS data. 
##
If atoms have the same EXAFS labelling, it indicates that the atoms were refined at the same distance from the absorbing atom.  
*Abbreviations: atoms marked a.a. - axial atoms belong to the drug molecule coordinated to Fe(III)PPIX via the deprotonated alcohol functional 
group, and the atoms marked o.r. – atoms outside the Fe(III)PPIX ring belong to the partner porphyrin which is involved in π-π stacking in the 
crystal structure. α, β and meso indicates the atoms in the Fe(III)PPIX ring. 
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4.3.6.2 EXAFS Studies of QN-Fe(III)PPIX 
 
The EXAFS spectra recorded of the crystals of QN-Fe(III)PPIX as well as the solution 
from which the crystal was grown were first fitted to a model which was based on the SCD 
structure of the QN-Fe(III)PPIX complex. Atoms involved in the EXAFS refinement are 
shown in Figure 4.19. The raw EXAFS oscillations  ( ) and the corresponding Fourier 
transforms (direct and following phase corrected) that were obtained for the crystals of 
QN-Fe(III)PPIX and their crystallisation solution are shown in Figure 4.20.  
 
Figure 4.19 The asymmetric unit of QN-Fe(III)PPIX determined by SCD. The atoms considered in 
the EXAFS model refinement are labelled, while the intramolecular hydrogen bond observed in the 
solid-state is shown with a red dashed line. Atom colour labelling: grey – C, cyan – Fe, dark blue – 
N, red – O and white – H. 
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Figure 4.20 Experimental EXAFS spectra of QN-Fe(III)PPIX crystals (a, b, c) and the 
corresponding crystallisation solution (d, e, f). (a, d) The Fe Kα-edge k
3
-weighted experimental 
(blue) and the best fit (red) EXAFS oscillations; (b, e) the corresponding Fourier transforms and (c, 
f) Fourier transforms with phase corrections applied.  
 
The raw EXAFS oscillations χ(q) show slight differences between the EXAFS model and 
the experimental spectra which can be observed in the range of 2-8 Å
-1
 for the crystals and 
in the range of 2-6 Å
-1
 for the crystallisation solution (Figure 4.20 a and d). In the 
corresponding Fourier transform radial distribution functions shown in Figure 4.20, 
similarities between the crystal and corresponding crystallisation medium are observed 
(a)
(c)
(d)
(e)(b)
(f)
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with deviation from the model in the region after 2.0 - 4.0 Å in the phase corrected spectra. 
It is worth remembering that the concentration of Fe(III)PPIX in the crystallisation 
solution was much lower than 10 mM due to the low solubility of Fe(III)PPIX in 
acetonitrile. This together with the fact that molecules are able to move more freely in 
solution as well as “breaking” or dissolving of the crystals during EXAFS collection, could 
account for the observed differences in the spectra when comparing the crystal spectrum to 
the crystallisation solution spectrum. 
The results of the detailed EXAFS analysis are presented in Table 4.8 together with the 
atomic positions of the model obtained from SCD data. The results indicate that there is a 
good fit between the crystal structure of QN-Fe(III)PPIX and crystallisation solution when 
comparing the R factors for the best fit to the model, of 0.021 and 0.029, and a χ2 value of 
1.162 and 1.587 for the crystals and crystallisation solution respectively. When comparing 
the distances from the Fe absorber of the individual atoms in the crystal EXAFS to the 
crystallisation solution EXAFS, the atoms refined to almost identical distances from the Fe 
absorber. Therefore the results indicate that the local Fe environment in the crystallisation 
solution and in the crystal structure of QN-Fe(III)PPIX are the same and that the species 
shown to exist in the solid state by SCD persists in solution.  
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Table 4.8 Refined EXAFS parameters of the crystals of QN-Fe(III)PPIX and the QN-Fe(III)PPIX crystallisation solution. 
 QN-Fe(III)PPIX (SCD)
#
 QN-Fe(III)PPIX Crystals EXAFS  QN-Fe(III)PPIX Crystallisation Medium 
EXAFS 
E0(eV) - 1.4(5) 0.86(1.9) 
So
2
 - 0.80(8) 1.0(1) 
nind - 20.0 23.11 
nvar - 14 19 
R - 0.021 0.029 
2 - 1.162 1.587 
    
EXAFS 
labelling
##
 
Atom in 
SCD 
Distance 
from Fe (Å) 
Average Atom (X) N(X) Distance 
from Fe (Å) 
   (Å2) Atom (X) N(X) Distance 
from Fe (Å) 
   (Å2) 
N1 N1 2.042  N1 1 2.03(2) 0.001(1) N1 1 2.021(8) 0.002(1) 
N2 N2 2.059  N2 1 2.07(2) 0.001(1) N2 1 2.062(8) 0.002(1) 
N3 N3 2.069  N3 1 2.06(2) 0.001(1) N3 1 2.047(8) 0.002(1) 
N4 N4 2.059  N4 1 2.05(2) 0.001(1) N4 1 2.036(8) 0.002(1) 
C2 C1α 3.089 3.084 C2 4 3.03(3) 0.002(1) C2 4 3.05(1) 0.003(2) 
C2 C4 α 3.097          
C2 C6 α 3.082          
C2 C9 α 3.071          
C3 C11 α 3.064 3.073 C3 4 3.03(3) 0.002(1) C3 4 3.01(1) 0.003(2) 
C3 C14 α 3.083          
C3 C16 α 3.076          
C3 C19 α 3.073          
C5 C2 β 4.309 4.273 C5 4 4.29(6) 0.001(2) C5 4 4.29(6) 0.003(3) 
C5 C3 β 4.340          
C5 C7 β 4.300          
C5 C8 β 4.273          
C4 C12 β 4.284 4.284 C4 4 4.28(6) 0.001(2) C4 4 4.28(6) 0.003(3) 
C4 C13 β 4.272          
C4 C17 β 4.278          
C4 C18 β 4.302          
C6 C5 meso 3.445 3.421 C6 4 3.5(1) 0.001(2) C6 4 3.5(1) 0.003(3) 
C6 C10 meso 3.392          
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Table 4.8 Continued from previous page        
            
EXAFS 
labelling
##
 
Atom in 
SCD 
Distance 
from Fe (Å) 
Average Atom (X) N(X) Distance 
from Fe (Å) 
   (Å2) Atom (X) N(X) Distance 
from Fe (Å) 
   (Å2) 
C6 C15 meso 3.441          
C6 C20 meso 3.406          
O1 O2 a.a. 1.866  O1 1 1.859(-.08) 0.001(2) O1 1 1.8(-0.1) 0.002(1) 
C7 C44 a.a. 2.939  C7 1 3.113 0.002(1) C7 1 2.9(-0.09) 0.003(3) 
O2 C40 a.a. 4.188  O2 1 4.2(2) 0.001(1) O2 1 4.2(2) 0.003(3) 
C8 C45 a.a. 3.622  C8 1 4.3(7) 0.001(1) C8 1 3.55(-0.05) 0.003(3) 
Cp1 C46 a.a. 3.752 3.959 Cp1 6 3.85(5) 0.005(3) Cp1 5 3.87(7) 0.002(2) 
Cp2 C38 a.a. 4.429 4.392 Cp2 6 4.5(2) 0.006(0.01) Cp2 2 4.5(2) 0.007(.01) 
Cp3 C47 a.a. 4.868 4.708 Cp3 6 4.648(-.005) 0.007(5) Cp3 11 4.68(3) 0.01(2) 
Cp3 C41 a.a. 4.706          
Cp1 C39 a.a. 4.147          
Cp3 C53 a.a. 4.729          
Cp3 N5 a.a. 4.638          
Fe Fe o.r. 4.353  Fe 1 4.4(-.02) 0.001(3) Fe 1 4.5(-0.2) 0.002(7) 
Cp1 N3 o.r. 3.678          
Cp3 N2 o.r. 4.406          
Cp2 C15 o.r. 4.342          
Cp1 C14 o.r. 4.034          
Cp3 C13 o.r. 4.696          
Cp3 C12 o.r. 4.801          
Cp1 C11 o.r. 4.182          
Cp3 C10 o.r. 4.627          
Cp3 C9 o.r. 4.789          
Cp3 C16 o.r 4.524          
#
The model was built from the SCD data of QN-Fe(III)PPIX. The atoms used to model distances from the Fe centre of the porphyrin are included to 
compare with the distances refined in the EXAFS data. 
##
If atoms have the same EXAFS labelling, it indicates that the atoms were refined at the same distance from the absorbing atom. 
*Abbreviations: atoms marked a.a. - axial atoms belong to the drug molecule coordinated to Fe(III)PPIX via the deprotonated alcohol functional 
group, and the atoms marked o.r. – atoms outside the Fe(III)PPIX ring belong to the partner porphyrin which is involved in π-π stacking in the 
crystal structure. α, β and meso indicates the atoms place in the Fe(III)PPIX ring.  
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4.3.6.3 EXAFS Studies of MQ-Fe(III)PPIX 
 
The EXAFS spectra recorded of the MQ-Fe(III)PPIX crystallisation solution as well as the 
crystals were first fitted to a model which was based on the SCD structure of the MQ-
Fe(III)PPIX complex. Atoms involved in the EXAFS refinement are shown in Figure 4.21. 
The raw EXAFS oscillations  ( ) and the corresponding Fourier transforms obtained for 
the MQ-Fe(III)PPIX crystallisation solution and the crystals are shown in Figure 4.22.  
 
 
Figure 4.21 The two moieties in the asymmetric unit of MQ-Fe(III)PPIX (I and II), determined by 
SCD, are displayed separately above to make numbering of the atoms involved in the EXAFS 
refinements more visible. The atoms considered in the EXAFS model refinement are labelled, 
while the intramolecular hydrogen bonds observed in the solid-state are shown with red dashed 
lines. Atom colour labelling: grey – C, cyan – Fe, dark blue – N, light blue – F, red – O and white – 
H. 
 
The EXAFS data obtained for the spectra of the MQ-Fe(III)PPIX crystallisation solution 
cannot be used as a representative of the bulk solution. This is due to the fact that, out of 
the triplicate data sets that were collected, only one was used as the experimental data to fit 
to the model since the other two sets deviated from the model. This deviation from the 
model was attributed to the lower concentration of Fe(III)PPIX in the solution (much lower 
than 10 mM) since Fe(III)PPIX is only sparingly soluble in acetonitrile.  
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Figure 4.22 Experimental EXAFS spectra of MQ-Fe(III)PPIX crystals (a, b, c) and the 
corresponding crystallisation solution (d, e, f). (a, d) The Fe Kα-edge k
3
-weighted experimental 
(blue) and the best fit (red) EXAFS oscillations; (b, e) the corresponding Fourier transforms and (c, 
f) Fourier transforms with phase corrections applied.  
 
The raw EXAFS oscillations χ(q) show no significant differences between the EXAFS 
model and the experimental spectra from the one data set. In the corresponding Fourier 
transforms EXAFS shown in Figure 4.22, similarities between the crystal and 
corresponding crystallisation solution are observed, with the only deviation from the model 
in the region after 2.5 - 4.0 Å in the phase corrected spectra for the crystallisation solution.  
(a)
(c)
(d)
(e)(b)
(f)
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The slight increases and decreases observed in both the crystals and the crystallisation 
solution EXAFS when compared to the model could be due to traces of mother liquor 
present in the crystal sample during data collection and the fact that molecules are able to 
move more freely in solution. Furthermore, the very low concentration of Fe(III)PPPIX in 
solution may have also been a contributing factor. Therefore, deviation from the model is 
expected in the spectra of the crystallisation solution.  
When comparing the R factors for the best fit to the model, 0.021 and 0.022 and a χ2 value 
of 1.63 and 2.46 for the crystals and crystallisation solution respectively, the results of the 
detailed EXAFS analysis presented in Table 4.9 indicate that there is a reasonable fit 
between the crystal structure of MQ-Fe(III)PPIX and the crystallisation solution.  
Furthermore, when comparing the distances from the Fe absorber of the individual atoms 
in the crystal EXAFS to the crystallisation solution EXAFS, the atoms refined to almost 
identical distances from the Fe absorber. Therefore, the results indicate that the local Fe 
environment in the crystallisation solution (despite being from one data set) and the crystal 
structures are comparable. Even though there is a good fit between the experimental and 
the model, the data cannot be assumed to be representative of the bulk solution. Therefore 
it only suggests that the first shell of atoms surrounding the absorbing Fe atom are the 
same, which could indicate that the species observed in the crystal and crystallisation 
medium of MQ-Fe(III)PPIX are the same. 
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Table 4.9 Refined EXAFS parameters of the crystals of MQ-Fe(III)PPIX and the MQ-Fe(III)PPIX crystallisation solution.  
 MQ-Fe(III)PPIX (SCD)
#
 MQ-Fe(III)PPIX Crystal EXAFS MQ-Fe(III)PPIX Crystallisation 
Medium EXAFS 
E0(eV) - 
- 
- 
- 
- 
0.70(1.7) 1.27(1.25) 
So
2
 0.65(6) 0.89(9) 
nind 24.99 22.48 
nvar 16 18 
R 0.021 0.022 
2 1.63 2.46 
 
EXAFS 
labelling
##
 
Atom in 
SCD 
Distance  
from 
Fe(1)(Å) 
Atom Distance  
from 
Fe(2)(Å) 
Average Atom 
(X) 
N(X) Distance 
from Fe 
(Å) 
   (Å2) Atom 
(X) 
N(X) Distance 
from Fe  
(Å) 
   (Å2) 
N1 N1 2.071 N7 2.069  N1 1 2.008(5) 0.0001(9) N1 1 2.008(-5) 0.0003(9) 
N2 N2 2.071 N8 2.068  N2 1 2.048(5) 0.0001(9) N2 1 2.048(-5) 0.0003(9) 
N3 N3 2.061 N9 2.054  N3 1 2.034(5) 0.0001(9) N3 1 2.034(-5) 0.0003(9) 
N4 N4 2.058 N10 2.060  N4 1 2.023(5) 0.0001(9) N4 1 2.023(-5) 0.0003(9) 
C2 C1α 3.093 C52 α 3.101 3.094 C2 4 3.0384(3) 0.002(1) C2 4 3.0384(-3) 0.001(1) 
C2 C4 α 3.091 C55 α 3.084          
C2 C6 α 3.092 C57 α 3.095          
C2 C9 α 3.103 C60 α 3.096          
C3 C11 α 3.098 C62 α 3.077 3.080 C3 4 3.002(2) 0.002(1) C3 4 3.002(-2) 0.001 
C3 C14 α 3.077 C65 α 3.063          
C3 C16 α 3.065 C67 α 3.070          
C3 C19 α 3.086 C70 α 3.106          
C5 C2 β 4.315 C53 β 4.323 4.318 C5 4 4.28(5) 0.001(3) C5 4 4.28(5) 0.004(2) 
C5 C3 β 4.314 C54 β 4.311          
C5 C7 β 4.323 C58 β 4.310          
C5 C8 β 4.333 C59 β 4.316          
C4 C12 β 4.311 C63 β 4.290 4.300 C4 4 4.27(5) 0.001(3) C4 4 4.27(5) 0.004(2) 
C4 C13 β 4.305 C64 β 4.289          
C4 C17 β 4.286 C68 β 4.306          
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#The model was built from the SCD data of MQ-Fe(III)PPIX. The atoms used to model distances from the Fe centre of the porphyrin are included to 
compare with the distances refined in the EXAFS data. 
##
If atoms have the same EXAFS labelling, it indicates that the atoms were refined at the same distance from the absorbing atom. 
*Abbreviations: atoms marked a.a. - axial atoms belong to the drug molecule coordinated to Fe(III)PPIX via the deprotonated alcohol functional 
group, and the atoms marked o.r. – atoms outside the Fe(III)PPIX ring belong to the partner porphyrin which is involved in π-π stacking in the 
crystal structure. α, β and meso indicates the atoms place in the Fe(III)PPIX ring. 
 
 
Table 4.9 Continued from previous page. 
 
        
EXAFS 
labelling
##
 
Atom 
SCD 
Distance  
from Fe  
(Å) 
Atom Distance  
from Fe  
(Å) 
Average Atom 
(X) 
N(X) Distance 
from Fe  
(Å) 
   (Å2) Atom 
(X) 
N(X) Distance 
from Fe  
(Å) 
   (Å2) 
C4 C18 β 4.297 C69 β 4.316          
C6 C5 meso 3.447 C56meso 3.444 3.44 C6 4 3.5(1) 0.001(3) C6 4 3.5(1) 0.004(2) 
C6 C10meso 3.457 C61meso 3.444          
C6 C15meso 3.421 C66meso 3.423          
C6 C20meso 3.449 C71meso 3.467          
O1 O5 a.a. 1.899 O10 a.a. 1.891 1.895 O1 1 1.87(6) 0.0001(1) O1 1 1.87(-6) 0.001 
C7 C46 a.a. 2.904 C97 a.a. 2.905 2.905 C7 1 2.97(8) 0.002((1) C7 1 2.97(-8) 0.001(1) 
C8 C37 a.a. 3.605 C88 a.a. 3.604 3.605 O2 1 3.7(3) 0.001(3) O2 1 3.7(-3) 0.0001(9) 
Cp1 C36 a.a. 3.849 C87 a.a. 3.841 3.864 C8 1 3.53(6) 0.001(3) C8 1 3.53(-6) 0.004(2) 
Cp3 C38 a.a. 4.683 C102a.a. 4.848  4.659 Cp1 4 3.9(4) 0.007(1) Cp1 3 3.9(4) 0.004(2) 
Cn1 C47 a.a. 4.211 C98 a.a. 4.209  4.156 Cp2 8 4.6(4) 0.003(0.01) Cp2 2 4.6(4) 0.004(2) 
Cp3 C51 a.a. 4.866 C89 a.a. 4.682  Cp3 7 4.57(8) 0.004(5) Cp3 7 4.57(-8) 0.004(2) 
Cp2 N6 a.a. 4.448 N9 a.a. 4.389 4.428  2   Cp4    
Fe Fe o.r. 4.566 Fe o.r. 4.463  Fe 1 4.4(2) 0.002(5) Fe 1 4.4(-2) 0.04(5) 
Cp1 N1 o.r. 3.744 N9 o.r. 3.712          
Cp3 N4 o.r. 4.532 N10 o.r. 4.555          
Cp3 C6 o.r. 4.898 N8 o.r. 4.526          
Cp3 C5 o.r. 4.617 C66 o.r. 4.558  Cn1 4 3.8(2) 0.004(6) Cn1 2 3.8(-2) 0.004(2) 
Cn1 C4 o.r. 4.1 C65 o.r. 4.106          
Cp3 C3 o.r. 4.583 C64 o.r. 4.676          
Cp3 C2 o.r. 4.533 C63 o.r. 4.634          
Cp1 C1 o.r. 3.994 C62 o.r. 4.047          
Cp2 C20 o.r. 4.385 C61 o.r. 4.491          
Cp3 C19 o.r. 4.64 C30 o.r. 4.713          
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4.4 Discussion 
 
When considering the history of antimalarial drugs, it is interesting to note that the 
Cinchona alkaloids, particularly QN, have been effectively used for centuries. Taking into 
account that this drug along with CQ was used in high quantities and, for most part was the 
drug of choice, it took the parasite a long time to build resistance to these drugs compared 
to other drugs. Today QN is still used to treat cerebral malaria,
171
 therefore it is still 
relevant and understanding the mode of action of this and related quinoline antimalarial 
drugs is crucial in our fight against malaria. 
The possibility that the active Cinchona alkaloids (QN and QD) may form a dative 
covalent bond to the Fe(III) centre of Fe(III)PPIX through the benzylic alcohol functional 
group has been suggested by several authors.
48,49,172
 The crystal structures of QN-, QD- 
and MQ-Fe(III)PPIX determined in this work are the only structures to date of Fe(III)PPIX 
complexes with quinoline antimalarial drugs. It is noteworthy that all of the drug 
compounds can be further classified as quinoline methanols owning to the alcohol 
functional group in the benzylic position relative to the quinoline ring. These structures 
provide direct evidence that the antimalarial-active Cinchona alkaloids and MQ form five-
coordinate complexes with the porphyrin via their benzylic alcohol functional group and 
not through the quinuclidine, piperidine or quinoline nitrogen atoms as has been proposed. 
These findings provide direct evidence of coordination between the deprotonated alcohol 
functional group of the drug and the Fe centre of Fe(III)PPIX, which was proposed by 
various molecular research regarding the ability of the hydroxyl group of QN (and 
therefore QD) to interact with the Fe(III) centre of Fe(III)PPIX in some fashion.
48,85,88,89,172
  
The Fe-O bond length in all three structures is consistent with the coordination of the 
benzylic hydroxyl group to the Fe(III) centre as an alkoxide (1.816 – 1.867 Å),127,128,129,130 
rather than an alcohol (2.112 – 2.160 Å).131,132 The crystal structures confirm that the 
alcohol function is deprotonated in each case since no H-atoms were found to be present in 
the electron density map. When considering the pKa of the benzylic alcohol functional 
group and comparing it to the pKa of benzyl alcohol which is close to 15.2,
173
 the presence 
of an alkoxide species in the acidic food vacuole of the parasite (in vivo) seems 
questionable. However, Behere and Goff
48
 proposed that the deprotonation of the alcohol 
(to yield an alkoxide complex in a non-aqueous solution) is facilitated by the basic 
quinuclidine nitrogen atom, which is able to accept the proton. This is presumably how 
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complex formation was facilitated in the case of QN-Fe(III)PPIX, which was crystallised 
from an acetonitrile solution of Fe(III)PPIX and QN in its free base form (meaning that the 
quinuclidine N-atom was able to accept the proton transferred from the alcohol). In the 
crystallisation of QD-Fe(III)PPIX however, the drug was added to the 3:7 (v/v) DMSO-
methanol solution in its acid form (as a hemisulfate salt). Therefore the quinuclidine 
nitrogen atom was unavailable from the start to accept further protons. Since no 
counterions were observed in the crystal structure, the complex is not expected to have a 
net charge and this was rationalised in the following way. Substituting the chloride ligand 
from the starting material (haemin, Cl-Fe(III)PPIX) with an alkoxide species (QD) does 
not influence the neutral state of the porphyrin core. Deprotonation of only one of the 
Fe(III)PPIX propionic acid groups is therefore necessary to balance the positive charge on 
the protonated quinuclidine nitrogen atom and maintain an overall uncharged species. The 
formation of a single propionate group (while the other remains as a propionic acid) is 
confirmed in the crystal structure. The absence of a peak in the carbonyl region was 
recently used to support the presence of a fully deprotonated Fe(III)PPIX species 
precipitated from aqueous solution by the addition of QN free base
125
 and the infrared 
spectrum of the QD-Fe(III)PPIX complex (previously shown in Figure 4.6) supports this 
finding with a peak at approximately 1702 cm
-1
. Complex formation is thus accompanied 
by the overall loss of two protons. These observations suggest that the pKa of alcohols may 
be depressed below that of the propionic acid group (with a pKa lower than 5 to 6, which is 
the estimated pKa for the propionic acid group in free Fe(III)PPIX),
174
 due to the strong 
coordination to the Fe centre. Further investigation of the free energy associated with 
coordination of the alcohol form of the alkaloid versus the alkoxide, possibly via 
computation, would be useful in explaining this observation further. The possible 
formation of H2SO4 and HCl in situ is highly unlikely. A more likely explanation is that 
the alkaloids, which were added in excess to the crystallisation media, could act as a 
buffer, making use of the second most basic site (the quinoline nitrogen atom) after the 
quinuclidine nitrogen atom to accept protons.  
The crystal structures also confirm that within each complex, QN-Fe(III)PPIX and QD-
Fe(III)PPIX, there is an intramolecular hydrogen bond present between the propionate side 
chain of Fe(III)PPIX and the protonated quinuclidine nitrogen atom of the drug. This 
confirms the prediction made by using computational methods of the likely interactions in 
an environment void of hydrogen bonding partners.
85
 It was observed that QN and QD are 
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able to readily adopt a conformation which allows the formation of an intramolecular 
hydrogen bond at a much lower energy conformation than the inactive epimers. It is 
particularly interesting that the observed dihedral angles in the crystal structures of QD-
Fe(III)PPIX and QN-Fe(III)PPIX (required for salt-bridge formation) correlate with the 
previously computed dihedral angles (Table 4.10).
85
  
Table 4.10 Comparison of computed and experimental dihedral angles in the QD-Fe(III)PPIX and 
QN-Fe(III)PPIX complexes.  
Complex Dihedral angle Computed
#
 Experimental 
QD-Fe(III)PPIX 
ψ +210o +209 
φ +240o +300 
QN-Fe(III)PPIX 
ψ +145o +158o 
φ +155o +156o 
#
Values reproduced from reference.
85
  
 
 
The difference in the value for the dihedral angle (φ) of QD-Fe(III)PPIX, -60o for the 
experimental versus the computed value of +240
o
, is due to the effect of the alternative 
propionate group having been used in the calculations compared to that selected in the 
crystal structure. When the experimental and computed dihedral angle (φ) are compared 
for QN-Fe(III)PPIX, they are very similar as a result of the same propionate group having 
been used in the computed structure as well as the crystal structure. It is worth 
remembering that in the molecular modelling of the complexes, the choice of propionate 
group for the formation of the intramolecular hydrogen bond was to a large extent random 
and either one of the porphyrin propionates could have been chosen. A feature of the 
calculated relative strain energy surface for QD-Fe(III)PPIX, generated by rotating ψ and φ 
relative to one another and determining the free energy at each step, is the low energy 
furrow at the point that ψ is fixed at   210o (Figure 1.48), the value predicted by molecular 
modelling and observed in the current study. Thus, the barrier rotation about the Fe(III)-O5 
bond is minimal in this region which means that φ could essentially adopt any magnitude 
(Table 4.10). Interestingly, the complex observed in the solid-state, where φ is 300o, is 
only 1 kcal/mol higher in energy than the predicted complex where φ attained a magnitude 
of 240
o
 (Figure 1.48). 
The persistence of the intramolecular hydrogen bond in the QD-Fe(III)PPIX complex, 
despite its growth in an environment rich with hydrogen bonding partners (  72% (v/v) 
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methanol), is highly significant. Its existence in this environment supports the idea that QD 
may be structurally preorganised to favour such an interaction, which may be the reason 
for its greater activity compared to QN. All attempts to grow a QN-Fe(III)PPIX complex in 
the same crystallisation solution as the QD-Fe(III)PPIX complex were unsuccessful. 
It has previously been shown that the conformation of MQ is independent of the 
crystallisation environment and the starting form of MQ, be it as a salt, freebase, racemic 
or optically pure mixture.
175,176
 One question that has not been answered is whether the 
conformation of MQ remains unchanged upon complexing to Fe(III)PPIX. The geometries 
of different forms of MQ and the geometries of MQ as observed in the complex are shown 
in Table 4.11. The torsion angle (C4-C11-C12-N13 labelling as per Figure 4.11(a)) is 
essentially identical for all mefloquine molecules. Therefore, the SCD structure of MQ-
Fe(III)PPIX supports the proposal that some molecules are structurally preorganised to 
complex with Fe(III)PPIX owing to their stereochemical configuration. 
Table 4.11 Comparison of the geometries of different MQ species. 
Complex 
Torsion angle (
o
)  
C4–C11–C12–N13b  
Torsion angle (
o
)  
O1–C11–C12–N13b 
MQ-Fe(III)PPIX 
(C46S, C47S)* 
C37–C46–C47–N6* 
169.3 
O5–C46–C47–N6* 
-67.3 
MQ-Fe(III)PPIX 
(C97S, C98R)* 
C88–C97–C98–N12* 
-167.5 
O10–C97–C98–N12* 
68.4 
MQ methylsulfonate 
monohydrate
a -176.2
 
-54.5 
( )-MQ hydrochloride 174.7 -62.8 
( )-MQ free basea 169.7, 175.6# -61.4, -66.6 
( )-MQ hydrochloride 
hydrate
a 
168.5, 171.4, -176.8, -
179.4
## -71.6 to -54.4 
a 
Values reproduced from reference.
175
 
b 
Labelling as per Figure 4.11 (a). 
*
 
Labelling as in the crystal structure of MQ-Fe(III)PPIX. 
# 
The torsion angle represents one enantiomer and would be the opposite sign for the other one. 
## 
Values of the 4 different conformations as found in the crystal structure. 
 
 
Interestingly, only an intramolecular hydrogen bonding network is observed in the crystal 
structure of the MQ-Fe(III)PPIX complex. This network of intramolecular hydrogen 
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bonding is presumably also responsible for stabilising the complex when formed, therefore 
blocking β-haematin formation.  
Together the three crystal structures determined in this work provide direct and important 
evidence for the key interactions between the drug molecule and Fe(III)PPIX. Namely, 
coordination of the deprotonated benzylic alcohol group of the drug to the Fe(III) centre of 
Fe(III)PPIX, π-stacking between the aromatic porphyrin pyrrole and the drug quinoline 
rings, and most importantly, the intramolecular hydrogen bond formation between the 
porphyrin propionate group and the protonated quinuclidine nitrogen atom of the drug in 
the case of QN-Fe(III)PPIX and QD-Fe(III)PPIX and the intramolecular hydrogen bond 
network observed in MQ-Fe(III)PPIX between the propionate and propionic acid side 
chains of Fe(III)PPIX, with a further two between each of these groups and the 
piperidinium nitrogen atom of the drug. These three key interactions are supported by the 
recent publication of Alumasa et al.
125
 By investigating a series of QN analogues in order 
to define the structural features necessary for inhibition of Fe(III)PPIX and biological 
activity, they showed that the lack of either the benzylic alcohol function or the 
quinuclidine ring (and therefore the quinuclidine nitrogen atom) lowers Fe(III)PPIX 
affinity, haemozoin inhibition activity and antiplasmodial activity. This provides further 
circumstantial evidence for the importance of coordination of the benzylic alcohol group to 
the Fe(III) centre of Fe(III)PPIX and the intramolecular hydrogen bond formation between 
the porphyrin propionate group and the protonated quinuclidine nitrogen atom of the drug 
to the antimalarial activities of the quinoline methanols as they target Fe(III)PPIX. 
According to the model proposed for the formation of haemozoin and inhibition by the 
Cinchona alkaloids,
85
 the relative ease by which the intramolecular hydrogen bond can be 
formed by the active alkaloids would render Fe(III)PPIX incapable of forming the 
haemozoin precursor dimer by preventing the release of Fe(III)PPIX from the complex 
and, therefore, inhibiting haemozoin formation.
85
 The results obtained in the current study 
provide the first experimental evidence to support these previous proposals.  
Both QN and QD are active antimalarial compounds and the formation of the 
intramolecular hydrogen bond is proposed to be crucial to their activity. The 9-epiquinine 
(EQN) and 9-epiquinidine (EQD) are inactive, and therefore a crystal structure would have 
been complementary to understanding the greater activity of the active alkaloids (QN and 
QD) compared to the inactive alkaloids (EQN and EQD). Unfortunately, however, none of 
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the attempts to obtain single crystals of Fe(IIII)PPIX complexing with 9-epiquinine (EQN) 
have been successful to date. Attempts to crystallise Fe(III)PPIX and 4-aminoquinoline 
drug complexes were also unsuccessful. This could be due to the fact that 4-
aminoquinoline drugs are thought to not act by direct coordination to Fe(III)PPIX which 
could make crystallisation either very difficult or impossible. Walczak et al.
163
 showed in 
an EXAFS study of the mode of action of CQ at a molecular level with a soluble analogue 
of the β-haematin that a reduction in the oxygen coordination number rules out the 
possibility of CQ forming a stable complex in the same way that quinoline methanol 
antimalarials do.  
From the observed spectra of Fe(III)PPIX recorded in the different solutions, it is evident 
that the speciation of Fe(III)PPIX is the same in 3:7 (v/v) DMSO-methanol, acetonitrile, 
and 1-pentanol following titration with either QD.HSO4 or QD freebase, yet distinctly 
different to that observed in aqueous solution (Figure 4.14 (d)). The observed charge 
transfer band at 603 nm in each of the final spectra (Figure 4.14 a, b and c insert and 
Figure 4.15 a and b insert) resembles that of HO―Fe(III)PPIX when the hydroxide is 
coordinated to the metal centre.
79
 This is consistent with the observation in both crystal 
structures that the alkoxide form of the alkaloid (RO―Fe(III)PPIX) coordinates to the 
metal centre rather than the alcohol form (R(H)O―Fe(III)PPIX). The alcohol form would 
be expected to result in spectral changes similar to those observed for H2O―Fe(III)PPIX.  
Warhurst et al.
124
 defined characteristic peaks at 490 and 602 nm in the absorption spectra 
for QN-Fe(III)PPIX coordination complexes in benzene (Figure 4.23). He proposed that 
the atom coordinated to the Fe centre of Fe(III)PPIX is the quinuclidine nitrogen atom of 
QN. He also proposed that in the case of MQ, coordination takes place via the nitrogen 
atom of the piperidine ring. The results represented in this chapter concur with Warhurst in 
so far as a coordination complex exists. However, based on SCD evidence, the final 
spectrum in each of the spectrophotometric titrations is attributed to the complex in which 
the alkaloid compound coordinates to the porphyrin Fe(III) centre via its benzylic alcohol 
(alkoxide) functional group.  
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Figure 4.23 The absorption spectrum of QN-Fe(III)PPIX coordination complexes in benzene. The 
defined peaks at 490 and 602 nm were attributed to QN coordinating to the Fe centre of 
Fe(III)PPIX via the quinuclidine nitrogen atom. Reproduced from reference.
124
 
 
Since the peak which represents the coordination of the drug molecule to Fe(III)PPPIX is 
absent in the spectrum recorded from aqueous solution, complex formation between 
Fe(III)PPIX and the Cinchona alkaloids is considered more likely to take place in a non-
aqueous environment. Since the observation of haemozoin formation in association with 
lipids, the likely intracellular microenvironment of Fe(III)PPIX crystallisation shifted from 
a polar aqueous environment to a non-polar neutral lipid environment.
60
 These findings 
support the most recent theories regarding the site of haemozoin formation and the 
likelihood that drug action takes place in a non-aqueous environment near the lipid-water 
interface inside the digestive vacuole of the malaria parasite.
177
  
When taking the EXAFS data into account, which indicates that the species shown to exist 
in the solid state by SCD also exist in solution, the results suggest that coordination via the 
drugs deprotonated benzylic alcohol functional group to the Fe(III) centre of Fe(III)PPIX, 
is likely to occur in a non-aqueous solution environment. Since the EXAFS experiments do 
not provide sufficient resolution beyond ~4 Å from the Fe atom, it is not possible to 
comment on the presence or absence of the intramolecular hydrogen bond in solution.  
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4.5 Conclusion 
 
The SCD data of QN-Fe(III)PPIX, QD-Fe(III)PPIX and MQ-Fe(III)PPIX complexes 
shown in this work confirm the long standing belief that the quinoline methanol 
antimalarials form 1:1 complexes with Fe(III)PPIX. These results provide the first 
experimental evidence for the activity of the drug compounds in the solid state. Due to new 
insight into the formation of haemozoin taking place at a lipid-water interface, the site of 
action of quinoline antimalarials has also shifted from an aqueous environment to a non-
aqueous hydrophobic environment. The association studies presented in this chapter 
indicate that it is most probably the case that drug activity is taking place in a non-aqueous 
hydrophobic environment. Therefore, as observed in the SCD structures, activity involves 
three key interactions. These include direct coordination of the drug to the Fe(III) centre, 
π-stacking between the drug and porphyrin aromatic systems and, finally, intramolecular 
hydrogen bond formation. Whether these interactions are represented in the solution 
medium of the food vacuole of the parasite remains to be addressed. The EXAFS data 
certainly indicate that the species shown to exist in the solid state also exist in the 
crystallisation solution environment, which suggests that there is a good chance that the 
observed complexation mode would occur in vivo. Regardless, the SCD structures provide 
clear insight into the antimalarial interactions possible between quinoline methanol drugs 
and Fe(III)PPIX, and will be important to consider in designing new haemozoin inhibitors. 
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5 Inhibition of β-Haematin Formation at the Lipid-Water Interface 
 
5.1 Introduction 
 
To date, the inhibition of β-haematin formation by current antimalarial drugs has only been 
investigated under non-biological conditions.
66,67
 Recent evidence by Pisciotta et al.
60
 has 
provided insight into the mechanism of haemozoin formation through the observation of 
haemozoin crystals inside neutral lipid droplets in the aqueous digestive vacuole of the 
malaria parasite. On this basis, a novel biomimetic method for studying the formation of β-
haematin at a lipid water interface was developed, with kinetic studies undertaken in this 
model system showing biologically relevant half-lives for β-haematin formation which are 
in the order of minutes.
73,74
 Due to increasing interest in the lipid-mediated mechanism of 
β-haematin formation, and the fact that drug action is now thought to take place in this 
environment, the modified Phiβ assay (lipid-water interface system)74 was chosen for 
measuring the inhibition of β-haematin formation by clinically-relevant antimalarials under 
biomimetic conditions. The kinetic effects of β-haematin formation in the presence of CQ, 
AQ, QD and QN were investigated as they represent the two different sub-classes within 
the quinoline family, namely 4-aminoquinoline and quinoline methanol antimalarial drugs, 
respectively. The study made use of monopalmitic glycerol (MPG) to model the lipid 
environment, since significant amounts of MPG have been detected in the digestive 
vacuole surrounding haemozoin.
60
 This is the first systematic study of the effect of 
quinoline antimalarial drugs on β-haematin formation under biomimetic conditions, and 
has provided insight into the mechanism of action of this important class of antimalarial 
drugs. 
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5.2 Experimental Methods 
 
The methods in this section describe how the MPG (lipid)-water interface system was used 
to investigate the formation of β-haematin in the presence of CQ, AQ, QD, QN and MQ. 
The effect of altering the concentrations of these quinoline methanol and 4-amino-
quinoline drugs (incorporated into the aqueous buffer) was studied. The materials used 
have been previously listed in Table 3.1. 
 
5.2.1 General Preparations: Lipid-Water Interface 
 
5.2.1.1 0.10 M NaOH Solution 
 
Solid pellets (4.00 g, 100.0 mmol) of NaOH were dissolved in distilled water to a total 
volume of 1000.0 mL in a volumetric flask. 
 
5.2.1.2 0.20 M HEPES Buffer, pH 7.5 
 
4.76 g of HEPES acid was dissolved in 80.0 mL distilled water. The pH was adjusted to 
7.5 using a concentrated solution of sodium hydroxide (NaOH). The solution was 
transferred quantitatively and made to volume in a 100.0 mL volumetric flask. 
 
5.2.1.3 2.0 M HEPES Buffer, pH 7.5 
 
47.66 g of HEPES acid was dissolved in distilled water until a volume of 80.0 mL was 
reached in a beaker. The pH was adjusted to 7.5 using a concentrated solution of sodium 
hydroxide (NaOH). The solution was transferred quantitatively and made to volume in a 
100.0 mL volumetric flask. 
 
5.2.1.4 5:45:50 (v/v) Pyridine: Water: Acetone Solution 
 
To 10.0 mL of 0.2 M HEPES buffer (pH 7.5), 5.0 mL pyridine and 50.0 mL acetone were 
added and thoroughly mixed together. The solution was made up to a final volume of 
100.0 mL with distilled water in a volumetric flask. The mole ratio corresponding to the 
volumes used is 1:42:11 for pyridine, water and acetone respectively. 
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5.2.1.5 30:30:40 (v/v) Pyridine: Water: Acetone Solution 
 
To 10.0 mL of 2.0 M HEPES buffer (pH 7.5), 30.0 mL pyridine and 40.0 mL acetone were 
added and thoroughly mixed together. The solution was made up to a final volume of 
100.0 mL with distilled water. The mole ratio corresponding to the volumes used is 1:5:2 
for pyridine, water and acetone respectively. 
 
5.2.1.6 50 mM Citrate Buffer, pH 4.8 
 
This buffer solution was prepared directly in a 1 litre Schott bottle. Citric acid 
monohydrate (10.51 g, 50.0 mmol) was dissolved in 950.0 mL distilled water. The pH was 
adjusted to 4.8 using a concentrated solution of sodium hydroxide (NaOH) after which the 
solution was made up to a final volume of 1000 mL. This buffer solution is referred to as 
“regular” citrate buffer in the remainder of the chapter to distinguish it from preparations 
in which antimalarial drugs are included. 
 
5.2.1.7 1:9 (v/v) Acetone: Methanol Solution 
 
10.0 mL of acetone was mixed together with methanol in a volumetric flask to a total 
volume of 100.0 mL. 
 
5.2.1.8 Lipid Solution 
 
18.0 mg MPG (1-monopalmitoyl-rac-glycerol, Figure 5.1) was dissolved in 18.0 mL of the 
1:9 acetone: methanol solution to give a final concentration of 1.0 mg/mL. This solution 
was stored in a sealed glass vial below 0 
o
C and prepared fresh for each set of experiments. 
O
O OH
HHO
 
Figure 5.1 The chemical structure of 1-monopalmitoyl-rac-glycerol (MPG), the lipid used 
in this study as a model of the lipid environment associated with haemozoin.
60
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5.2.1.9 Fe(III)PPIX Solution 
 
10.0 mg Fe(III)PPIX (haematin) was dissolved in 2.0 mL of 0.1 M NaOH in a Greiner 
Falcon centrifuge tube. After complete dissolution of the solid, 3.0 mL of the 1:9 (v/v) 
acetone: methanol solution was added and the new solution was thoroughly mixed to give 
a final concentration of 0.67 mg/mL. This solution was prepared fresh for each set of 
experiments. 
 
5.2.2 Preparation of β-Haematin at the MPG-Water Interface 
 
Experiments were carried out in Schott Duran crystallising dishes with an internal diameter 
of 9 cm. For the purpose of incubation, these glass vessels were partially immersed into a 
water bath set at 38 
o
C to ensure that the working temperature of the experiments remained 
close to biological temperature (37 
o
C) at all times. Aluminium foil was used to cover each 
vessel. 
Regular citrate buffer (50.0 mL, 50.0 mM, pH 4.8) was measured into each glass vessel 
and pre-incubated at 37 
o
C for 45 minutes while the lipid and Fe(III)PPIX solutions were 
prepared. A solution of 1.0 mL of lipid solution and 0.5 mL of the Fe(III)PPIX solution 
was then prepared. This “premix” was added dropwise over the surface of the citrate buffer 
using a syringe with a needle diameter of 0.5 mm creating a lipid-water emulsion at the 
lipid-water interface. Once the Fe(III)PPIX had been delivered to the interface via the 
“premix”, the vessels were left to incubate for a further 30 minutes. 
At the end of the incubation period, the surface was agitated to release the product into the 
bulk aqueous medium. The total volume (  51.5 mL) was then transferred to a centrifuge 
tube and centrifuged at 6000 revolutions per minute (rpm). The supernatant was discarded 
and the pellet kept for further analysis. 1.0 mL of the 5:45:50 (v/v) pyridine: water: acetone 
solution (pH 7.5) was added to “wash” the pellet. 5% (v/v) pyridine at pH 7.5 selectively 
dissolves unreacted Fe(III)PPIX in the presence of β-haematin, while 50% (v/v) acetone 
has proven useful in dissolving any co-pelleted lipid.
74
 After a second centrifugation, the 
remaining product (pellet) was dried in a desiccator over phosphorus pentoxide for up to 
52 hours before further analysis. The experimental procedures described above are shown 
in schematic form in Figure 5.2. 
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Figure 5.2 The experimental procedures for the formation of β-haematin at the lipid-water 
interface. 
 
5.2.3 Modified Phiβ Assay for Measuring Inhibition of β-Haematin Formation. 
 
The pyridine hemichrome inhibition of β-haematin (Phiβ) assay exploits the ability of a 
5% (v/v) aqueous pyridine solution, pH 7.5, to selectively form a low-spin bis-pyridyl 
complex with free Fe(III)PPIX and not β-haematin.134 The formation of the Fe(III)PPIX-
pyridine complex yields an orange-pink coloured solution making it possible for the free 
Fe(III)PPIX concentration to be determined from the spectroscopic absorbance of the Soret 
band at 405 nm. In the current work, the principles of the Phiβ assay were applied when 
investigating the inhibition of β-haematin formation in the lipid-water interface model 
system.
74
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5.2.3.1 Inhibition of β-Haematin Formation at the MPG-Water Interface by Antimalarial 
Drugs  
 
In order to investigate the effect of antimalarial drugs, the method of Hoang et al.
74
 was 
modified to include aqueous-soluble antimalarial drugs in the citrate buffer. β-Haematin 
formation was then brought about in the same manner as before. The antimalarial drugs 
discussed in this work have been shown in Figure 1.36. 
 
5.2.3.2 Citrate Buffer Solutions Containing Antimalarial Drugs  
 
A stock solution of citric acid monohydrate was prepared by dissolving 10.51 g (50.0 
mmol) in 950.0 mL distilled water together with the appropriate mass of antimalarial drug 
(Table 5.1). The pH was adjusted to 4.8 using a concentrated solution of sodium hydroxide 
(NaOH). The solution was made up to a final volume of 1000 mL. This approach is 
suitable for compounds that are soluble in aqueous solution and was used in this study to 
prepare buffer solutions containing CQ, AQ, QD and QN. MQ, which is not soluble in 
aqueous solution, was dissolved in a 1:9 (v/v) acetone:methanol solution and added 
together with the lipid premix as described later. 
Table 5.1 Quantities of antimalarial salts required for the preparation of 0.1 mM solutions (volume 
= 1 000 mL) containing 50.0 mM citrate, pH 4.8. 
COMPOUND 
AVERAGE MOLECULAR 
MASS / Da
 MASS/g 
Chloroquine diphosphate (CQ) 515.86 0.0516 
Amodiaquine dihydrochloride dihydrate (AQ) 464.8 0.0464 
Quinine sulphate dihydrate (QN) 782.94 (391.45)* 0.0391 
Quinidine sulphate dihydrate (QD) 782.94 (391.45)* 0.0391 
Mefloquine hydrochloride (MQ) 414.077 0.0414
#
 
Primaquine bisphosphate 455.35 0.0455 
*The molecular mass of QD and QN is the value reported in brackets. These compounds are supplied as 
hemisulphate salts. 
#
Mefloquine hydrochloride is insoluble in the aqueous citrate buffer. The mass represents that needed to 
prepare 1000 mL of a 0.1 mM solution. However the mass incorporated into the lipid solution was equal to 
the amount that would be expected in the aqueous citrate buffer if the drug was soluble. 
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5.2.3.3 Determination of IC50 Values 
 
5.2.3.3.1 Aqueous Soluble Antimalarial Drugs 
 
All experiments were carried out in 15 mL Greiner Falcon centrifuge tubes with an internal 
diameter of 1.6 cm. For the purpose of incubation, these plastic tubes were partially 
immersed into a water bath set at 38 
o
C to ensure that the working temperature of the 
experiments remained 37 ± 1 
o
C at all times.  
Serial dilutions of the respective drug-containing citrate buffer solution were prepared 
using calibrated micro-pipettes. Regular citrate buffer (50.0 mM, pH 4.8) was used to 
dilute the citrate/drug stock solutions to a series of different concentrations as required. 
Initially, the working concentration range was more-or-less determined by trial and error 
for each drug initially and subsequently refined in repeat measurements. Each tube 
contained a total volume of 5 mL of drug-containing citrate buffer. Each plastic tube was 
pre-incubated at 37 
o
C for approximately 45 minutes while the lipid and Fe(III)PPIX 
solutions were prepared. 
A solution containing 0.2 mL (200 μL) of lipid solution and 0.005 mL (5 μL) of 
Fe(III)PPIX solution was prepared in a 2 mL Eppendorf tube for each experimental tube 
(i.e. 27 per triplicate set). The interface was prepared as before by adding the premix 
solution drop-wise to the pre-incubated interface using a syringe with a needle diameter of 
0.5 mm. Once the premix solution had been delivered to the interface, the plastic tubes 
were capped and left to incubate for a further 30 minutes.  
At the end of the incubation period, the interface was agitated to release the product into 
the bulk medium. 1.0 mL of an aqueous solution containing 30% pyridine solution, 10% 
HEPES buffer (2.0 M, pH 7.5) and 40% acetone (v/v) was added directly into the 
experimental solution to yield a solution which contained 5% (v/v) pyridine overall. After 
vigorous shaking of each tube to allow the pyridine to fully interact with the unreacted 
Fe(III)PPIX, the tubes were centrifuged at 6000 rpm for 10 minutes. At this point there 
was often the need to allow visible lipid precipitate to settle before transferring a 2.0 mL 
aliquot of the supernatant to a quartz cuvette. The absorbance value for each tube was 
measured at 405 nm to quantify the unreacted Fe(III)PPIX for each drug concentration. 
The experimental procedures described above are shown in schematic form in Figure 5.3.  
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Figure 5.3 Experimental procedures for the inhibition of β-haematin formation at the lipid-water 
interface by antimalarial drugs. 
 
Biological measurements are typically carried out in triplicate, however, due to the 
irreproducibility of the lipid emulsion formed at the interface, measurements at each time 
point, were performed nine times in order to increase certainty in the data (Figure 5.4).  
 
Figure 5.4 Schematic presentation of IC50 determination. For each tube (1 – 9) the incubation time 
was constant and the drug concentration varied. Measurements are routinely performed in 
triplicate. However, owing to poor reproducibility of the lipid-water interface, measurements were 
repeated nine times. 
 
The absorbance values were plotted as a function of drug concentration and fitted to a 
simple sigmoidal or hyperbolic equation. Data were analysed by nonlinear least squares 
fitting using GraphPad Prism 5 software.
164
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change is a measure of the IC50 which is the drug concentration required to inhibit 50% β-
haematin formation. A schematic of the data handling is shown in Figure 5.5. 
 
Figure 5.5 Schematic indicating how the absorbance data was used to calculate the drug 
concentration required to inhibit 50% of β-haematin formation (IC50). The A50 is worked out by 
subtracting the initial absorbance (Ai) value, recorded for low drug concentrations, from the final 
absorbance value (Af), at higher drug concentration and dividing the difference by two. The drug 
concentration corresponding to the 50% absorbance change value (A50) is the drug concentration 
required to inhibit 50% of β-haematin formation (IC50). 
 
5.2.3.3.2 Non-Aqueous Soluble Antimalarial Drugs 
 
Mefloquine hydrochloride (MQ) is insoluble in the citrate buffer solution. Therefore, the 
drug was incorporated into 100 μL of the lipid solution, while the remaining 100 μL of 
lipid solution plus Fe(III)PPIX solution was used to make up the premix. The drug-lipid 
solution was added drop wise first followed by the Fe(III)PPIX-lipid solution. The quantity 
of MQ incorporated into the lipid solution was equal to the amount that would be expected 
in the aqueous citrate buffer if the drug was soluble. Therefore, the concentrations were 
calculated relative to the total volume of the system. 
 
5.2.3.4 The Effect of Time on Drug IC50 Values 
 
Following the procedures outlined in section 5.2.3.3, the experiments to determine the IC50 
value of a particular drug were repeated at different incubation times which were varied in 
turn between 10 and 1200 min. The extent of reaction was monitored using the Phiβ assay. 
Data handling and analysis were carried out as before (section 5.2.3.3). 
Increase in Drug Concentration
Ai
Af
A50
IC50
A405
Af ─ Ai
2
A50  =
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5.2.3.5 Effects of Quinoline Antimalarial Drugs on the Kinetics of β-Haematin Formation 
at the Lipid-Water Interface 
 
Following the procedures outlined in section 5.2.3.3, the kinetics of β-haematin formation 
in the presence of various drug concentrations were recorded as follows: a series of 9 
tubes, each containing the same drug concentration, ranging from zero to approximately 
three times the previously determined IC50 value, was incubated for different lengths of 
time in order to generate the data points for a single kinetic trace. Measurements at a 
particular drug concentration were performed at least three times (Figure 5.6). The 
absorbance value at 405 nm is a direct quantitative measure of the unreacted Fe(III)PPIX 
remaining after the reaction and consequently, the % β-haematin formed during the 
reaction could be determined. 
 
Figure 5.6 A schematic presentation of kinetic determinations. For each tube (1 – 9) the drug 
concentration was fixed and the incubation time varied with each time point determined three 
times. 
 
The experimental procedure for the kinetic studies was the same as described in section 
5.2.3.3, but with the following changes. In earlier work, 5 μL aliquot of Fe(III)PPIX 
solution (3.1 μM in 5.2 mL) for the IC50 determination were used. However, the 
publication of the kinetic studies of β-haematin formation74 showed that a 2 μL aliquot (1.2 
μM in 5.2 mL) of Fe(III)PPIX produced optimal yields of β-haematin. Thus these revised 
conditions were used in the kinetic studies on β-haematin inhibition. As a result, the 
premix solution delivered to each reaction contained 0.2 mL (200 μL) of lipid solution and 
0.002 mL (2 μL) of Fe(III)PPIX solution.  
Data were analysed by nonlinear least squares fitting of the data using GraphPad Prism 5 
software,
164
 which allowed the length of time required for the formation of β-haematin to 
proceed to half its extent, that is the half life (t1/2), to be determined.  
1 2 3 4 5 6 7 8 9
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5.2.4 CQ and QD Adsorption to β-Haematin Crystals 
 
5.2.4.1 Preparation of β-Haematin Crystals at the Pentanol-Water Interface 
 
The pentanol-water interface system was used, since crystals grown from this environment 
have been shown to be of a better quality, largely due to the fact that traces of pentanol can 
be removed from the crystals if they are washed thoroughly. On the other hand, traces of 
lipid are routinely observed by SEM despite extensive washing of the crystals.  
Experiments were carried out in Schott Duran crystallising dishes with an internal diameter 
of 9 cm. For the purpose of incubation, these glass vessels were partially immersed into a 
water bath set at 38 
o
C to ensure that the working temperature of the experiments remained 
close to 37 
o
C at all times. Aluminium foil was used to cover each vessel. 
Regular citrate buffer (50.0 mL) was measured into each glass vessel after which 10 mL of 
1-pentanol was layered on top of this aqueous layer. Vessels were then pre-incubated at 37 
o
C for 30 minutes while the Fe(III)PPIX solution was prepared. A solution of 1.0 mL 
Fe(III)PPIX (in acetone:methanol) was introduced close to the pentanol-water interface 
making use of a syringe with a needle diameter of 0.5 mm to deliver the solution dropwise 
over the whole interface. Once the Fe(III)PPIX had been loaded on to the interface, the 
experiments were left to incubate for a further 30 minutes. 
At the end of the incubation period, the surface was agitated to release the product into the 
pentanol layer. The total volume of the pentanol layer (  11.0 mL) was transferred to a 
centrifuge tube and centrifuged at 6000 rpm. The supernatant was discarded and the pellet 
kept for further analysis. 1.0 mL of the 5:45:50 (v/v) pyridine: water: acetone solution (pH 
7.5) was added to wash the pellet. After a second centrifugation, the remaining product 
(pellet) was dried in a desiccator being exposed to phosphorus pentoxide for up to 52 hours 
before further analysis. 
 
5.2.4.2 CQ and QD Adsorption  
 
To investigate adsorption of CQ and QD to the surface of β-haematin crystals, Eppendorf 
tubes containing 1.0 mg β-haematin crystals (prepared from the 1-pentanol-water interface) 
suspended in 2.0 mL of citric buffer with the desired drug concentration (prepared as 
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described in section 5.2.3.2) were setup and allowed to stand for a period of 3 days after 
which the absorbance of the supernatant was measured. 
The amount of the drug that is proposed to be adsorbed by the crystal was calculated from 
Beer’s law plots determined for CQ and QD respectively. From Beer’s law, it is evident 
that there is a relationship between the transmission of light through a solution and the 
concentration of the solution being investigated (eq. 5.1).
147
  
       5.1 
In the above relationship, A is the measured absorbance, ε is the molar absortivity, c is the 
concentration of the compound in solution and l is the path length of the sample. By 
measuring the absorbance of the supernatant at 344 and 236 nm for CQ and QD 
respectively, and comparing to the initial absorbance reading of a drug solution of 
particular concentration, the extent of depletion was considered a measure of the 
adsorption of the drug to the β-haematin crystals. Studies were carried out in the presence 
of different drug concentrations, with each determination per drug concentration performed 
at least three times. Data were analysed by nonlinear least squares fitting using GraphPad 
Prism.
164
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5.3 Results 
 
5.3.1 Formation and Characterisation of β-Haematin at the Lipid-Water Interface 
 
Making use of the lipid-water interface system developed by Egan et al., the first objective 
was to confirm that β-haematin could be reproducibly recovered using this method.73 
Before proceeding with an investigation of drug activity in this system, it was important to 
ensure that the material we were aiming to inhibit (β-haematin) could be successfully 
synthesised and characterised. Formation of β-haematin was brought about by incubating a 
premixed solution of Fe(III)PPIX (3.2 mM) and 1-monopalmitoyl-rac-glycerol (MPG) 
lipid (3.3 mM) for 30 min on the surface of 50 mL citrate buffer solution (50 mM, pH 4.8) 
pre-incubated at 37 
o
C for 45 min. Following incubation, the reaction was quenched with 
pyridine. It has previously been shown in the pyridine hemichrome inhibition of β-
haematin (Phiβ) assay, that 5% (v/v) aqueous pyridine solution, pH 7.5, can selectively 
react with free Fe(III)PPIX resulting in a characteristic orange-pink bis-pyridyl complex in 
solution with a distinctive absorbance maximum at 405 nm.
134
 In the current work, the 
principles of the Phiβ assay were adapted for use with the lipid-water interface model 
system. Centrifugation allowed the β-haematin, which is not soluble in 5% (v/v) pyridine, 
to be recovered. β-Haematin yields a characteristic FT-IR spectrum as well as PXRD 
pattern and thus the final product obtained in these experiments was compared to literature 
standards.  
Previously shown in Figure 1.9 (a), the centrosymmetric haemozoin dimer comes about 
due to the propionate group of one Fe(III)PPIX molecule coordinating to the Fe(III) centre 
of the second Fe(III)PPIX and vice versa.
35
 The strong absorbance bands at 1211 cm
-1 
and 
1664 cm
-1
 in the FT-IR spectrum, assigned by Slater et al.
30
 to the C-O and C=O stretching 
frequencies of the coordinated propionate ligand are visible in the spectrum of the product 
recovered from the lipid-water interface (Figure 5.7). The ATR-IR spectrum and PXRD 
pattern of the product recovered from the interface are shown in Figure 5.7 and Figure 5.8 
respectively, and confirm the formation of β-haematin.  
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Figure 5.7 ATR-IR spectra of Fe(III)PPIX (dashed line) and β-haematin (solid line) recovered 
from the lipid-water interface. Characteristic peaks at 1211 and 1664 cm
-1
 in the spectrum of β-
haematin are indicated with arrows and are absent in the spectrum of Fe(III)PPIX.  
 
 
Figure 5.8 PXRD pattern of β-haematin recovered from the lipid-water interface. The (100) and 
(131) reflections are denoted. Comparison to the literature pattern previously reported by Egan et 
al.
71
 (inset) supports the conclusion that β-haematin is indeed formed at the lipid-water interface.  
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5.3.2 Effect of Antimalarial Drugs on Lipid-Mediated Formation of β-Haematin 
 
In order to validate the lipid-water interface system as a means of assaying antimalarial 
drug activity against β-haematin formation, the observed IC50 values were compared to the 
in vitro biological activities previously determined against CQ-sensitive (CQS) strains 
(3D7 and HB3) and CQ-resistant (CQR) strains (K1 and PH3) of the malaria parasite.
94
 
 
5.3.2.1 Validation of the Lipid-Water Interface System as a Means of Assaying Drug 
Activity 
 
The drug concentration required to inhibit β-haematin formation by 50% is referred to as 
the IC50 value. The more active a particular compound the lower its IC50 value. The dose-
response curves for the inhibition of β-haematin formation by quinoline antimalarials 
amodiaquine (AQ), chloroquine (CQ), quinidine (QD), quinine (QN) and mefloquine 
(MQ) after 30 minutes incubation time in the lipid-water interface model system are shown 
in Figure 5.9. This incubation time was arbitrarily chosen as a starting point while the 
concentration of drug was systematically increased. In contrast to a previous study by 
Ncokazi et al.
134
 in which drug concentrations were prepared as equivalents relative to 
Fe(III)PPIX and β-haematin formation was brought about in 4.5 M acetate (pH 4.5, 60 oC), 
the present study made use of actual molar concentrations. Following quenching of the 
reaction with 30% (v/v) aqueous pyridine to yield a final solution containing 5% (v/v) 
aqueous pyridine (pH 7.5), the extent of reaction was monitored by quantitating the 
remaining fraction of Fe(III)PPIX spectroscopically at 405 nm (Figure 5.9). The observed 
IC50 data are summarised in Table 5.2.  
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Figure 5.9 The inhibition of β-haematin formation by antimalarial drugs in a lipid-water interface 
model system. Dose-response curves determined after 30 minutes incubation as a function of 
increasing antimalarial drug concentration. The compounds investigated were (a) CQ, (b) AQ, (c) 
QD, (d) QN and (e) MQ. The solid line represents the best fit of the data to a sigmoidal (a and b) or 
simple hyperbolic (c, d and e) function in order to determine the IC50 for each drug.   
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Table 5.2 IC50 data obtained for the inhibition of β-haematin at the lipid-water interface. 
Antimalarial drug Observed IC50 ( M) 
CQ 16.4 ± 0.5
* 
AQ 9.0 ± 0.4 
QD 51.1 ± 5.8 
QN 73.9 ± 12.8 
MQ 12.2 ± 0.1 
*
Error calculated as standard error of the mean (SEM), following nine repeat measurements. 
 
 
A corresponding increase in absorbance (A405) is observed in each case as the 
concentration of the inhibitor is increased. This is expected due to an increase in the 
amount of free Fe(III)PPIX which is prevented from being incorporated into β-haematin. 
Notably, the inhibition profiles brought about in the presence of 4-aminoquinoline and 
quinoline methanol antimalarial drugs appear to differ. While AQ and CQ appear to induce 
a sigmoidal dose-response, the QD, QN and MQ dose-response curves conform to a simple 
hyperbola. Initially it was thought that the IC50 results pointed to different mechanisms for 
the 4-aminoquinoline and quinoline methanol compounds, however, careful 
reconsideration as discussed below, suggests that this is not the case. 
When comparing the observed IC50 values to the in vitro biological activities previously 
determined against the CQ-sensitive (CQS) strains (3D7 and HB3) and CQ-resistant 
(CQR) strains (K1 and PH3) of the malaria parasite.
94
 The results of the current study are 
in good agreement and show a linear correlation (Figure 5.10). In the case of the CQR 
correlation, data points for CQ have been omitted since the lipid-water interface cannot 
account for the CQR mechanism where the CQ concentration within the infected cell is 
diminished. This reduction is probably due to the removal of CQ by PfCRT.
178
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Figure 5.10 Inhibition of β-haematin formation by quinoline antimalarials at the lipid-water 
interface (LW). The correlation between the inhibitory activities of antimalarial drugs at the lipid-
water interface (IC50 (LW) values obtained after 30 min incubation time), and their biological 
activity against CQ-susceptible strains, 3D7 (●) and HB3 (grey box), and CQ-resistant strains, K1 
(●) and PH3 (●), of P. falciparum.94 The r2 values for CQS and CQR correlations are 0.92 and 
0.96, respectively. The data points for CQ against the CQR strains indicate very poor activity and 
have not been included in the linear regression analysis. The slope values are different for the CQR 
and CQS strains: 0.92  0.10 and 0.37  0.04, respectively.  
 
Since it is argued that MQ is the only drug which is not readily soluble in the aqueous 
layer, MQ has been excluded from the above correlation, and it is therefore difficult to 
compare its activity directly with the activity of other compounds. The statistical 
significance of the linear correlation observed between the biological activities of CQ, AQ, 
QN and QD against CQS and CQR strains of P. falciparum is good with r
2
 values of 0.92 
and 0.96 respectively. It is observed that different slopes are obtained for each correlation. 
The deviation from zero in each case is significant as indicated by a P value of < 0.05. 
However, the slope in the CQR correlation (slope = 0.92   0.10) is steeper when compared 
to the slope of the CQS correlation (slope = 0.37   0.04). Since the IC50 (LW) values are 
constant, the contributing factor to the differing slope values is simply the greater IC50 
values reported for CQR compared to CQS strains. Overall, the correlations do indicate 
that the lipid-water interface system is a valid system in which to investigate drug activity.  
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5.3.2.2 Observed Kinetic Behaviour in the Presence of Quinoline Antimalarials 
 
A detailed kinetic investigation of β-haematin formation at the lipid-water interface in the 
presence of quinoline antimalarial drugs CQ, QD, AQ and QN was subsequently 
undertaken. The rapid rate at which β-haematin forms in the lipid-water interface model 
system compared to 4.5 M acetate (pH 4.5, 60 
o
C) made it possible to investigate the 
kinetics for this process in the presence of antimalarial drugs. The observed kinetic 
behaviour in the presence of CQ is shown in Figure 5.11. 
 
Figure 5.11 The effects of CQ on the kinetics of β-haematin formation. (a and b) In the absence 
(black circle) and presence of 0.005 (●), 0.01 (●), 0.015 (●), 0.02 (●), 0.03 (●), 0.05 (●) and 0.1 (●) 
mM CQ, differences in the rate of the reactions are observed as the drug concentration is increased. 
The absorbance readings at 405 nm were converted into % β-haematin formed after each reaction. 
At relatively low drug concentration, there is a decrease in the rate constant, with the same yield of 
β-haematin eventually forming after longer periods of time. However, when the drug concentration 
is increased, a decrease in the final yield of β-haematin is observed. (c) The observed decrease in 
the rate constant of β-haematin formation with an increase in drug concentration. 
 
In studying the kinetic effect of the drug on the formation of β-haematin under biomimetic 
conditions (lipid-water interface), a decrease in the rate at which β-haematin is formed is 
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observed at low drug concentration. As the drug concentrations are increased further, a 
decrease in the final yield of β-haematin is observed. Similar results were obtained for the 
other quinoline antimalarial drugs. 
It could be argued that the decrease in absorbance measured as a function of time may be 
due to the formation of an unknown higher aggregate of Fe(III)PPIX or a Fe(III)PPIX-drug 
complex which is also insoluble in pyridine. However, using both infrared spectroscopy 
and powder X-ray diffraction, the formation of β-haematin was confirmed as the cause of 
the lower absorbance values, even in the presence of lower drug concentrations. Infrared 
spectra of the product obtained in the presence of 18  M CQ (roughly the IC50 value for 30 
minutes incubation time) and 50 µM QD (roughly the IC50 value for 30 minutes incubation 
time) after 5, 30 and 300 minutes incubation time are shown in Figure 5.12 a and b 
respectively, where prominent β-haematin peaks at 1211 and 1664 cm-1 are clearly visible 
in the infrared spectra. No new peaks or significant shifts are observed with increasing 
time, confirming that only unreacted Fe(III)PPIX and β-haematin are present. Owing to the 
fact that the lipid (MPG) is only ~ 70% efficient in its conversion of Fe(III)PPIX to β-
haematin, a significant fraction of unreacted Fe(III)PPIX remains. It is indicated in the IR 
spectrum as a large broad signal centred at approximately 1590 cm
-1
.  
 
Figure 5.12 Infrared spectra of the Fe(III)PPIX species formed in the presence of (a) 18 µM CQ 
and (b) 50 µM QD after 5, 30 and 300 minutes (fine, medium and dashed lines respectively) 
incubation time. The two characteristic β-haematin bands at 1211 and 1664 cm-1 are indicated by 
dashed vertical lines. The signal for the unreacted Fe(III)PPIX in the grey block is expected owing 
to the lipid being only   70% efficient.74  
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PXRD patterns of the product obtained in the presence of 18  M CQ and 50 µM QD after 
5, 30 and 300 minutes incubation time are shown in Figure 5.13 a and b respectively. The 
PXRD patterns demonstrate the presence of β-haematin. 
 
Figure 5.13 PXRD patterns of the Fe(III)PPIX species formed in the presence of (a) 18  M CQ 
and (b) 50  M QD after 5 minutes (green), 30 minutes (red) and 300 minutes (black) incubation 
time respectively. The PXRD patterns are characteristic of β-haematin.71 
 
The quality of the PXRD pattern for Fe(III)PPIX species formed in the presence of 50 µM 
QD after 5 minute incubation time does not demonstrate the presence of β-haematin as 
clearly as at longer incubation times. This could be due to the fact that at short incubation 
time β-haematin crystal nucleation is still taking place and Fe(III)PPIX has not been 
converted to β-haematin or possibly due to a QD-Fe(III)PPIX complex forming. 
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5.3.2.3 Theoretical Model to Explain the Observed Kinetic Behaviour 
 
Since simple kinetic models could not account for the observed effects of drug on the rate 
and yield of β-haematin formation, we set out to derive our own. In the first instance, an 
equilibrium in which the drug associates with free Fe(III)PPIX (haematin) in solution, and 
in the process reduces the concentration available to form β-haematin, was considered 
(Scheme 1). This equilibrium would account for the observed decrease in the rate of β-
haematin formation, while the presence of an inhibiting drug may also be expected to 
promote a competing process that results in the irreversible precipitation of haematin, 
possibly as a drug complex. The latter would account for the decreased yield of β-haematin 
at higher drug concentrations. Irrespective of how strongly a drug compound associates 
with haematin in solution, as determined by the magnitude of the association constant K, 
the rate constant for the formation of β-haematin, k1, is expected to dominate the rate 
constant for the precipitation of a drug-haematin complex, k2, at low drug concentrations. 
Thus, the final yield of β-haematin would remain constant, but the rate of formation would 
decrease. However, as the concentration of drug is raised, k2 will begin to have influence, 
and precipitation of the haematin (possibly as a drug complex) would begin to decrease the 
yield of β-haematin. 
 
Scheme 1 A possible model to explain the effect of a drug on the rate of β-haematin formation.     
(i) Haematin (H(aq)) dimerises in solution to form β-haematin (β(S)) with rate constant k1. (ii) The 
irreversible precipitation of a drug-haematin complex (DH(s)), with rate constant k2. (iii) 
Equilibruim reaction in which drug (D(aq)) associates with free Fe(III)PPIX (H(aq)) in solution 
forming a drug-haematin complex (DH(aq)) with an association constant, K. 
D(aq)
DH(aq)
K
H(aq)
H(aq)+
+
k2
k1
DH(s)
β(s)H(aq)  
+
(iii)
(i)
(ii)
Competing 
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For this equilibrium reaction, the rate-determining step in the formation of β-haematin is a 
solution reaction, the rate of which is determined by the concentration of dissolved 
haematin species. Furthermore, if formation of the µ-propionato dimer of haematin (the 
precursor to β-haematin) in solution is rate-determining, the reaction would be expected to 
be second-order with respect to haematin. Alternative rate-limiting steps, such as 
dissociation of the axial ligand, would result in a process that is first order with respect to 
haematin.  
While plausible, however, the mechanism presented in Scheme 1 is considered physically 
unrealistic for the process in question. A more likely scenario is that β-haematin crystal 
growth is rate determining. In this case the rate of β-haematin formation would be expected 
to depend on the rates of crystal nucleation and growth and not on the dissolved haematin 
concentration. While kinetics cannot definitively distinguish between this mechanism and 
the solution mechanism presented above, it was considered the more likely scenario, and 
therefore a crystal growth kinetic model was sought which may account for the 
observations. 
The Avrami equation (eq. 5.2) has been used to model crystallisation processes, that is how 
solids transform from one phase into another at a constant temperature. It specifically 
describes the kinetics involved in crystallisation.
69,70
 
  
  
     
 
 (5.2) 
In the above equation,   is the mass of Fe(III)PPIX remaining at time t compared to the 
initial mass  , z is an empirical rate constant and n is a constant known as the Avrami 
constant, which is usually an integer ranging between 1 and 4. In previous studies in which 
the kinetics of β-haematin formation were investigated in acetate medium, the yield of β-
haematin formed were shown to exhibit sigmoidal time dependence. The best fit of the 
data to the Avrami model was when the Avrami constant was equal to 4. This indicates 
spontaneous nucleation and three dimensional crystal growth.
68
 
The kinetic profile obtained for β-haematin formation in the lipid system conversely fits to 
an exponential function. When the Avrami constant is equal to 1, eq. 5.2 becomes 
mathematically indistinguishable from that of first order kinetics and thereby, accounts for 
the exponential shape observed. With a value equal to 1, the Avrami constant indicates that 
the process involves a fixed number of preformed nuclei, and that β-haematin crystal 
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growth takes place in approximately one dimension [1-D (linear) crystal growth]. This 
growth pattern is consistent with the observed morphology of β-haematin with crystals 
appearing as long needles.
179,180
 Furthermore, the mode of nucleation is consistent with the 
proposed epitaxy model, with the lipid providing a fixed number of preformed nuclei (i.e. 
the nucleation sites are present before the reaction begins).
181
 
In the model put forward by Leiserowitz and co-workers
40,180
, the fastest-growing face of 
the β-haematin crystals was shown to contain a favourable binding site for quinoline 
antimalarial drugs (refer back to Figure 1.39, section 1.6.4). Their proposed mechanism for 
the inhibition of β-haematin formation by antimalarial drugs suggests that drug molecules 
are able to adsorb to sites on the surface of the growing crystal in order to impede further 
growth. Based on this hypothesis, a more realistic mechanistic explanation of the effect of 
drug on the rate of β-haematin formation was considered (Scheme 2). 
In Scheme 2, [H] is the concentration of free Fe(III)PPIX (haematin). As the reaction 
progresses, there are two processes that compete for the starting material, namely the 
formation of β-haematin (β(s)) or the precipitation of a haematin-drug complex (DH(s)). The 
rate constant for the formation of β-haematin, zobs, is expected to dominate the rate constant 
for the precipitation of a drug-haematin complex, k2, at low drug concentrations. However, 
as the concentration of drug is raised, k2 will begin to have an influence, and precipitation 
of the proposed complex will begin to decrease the yield of β-haematin.  
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Scheme 2 Proposed model to explain the effect of drug molecules on the rate of β-haematin 
formation. (i) Haematin (H(aq)) is added to the binding site (S) on the growing face of β-haematin 
(β(s)), with a rate constant zobs (ii) The irreversible precipitation of a drug-haematin complex (DH(s)), 
with rate constant k2. (iii) Equilibruim reaction in which drug (D(aq)) adsorption onto the binding 
site (S) on the growing face of β-haematin crystals, form the adsorption complex (DS), with an 
adsorption equilibrium constant, Kads (b) Representation of the formation of a drug monolayer on 
the fastest growing surface of β-haematin crystal by adsorption onto the binding sites. For the 
detailed model showing the docking of quinoline antimalarials into grooves on the fastest growing 
(001) face of a β-haematin crystal, please refer back to Figure 1.39. 
 
The full derivation of the kinetic model discussed below is presented in Appendix 1. In this 
model, the process of adsorption of the drug onto the growing face of β-haematin was 
considered reminiscent of the Langmuir isotherm (eq. 5.3) where the extent of monolayer 
coverage of a solid surface is related to the partitioning of an adsorbant between the gas 
phase and the adsorbed state as a function of applied pressure.
182
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Here the Langmuir isotherm (eq. 5.3) relates the fraction of occupied binding sites on a 
solid surface   to the pressure P of the adsorbing reactant in the gas phase and the 
equilibrium adsorption constant Kads. The Langmuir isotherm can be used to characterise 
the adsorption of antimalarial drugs onto the growing face of β-haematin in a similar 
manner (eq. 5.4): 
  
    [ ]
      [ ]
 (5.4) 
Here the drug concentration, [D], can be thought of in the same way as the pressure of the 
adsorbing reactant in the gas phase. The number of free sites that are available for 
continued crystal growth is therefore equal to    . It is reasonable to propose that any 
continued growth of β-haematin is then dependent on the number of free sites (   ), and 
therefore the growth rate of β-haematin, in the presence of a drug, zobs, (Scheme 2) relative 
to its growth rate in the absence of drug, z, is proportional to the number of vacant binding 
sites. The rate constant for the formation of β-haematin in the presence of an inhibition 
drug,     , is given by eq. 5.5; since 
    
 
    , then 
      (   )  
 
      [ ]
 (5.5) 
In the above equation, z is the rate constant for β-haematin formation in the absence of 
drug while zobs is the observed rate constant for β-haematin formation in presence of drug. 
From eq. 5.5, the observed rate constant is predicted to decrease with increasing drug 
concentration. Although this model is mathematically indistinguishable to that presented in 
Scheme 1, it is considered to be a more physically-realistic interpretation. It accounts for 
the observed decrease in the rate constant (Figure 5.11 c) of β-haematin formation with an 
increase in drug concentration in the experimental results where the kinetics of β-haematin 
formation in the presence of quinoline antimalarials at the lipid-water interface was studied 
as well as the fact that β-haematin crystals were able to form in the presence of an 
inhibitor. 
A plot of the inverse of the observed rate constant, zobs, as a function of drug concentration, 
yields a linear regression from which the values of z and Kads can be determined from the 
values of the y-intercept and slope, respectively, according to eq.5.6. 
 
    
 
      [ ]
 
 
    
 
[ ]  
 
 
  (5.6) 
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To explain the observed decrease in final yield of β-haematin formed at higher drug 
concentrations, it was necessary to incorporate a competing drug concentration-dependent 
process that would result in the irreversible precipitation of haematin, most likely as a drug 
complex (DH(s)). The experimental kinetics show that such a process is required to fully 
account for the observations (Figure 5.11). While the details of this process have not been 
probed in this work, we found that satisfactory agreement with the experiment was 
achieved by incorporating the reaction included in Scheme 2. According to this 
mechanism, the rate of depletion of haematin in solution (H(aq)) can be determined by eq. 
5.7. 
 [ (  )]
  
  [ (  )](       [ (  )]
 
) (5.7) 
In the above equation,    is the rate constant for the irreversible precipitation of haematin 
brought about by interaction with the drug. [ (  )] (simplified as [ ] in the equations 
below) and [   ] are the respective concentrations of drug and haematin in solution and 
   . It was found that the best agreement with the experimental results is achieved 
when m = 2 and this value is assumed for the remainder of the derivation. Assuming [D(aq)] 
to be in large excess compared to haematin ([ (  )]  [   ]), the percentage yield of β-
haematin (%β(s)), as a function of time, t, is shown to depend on the rate of both competing 
reactions (eq. 5.8): 
 [ ( )]  
       
(       [ ] )
(    (       [ ]
 ) ) (5.8) 
Substituting eq. 5.7 into the above relationship yields eq. 5.9: 
 [ ( )]  
    
(    [ ]        [ ] )
(   
 (
    [ ]
        [ ]
 
      [ ]
) 
) (5.9) 
To take into account that the lipid (MPG) is not able to convert [   ] into a yield of 100% 
β-haematin, an additional term, Y was introduced to account for the fractional yield. It has 
been shown previously that in the absence of an inhibitor, MPG is capable of mediating β-
haematin with approximately 70% efficiency.
74
 Therefore, Y represents the fraction of the 
total theoretical yield that can physically be attained at any given drug concentration. To 
obtain identical lipid emulsion conditions is very difficult in practice: therefore this value 
exhibits a considerable degree of random variability. With no drug present in the system, 
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the value of Y is equal to          . Therefore during data fitting for all other 
experiments, Y was allowed to refine freely within three standard deviations of this value 
(i.e. between 0.62 and 0.8). It should also be noted that as the drug concentration is 
increased, the value of Y can start to decrease as a result of the irreversible precipitation of 
Fe(III)PPIX.  
The values of Kads and z were obtained from equation 5.6 and the values for [D] were the 
drug concentration used in each individual experiment. Since the competition reaction, 
which results in the precipitation of haematin, as something other than β-haematin, is 
poorly understood, an accurate value of k2 could not be determined independently. 
However, since k2 and Y are correlated, and understanding the limits of the experiment 
permitted us to select a sensible value for Y, a range of values for k2 could be determined 
during the data analyses.  
Taking all of the above consideration into account, the overall kinetic model is represented 
by eq. 5.10. 
  ( )  
     
(    [ ]        [ ] )
{   
 (
    [ ]
        [ ]
 
      [ ]
) 
} (5.10) 
Based on this model, it is possible to predict the kinetics of β-haematin formation in the 
absence and presence of an inhibiting drug. In order to apply the model, the experimental 
data was first fitted to a simple first-order equation to determine the values for zobs. As 
shown in Figure 5.14 (a), the model predicts adherence to exponential behaviour. 
Furthermore, it is notable that at low drug concentrations, the final yield of β-haematin 
remains almost constant, however as the dose is increased further, the final yield begins to 
decrease. According to the adsorption model based on the Langmuir isotherm (eq. 5.6 
above), a plot of the inverse of the observed rate constant as a function of drug 
concentration is predicted to be linear at low drug concentration (Figure 5.14 (b)). Linear 
regression in this region allows the adsorption equilibrium constant, Kads, as well as the rate 
constant in the absence of an inhibitor, z, to be determined.  
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Figure 5.14 (a) The kinetics of β-haematin formation predicted by the model (eq. 5.10) in the 
absence and presence of an inhibiting drug. Drug concentrations range from 0 (black trace) through 
increasing doses to a relatively high final value (grey curve). (b) The plot of the inverse of the 
predicted behaviour of the observed rate constant zobs as a function of drug concentration (grey 
line). Linear regression at relatively low concentration allows the values of the rate constant in the 
absence of drug (z) and the adsorption equilibruim constant (Kads) to be determined from the values 
of the y-intercept and slope, as per eq.5.6. 
 
It is also possible to predict the dose-response behaviour from the kinetic profiles by 
examining expected yields at various time points, as a function of drug concentration 
(Figure 5.15). 
Figure 5.15 The kinetics of β-haematin formation predicted by the model (eq. 5.10). (a) Taking 
slices through the kinetic profiles at various time points (dashed lines), the dose-response 
behaviour can be predicted. (b) The best-fit of the numerical output generated at different times 
from (a). At short incubations times, dose-response curves tend towards a hyperbola, compared to 
sigmoidal dose-response curves observed at longer incubation times. It is shown that the curves 
eventually converge on a single IC50 value (grey line).  
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As shown above, the model gives rise to a sigmoidal dose-response curve, although this is 
more evident at longer incubation times. At shorter incubation times, on the other hand, the 
dose-response profile tends toward a hyperbolic function. According to this model, 
reproducing IC50 values from the dose-response behaviour (Figure 5.16) demonstrates that 
the IC50 value is dependent on incubation time at short times. At long incubation time 
however, the individual dose-response curves are predicted to converge with very little 
change in the expected IC50 value with further increase in incubation time, leading to a 
hyperbolic dependence of IC50 on time (Figure 5.16 (b)). This dependence of IC50 value on 
time would not occur in the absence of the drug-induced irreversible precipitation of 
haematin. Rather a linear relationship would be expected, since over longer periods of 
time, more and more drug would be required to inhibit β-haematin formation. 
 
Figure 5.16 The dependence of IC50 value on incubation time. (a) The hyperbolic and sigmoidal 
dose-response curves produced from the numerical output generated at different times from the 
theoretical model (eq. 5.10). (b) Based on the theoretical outputs in (a), the corresponding IC50 
values from the dose-response curves could be predicted. The data conform to a hyperbolic 
function as indicated, showing that at shorter incubation times, the effect on the IC50 values is more 
pronounced with there being little further increase at longer incubation times. 
 
5.3.3 Observed Kinetics of β-Haematin Formation in the Presence of Antimalarial 
Quinolines 
 
The observed kinetics of β-haematin formation in the presence of CQ shown above (Figure 
5.11), are consistent with the theoretical behaviour predicted above; at low drug 
concentrations, the rate of β-haematin formation is decreasing with an increase in drug 
concentration. When the drug concentration is sufficiently high, a decrease in the final 
yield of β-haematin is observed. In the following section, the effects of CQ, AQ, QN and 
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QD on the kinetics of β-haematin formation are reported. Initially the kinetic data were 
fitted to a simple exponential equation in order to determine the observed rate constants 
(zobs). 
 
5.3.3.1 Kinetics of β-Haematin Formation in the Presence of CQ 
 
In order to generate a plot of the inverse of zobs as a function of increasing drug 
concentration (Figure 5.17 (a)), it was first necessary to fit the raw data to a simple 
exponential kinetic equation in order to determine the observed rate constants. Following 
the prediction of the proposed model based on the Langmuir isotherm, the inverse of zobs 
versus drug concentration yields a linear correlation up to a concentration of 0.03  10-3 
M. From the linear regression, the intercept and slope values were determined, which 
allowed the values for the observed rate constant of β-haematin formation in absence of 
CQ, z, and the adsorption equilibrium constant, Kads, to be calculated according to eq. 5.6. 
These values are given in Table 5.3. The kinetic data were subsequently fitted to eq. 5.10, 
where the best fit value for the rate constant for the formation of DH(s), k2, was found to be 
in the range between 0.3 and 0.6. Consequently, k2 was set to a value of 0.45 in order to 
generate the best fit of the experimental kinetic data shown in Figure 5.17 (b). The r
2
 
values range between 0.74 and 0.96, indicating good agreement between the proposed 
kinetic model and the experimental results. There seems to be an increase in data scatter 
when the drug concentration increases. Therefore at a concentration of 0.1 × 10
-3
 M, the 
scatter is possibly due to drug interaction with lipid and the r
2
 value is only 0.45.  
Table 5.3 Best fit values to the kinetic model for β-haematin formation in the presence of CQ 
Intercept (min) Slope (min M
-1
) z (min
-1
) Kads (M
-1
) Log Kads k2 
5.15 ± 0.51 (1.829  ± 30) × 103 0.19 ± 0.02 (3.55 ± 0.06) × 105 5.55 ± 0.03 0.45 
 
 
Shown in Figure 5.17 (c) is a dose-response curve extracted from the kinetic data at 30 
min. It is very difficult to extract dose-response profiles from the kinetic data due to fairly 
large scatter in the experimental data and non-identical incubation times chosen for 
different CQ concentrations. However, the data at 30 min show a reasonable fit to a 
sigmoidal function. The observed IC50 value (0.019 ± 0.005 × 10
-3
 M) from the kinetic data 
are within one standard deviation of the value determined in the independent dose-
response experiment (0.016 ± 0.001 × 10
-3
 M). The dependency of the IC50 value on 
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incubation time was also investigated. It is noted that at short incubation times there is a 
steep increase in the IC50 value, however it eventually converges on a value of ~0.045 × 
10
-3
 M when the incubation time exceeds 500 min. The IC50 values can be fitted to a 
simple hyperbola (Figure 5.17 (d)) in accordance with the predicted theoretical model.  
 
Figure 5.17 Kinetics of β-haematin formation in the presence of CQ. (a) As the kinetic model (eq. 
5.10) predicts, the plot of the inverse of the rate constant zobs as a function of drug concentration 
yields a linear correlation up to a concentration of 0.03 mM. The intercept value 5.15 ± 0.51 min 
and slope value of 1829 ± 30 × 10
3
 min M
-1
 were determined from the linear regression. Therefore, 
the values of z and Kads were calculated to be 0.19 ± 0.02 min
-1
 and 3.55 ± 0.06 × 10
5
 M
-1
, 
respectively. (b) Best fit of the experimental kinetic behaviour to the theoretical model (eq. 5.10), 
in the absence (black circle) and presence of 0.005 (●), 0.01 (●), 0.015 (●), 0.02 (●), 0.03 (●), 0.05 
(●) and 0.1 (●) mM CQ. (c) A slice through the kinetic at an incubation time of 30 min generates a 
dose-response profile; the data have been fitted to a sigmoidal function (r
2 
= 0.90). (d) The IC50 
values for the inhibition of β-haematin formation as a function of incubation time conform to a 
hyperbolic function. Error bars were taken as standard error of measurement (SEM). 
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5.3.3.2 Kinetics of β-Haematin Formation in the Presence of QD  
 
The quinoline methanol antimalarials were also investigated. The kinetics of β-haematin 
formation in the presence of QD also follow the predicted behaviour. A plot of the inverse 
of the observed rate constant as a function of increasing drug concentration is in 
accordance with the model, and linear regression is possible up to a value of  0.05 × 10-3 
M (Figure 5.18 (a)). From the linear regression line, the intercept and slope values were 
determined as before. This allowed the values of the observed rate constant of β-haematin 
formation in the absence of QD, z, and the adsorption equilibrium constant, Kads, to be 
determined according to eq. 5.6. These values are reported in Table 5.4. 
Table 5.4 Best fit values to the kinetic model for β-haematin formation in the presence of QD. 
Intercept (min) Slope (min M
-1
) z (min
-1
) Kads (M
-1
) Log Kads k2 
5.92 ± 0.12 (492  ± 4) × 103 0.17 ± 0.01 (8.36 ± 0.06) × 104 4.92 ± 0.01 0.55 
 
 
Fitting the kinetic data to the model, the value for k2 was found in the range between 0.2 
and 0.9. Therefore, a midrange value of 0.55 was used for the best fit of the experimental 
kinetics (Figure 5.18 (b)). A slice through the kinetics data at an incubation time of 30 min 
yields a dose-response curve, Figure 5.18 (c), which could be fitted to a sigmoidal function 
(r
2
 = 0.97). The dependence of IC50 values on incubation time is also shown (Figure 5.18 
(d)), increasing markedly over relatively short periods of time and eventually converging 
on a value of approximately 0.15 × 10
-3
 M at incubation times greater than about 300 min.  
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Figure 5.18 Kinetics of β-haematin formation in the presence of QD. (a) As the kinetic model (eq. 
5.10) predicts, the plot of the inverse of the rate constant zobs as a function of drug concentration 
yields a linear correlation up to a concentration of 0.05 mM. The intercept value 5.92 ± 0.12 min 
and slope value of 492 ± 4 × 10
3
 min M
-1
 were determined from the linear regression. Therefore, 
the values of z and Kads were calculated to be 0.17 ± 0.01 min
-1
 and 8.36 ± 0.06 × 10
4
 M
-1
, 
respectively. (b) Best fit of the experimental kinetic behaviour to the theoretical model (eq. 5.10), 
in the absence (black circle) and presence of 0.02 (●), 0.05 (●), 0.075 (●) and 0.100 (●) mM QD. 
(c) A slice through the kinetic at an incubation time of 30 min generates a dose-response profile; 
the data have been fitted to a sigmoidal function (r
2 
= 0.99). (d) The IC50 value for the inhibition of 
β-haematin formation as a function of incubation time by QD also conforms to a hyperbolic 
function. Error bars were taken as SEM. 
 
5.3.3.3 Kinetics of β-Haematin Formation in the Presence of AQ 
 
The kinetics of β-haematin formation in the presence of AQ were also investigated, and the 
results conform to the predicted kinetic behaviour. As shown previously for CQ and QD, a 
plot of the inverse of the observed rate constant as a function of increasing drug 
concentration agrees with the model, and can be linearised up to a value of  0.005 × 10-3 
M (Figure 5.19 (a)). From the linear regression, the intercept and slope values were 
determined, which subsequently allowed the values for the observed rate constant of β-
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haematin formation in absence of AQ, z, and the adsorption equilibrium constant, Kads, to 
be determined from eq. 5.6. The values are reported in Table 5.5. The value for k2 was 
found to vary between 0.2 and 0.9. Therefore, a midrange value of 0.55 was used in the 
best fit of the experimental data (Figure 5.19 (b)). 
Table 5.5 Best fit values to the kinetic model for β-haematin formation in the presence of AQ. 
Intercept (min) Slope (min M
-1
) z (min
-1
) Kads (M
-1
) Log Kads k2 
10.8 ± 3.8 (5399 ± 1268) × 103 0.09 ± 0.03 (4.99 ± 1.79) × 105 5.7 ± 0.4 0.55 
 
 
 
Figure 5.19 Kinetics of β-haematin formation in the presence of AQ. (a) As the kinetic model (eq. 
5.10) predicts, the plot of the inverse of the rate constant zobs as a function of drug concentration 
yields a linear correlation up to a concentration of 0.005 mM. The intercept value 10.8 ± 3.8 min 
and slope value of 5399 ± 1268 min M
-1
 were determined from the linear regression, from which 
the values of z and Kads were calculated to be 0.09 ± 0.03 min
-1
 and 4.99 ± 1.79 × 10
5
M
-1
, 
respectively. (b) Best fit of the experimental data to the theoretical model (eq. 5.10), in the absence 
(black circle) and presence of 0.001 (●), 0.002 (●), 0.003 (●), 0.004 (●), 0.005 (●), 0.007 (●) and 
0.008 (●) mM AQ. Error bars were taken as SEM. 
 
5.3.3.4 Kinetics of β-Haematin Formation in the Presence of QN  
 
Suspecting that the effect of QN may be similar to that of QD, the kinetics of β-haematin 
formation were followed in the presence of QN. The resultant kinetic data confirms this, as 
they are shown to follow the predicted behaviour. The plot of the inverse of the observed 
rate constant as a function of increasing drug concentration is consistent with the model, 
and is linear at concentrations less than 0.05 × 10
-3 
M (Figure 5.20 (a)). From the linear 
regression analysis, the intercept and the slope values were determined, which allowed the 
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values for the observed rate constant for β-haematin formation in the absence of QN, z, and 
the adsorption equilibrium constant, Kads, to be calculated out according to eq. 5.6. These 
values are reported in Table 5.6. The value for k2 was found to vary between 0.1 and 0.12, 
and a midrange value of 0.6 was therefore used in fitting the experimental data to the 
kinetic model (Figure 5.20 (b)). 
Table 5.6 Best fit values to the kinetic model for β-haematin formation in the presence of QN. 
Intercept (min) Slope (min M
-1
) z (min
-1
) Kads (M
-1
) Log Kads k2 
8.24 ± 4.27 (857 ± 118) × 103 0.12 ± 0.06 (1.04 ± 0.14) × 105 5.02 ± 0.14 0.6 
 
 
 
Figure 5.20 Kinetics of β-haematin formation in the presence of QN. (a) As the kinetic model (eq. 
5.10) predicts, the plot of the inverse of the rate constant zobs as a function of drug concentration 
yields a linear correlation up to a concentration of 0.075 mM. The intercept value 8.24 ± 4.27 min 
and slope value of 857 ± 118 × 10
3
 min M
-1
 were determined from the linear regression. Therefore, 
the values of z and Kads were calculated to be 0.12 ± 0.06 min
-1
 and 1.04 ± 0.14 × 10
5
 M
-1
, 
respectively. (b) Best fit of the experimental data to the theoretical model (eq. 5.10), in the absence 
(black circle) and presence of 0.02 (●), 0.03 (●), 0.04 (●), 0.06 (●), 0.08 (●), 0.1 (●), and 0.12(●) 
mM QN. Error bars were taken as SEM. 
 
5.3.3.5 Validation of the Theoretical Kinetic Model 
 
In order to assess whether the hypotheses underpinning the theoretical model could be 
related to the biological mechanism of the quinoline compounds investigated above, the 
Kads values determined for each compound were compared against the IC50 values for the 
biological activity previously determined against P. falciparum (chloroquine-sensitive 3D7 
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strain).
94
 The correlation below indeed shows a significant agreement between the 
biological data and the experimental adsoption constants (Figure 5.21). 
 
Figure 5.21 Linear correlation (R
2 
= 0.69) between the observed equilibrium adsorption constant 
(log Kads) and the IC50 for biological activity of 4-aminoquinoline (CQ and AQ) and quinoline 
methanol (QD and QN) compounds against P. falciparum (chloroquine-sensitive 3D7 strain). 
 
5.3.4 Direct Adsorption of CQ and QD to β-Haematin Crystals  
 
In order to investigate the adsorption of quinoline antimalarials onto the crystal surface of 
β-haematin directly, good quality crystals were required. The pentanol-water interface 
system was used since crystals grown from this environment have been shown to be of a 
better quality, due to the fact that traces of pentanol can be removed if they are washed 
thoroughly. Crystals formed in the presence of lipid often remain coated by the lipid 
despite extensive washing with acetone solution. β-Haematin formation was brought about 
by incubating a Fe(III)PPIX solution for 30 min at the pentanol-water interface. Following 
incubation, the pellet was recovered by centrifugation and washed with 5% (v/v) pyridine 
solution to dissolve unreacted Fe(III)PPIX. The formation of β-haematin was confirmed 
using both ATR-IR spectroscopy and PXRD (Figure 5.22). 
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Figure 5.22 Characterisation of β-haematin recovered from the pentanol-water interface. (a) ATR-
IR spectrum of β-haematin recovered from the pentanol-water interface. Characteristic peaks at 
1211 and 1664 cm
-1
 in the spectrum of β-haematin, confirming the formation of the µ-propionato 
coordination dimer, are indicated with arrows.
30
 (b) PXRD pattern of β-haematin recovered from 
the pentanol-water interface. The (100) and (131) reflections are denoted. 
 
The amount of a drug that is proposed to adsorb to the crystal was calculated using the 
Beer’s law plots shown in Figure 5.23. By measuring the absorbance of the supernatant at 
344 and 236 nm for CQ and QD respectively, and comparing to the initial absorbance 
reading of a drug solution of particular concentration, the extent of depletion was 
considered a measure of the adsorption of the drug to the β-haematin crystals. Studies were 
carried out in the presence of different drug concentrations, with each determination per 
drug concentration performed at least three times.  
 
Figure 5.23 Beer’s law plot of the maximum absorbance band of (a) CQ (measured at 344 nm) and 
(b) QD (measured at 236 nm) in citrate buffer (50 mM, pH 4.8). Corresponding r
2
 values are 0.99 
for both. Measurements were repeated three times. Error bars were taken as SEM. 
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A control study in which no β-haematin crystals were introduced into the CQ and QD 
solutions did not show any kind of decrease in the absorbance readings compared to their 
initial values. Thus the observed decrease in absorbance recorded in the presence of β-
haematin crystals was attributed to some form of interaction between the drugs and the β-
haematin crystals. The most likely interaction is considered to be adsorption. However, it 
could not be determined from these simple observations to which face, or more likely 
faces, the compounds were adsorbed to. 
 
Figure 5.24 Extent of adsorption of (a) CQ and (b) QD by β-haematin. The crystals were placed in 
buffered aqueous solutions of the drugs for 3 days. The amount of drug adsorbed by the crystals 
was calculated from the Beer’s law plots. Error bars were taken as SEM. 
 
The difference in the adsorption profiles, QD being linear compared to CQ showing 
saturation, could be due to the fact that higher QD concentrations were too high to obtain 
meaningful UV readings.  
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5.4 Discussion  
 
The discovery of haemozoin in association with neutral lipid bodies in vivo has 
revolutionised the way in which we think about the process of haemozoin formation and 
therefore inhibition. To date however, the mechanism of haemozoin formation has still not 
been fully explained and, in turn, neither has the mechanism of its inhibition by 
antimalarial drugs. The development of the lipid-water interface model has allowed the 
relevance of lipids in the formation of β-haematin (haemozoin) to be investigated in 
vitro.
74
 As the focus of the current study was on the interaction between quinoline 
antimalarial drugs and ferrihaem which lead to the inhibition of β-haematin formation, the 
lipid-water interface system was used to probe drug activity under conditions which mimic 
the biological environment where haemozoin is now thought to take place. Aqueous-
soluble antimalarial drugs were included into the aqueous buffer in order to investigate 
their inhibitory activities on the formation of β-haematin. The IC50 data obtained in the 
present study show a strong correlation with previously-determined biological activities for 
two CQS strains of the P. falciparum.
134
 This indicates that the lipid-water interface 
provides a valid system in which to investigate drug activity.  
It has previously been shown that quinoline antimalarials decrease the rate at which β-
haematin formation occurs.
71,137
 As evident from the time study on the formation of β-
haematin, the results support the findings of Egan et al.
71
, who showed that although 
quinoline drugs inhibit β-haematin formation when relatively short incubation times are 
used, β-haematin eventually forms after longer incubation times in 4.5 M acetate (pH 4.5, 
60 
o
C). Chong and Sullivan
137
 had made similar observations, recognising too that β-
haematin formation eventually occurs in the presence of CQ and QD. Indeed the results 
presented in this chapter show that there is a correlation between incubation time and IC50 
value; however, the relationship is not linear for either CQ or QD (Figure 5.17 (d) and 
Figure 5.18 (d) respectively). Shorter incubation times appear to have a more pronounced 
effect on the IC50 value while at longer incubation times little further change is observed. 
This growing body of evidence indicates that IC50 values for the inhibition of β-haematin 
by quinoline antimalarial drugs depend greatly on the incubation time. This must therefore 
be taken into consideration when investigating β-haematin inhibitors.  
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In the present study, the kinetic effects of quinoline antimalarial drugs on the formation of 
β-haematin show that, at low concentration of both 4-aminoquinoline (CQ and AQ) and 
quinoline methanol (QD and QN) compounds, there is a decrease in the rate at which β-
haematin is formed under biomimetic (lipid-water interface) conditions. However, as drug 
concentrations were increased, a decrease in the final yield of β-haematin was observed. 
To explain the decrease in yield of β-haematin formed at higher drug concentrations, a 
competing process to the formation of β-haematin - the irreversible precipitation of 
Fe(III)PPIX, probably as its drug complex - was postulated. These drugs are thought to 
associate with free Fe(III)PPIX in solution by forming complexes, either through π- 
stacking or coordination,
85
 and preventing its incorporation into β-haematin.116,117,118 In the 
case of the quinoline methanol antimalarial drugs, the decrease in yield of β-haematin at 
higher drug concentrations may indeed be a direct consequence of complex formation. 
This would be consistent with the results presented in chapter 4, where direct coordination 
and intramolecular interactions were observed in the crystal structures of QN-Fe(III)PPIX 
and QD-Fe(III)PPIX. One shortcoming of the lipid-water interface methodology used in 
this study is the fact that it is not suitable for drug compounds insoluble in aqueous 
medium, therefore this system needs to be developed further in order for it to be of wider 
applicability. 
It has previously been shown that the kinetics of β-haematin formation in a lipid-water 
emulsion conform to an apparent first-order process.
73,74
 In the present study, a model was 
developed to explain the observations in yield of β-haematin with time in the presence of 
antimalarial drugs, as well as to explain the shape of the kinetics in the presence of the 
lipid-water interface. It was based on the Avrami model,
69,70
 together with the Langmuir 
isotherm.
182,183
 The best-fit to the experimental data was achieved by considering the 
process to be second order with respect to drug. However, this does not necessarily imply 
that the drug-F(III)PPIX complex would have a 2:1 stoichiometry. The nature of the 
quinoline-Fe(III)PPIX complexes formed in the lipid-water emulsions was not investigated 
in any detail, since it is reasonable to propose that the kinetic effect of the drugs, both at 
lower concentrations and shorter incubation times, is of greater biological relevance. To 
model the decreasing rates of β-haematin formation in the presence of low drug 
concentrations, the premises of the Langmuir isotherm were applied. The model proposes 
non-covalent adsorption of drug molecules to the fastest growing face of the β-haematin 
crystal (Scheme 2).  
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As the model predicts, the dose-response behaviour from the kinetic profiles gives rise to a 
sigmoidal dose-response curve at longer incubation times while, at shorter incubation 
times the dose-response profile tends toward a hyperbolic function. Interestingly, both 
dose-response profiles are observed in the experimental inhibition profiles for IC50 
determination at 30 minutes incubation time; AQ and CQ appear to induce a sigmoidal 
dose-response, while QD and QN data conform to a simple hyperbola. Initially it was 
thought that this indicated a difference in mechanism, however it is now appreciated that 
the chosen incubation time for the IC50 study (30 min) may simply be a too short time for 
QD inhibition process, while sufficient time for CQ action. 
CQ’s adsorption equilibrium constant, Kads, predicted by the model and the experimental 
conditions, is approximately 4 times greater than that of QD. The difference in the 
adsorption equilibrium constant for the 4-aminoquinoline and quinoline methanol drugs 
may be accounted for by considering the theoretical model of antimalarials being able to 
bind to the (001) face of β-haematin put forward by Leisorwitz et al.40 They showed that 
antimalarial drugs such as the 4-aminoquinoline and quinoline methanol can adsorb onto 
the {001} surface of the β-haematin crystal via an (porphyrin)acid-(quinoline)amine salt 
bridge. They predicted that the side chain of CQ, being longer than that of either QN or 
QD, is able to interact more favourably with the free propionic acid groups at the surface 
of β-haematin resulting in a stronger interaction and offer an explanation for the observed 
results in the current work.  
An interesting observation when comparing the value of the adsorption constant for CQ 
with the surface of β-haematin, log Kads (         ), with the association constant of CQ 
with free Fe(III)PPIX in 40% (v/v) aqueous DMSO, log K (         ),91 is these values 
are very close to one another. Therefore association constants can be linked to the drugs 
ability to adsorp onto the crystal surface of β-haematin for active compounds. 
UV absorption spectra of CQ and QD, in the presence of β-haematin crystals, indicates 
some form of interaction, which is proposed to be adsorption of drugs onto β-haematin 
crystals. This form of inhibition by antimalarial drug was previously proposed by Buller et 
al. 
40
 Making use of the theoretical growth form of β-haematin, they suggested that the 
quinoline antimalarials are able to dock into grooves (binding sites) on the fastest growing 
face of the crystal as a result of being stabilised by interaction with surrounding functional 
groups. This proposed mechanism of inhibition of β-haematin formation by antimalarial 
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drugs is supported by the kinetic model developed in this study. However, other 
mechanisms of inhibition cannot be excluded and further studies are still needed to clarify 
these results. 
 
5.5 Conclusion  
 
The lipid-water emulsion provides a biologically-relevant medium to investigate the β-
haematin inhibitory activity of antimalarial drugs. Based on the results reported in this 
chapter, both 4-aminoquinoline and quinoline methanol antimalarial drugs decrease the 
rate of β-haematin formation at low concentration and induce irreversible precipitation of 
Fe(III)PPIX at higher doses. A kinetic model was developed to account for the kinetic 
results, and it lends support to a mechanism of action where antimalarial drugs adsorb to 
the growing face of β-haematin. However, since kinetics alone cannot account for the 
mechanism of a chemical process, and the drug adsorption to β-haematin crystals as 
monitored using UV-vis spectroscopy cannot determine which face, or more likely faces, 
the drugs were adsorbed to, further studies are required to support these findings. Overall 
however, the kinetic data provides a basis for furthering our understanding of β-haematin 
inhibition processes under biomimetic conditions, which may in turn inform the rational 
design of novel antimalarial haemozoin inhibitors. 
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6 Single Crystal Diffraction of β-Haematin DMSO Solvate and Haemin 
 
6.1 Introduction 
 
Rational design of new drug candidates requires an in-depth understanding of the drug 
target, and in the case of quinoline antimalarials, it is widely accepted that this is 
haemozoin. While the structure of haemozoin and its synthetic counterpart β-haematin is 
known from powder X-ray diffraction,
35
 the limitation of the technique have motivated 
ongoing efforts for a more definitive structure. Furthermore, the nature of the Fe(III)PPIX 
species with which antimalarial drugs interact to inhibit formation of haemozoin is not well 
understood. It is therefore essential to investigate the mechanism of the crystallisation 
process. More definitive knowledge of the crystal structure of haemozoin and its growth 
mechanism is likely to provide insight into the inhibition mechanisms of current quinoline 
antimalarials. 
In this section, the first single crystal X-ray diffraction (SCD) structure of β-haematin as a 
DMSO solvate is reported. This structure provides the most accurate structural 
interpretation to date of a Fe(III)PPIX model of haemozoin. Additionally, extended X-ray 
absorption fine structure (EXAFS) spectroscopy was used to probe whether the structure 
determined in the solid state is also observed in solution. The nature of Fe(III)PPIX in 
solution must also be considered as it has important implications for understanding the 
nucleation and formation of β-haematin. In this work Fe(III)PPIX is proposed to exist in 
solution as a π-π dimer prior to β-haematin DMSO solvate crystallisation. The SCD 
structure of haemin, crystals of which were grown in the presence of the antimalarial drug 
AQ, shows Fe(III)PPIX as a π-π dimer. This structure was used to generate a model to 
which EXAFS data of the species in solution prior to nucleation of the β-haematin DMSO 
solvate was fitted. In addition, the structure refinement offers improvements compared to 
the previously-reported haemin structure.
79
 Together, the structures presented in this 
chapter provide a basis for understanding and rationalising the nucleation and formation of 
haemozoin, the proposed target of quinoline antimalarial drugs.  
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6.2 Experimental Methods 
 
This section describes the methods used to grow the single crystals of Fe(III)PPIX species 
(β-haematin DMSO solvate and haemin) as well as methods used to fully characterise their 
structures. The materials used have been listed in Table 3.1. 
 
6.2.1 X-Ray Crystallography 
 
The Crystallographic Information Files (CIF) along with the final SHELX “.res” and 
“.hkl” files for all crystal structures presented in this chapter can be found on the attached 
CD. 
 
6.2.1.1 The Crystal Structure of β-Haematin DMSO Solvate: Crystallisation from 
Chloroquine Free Base  
 
6.2.1.1.1 Crystallisation Preparation 
 
A 0.76 mM stock solution of Fe(III)PPIX was prepared by dissolving Fe(III)PPIX (5.0 mg, 
7.6 μmol) in 10.0 mL DMSO. A 1.56 mM stock solution of CQ free base (CQfb) was 
prepared by dissolving CQ 5.0 mg (15.6 μmol) in 10.0 mL DMSO. The crystallisation 
medium was prepared by adding 1.0 mL of Fe(III)PPIX stock solution to 1.0 mL of the 
CQfb stock solution in a small 5 mL glass vial. Hence the solution contained 
approximately 2 mol equiv of CQfb relative to Fe(III)PPIX. The mixture was stirred at 100 
o
C for 30 min before
 
it was allowed to stand in a water bath at 37 
o
C for 24 hours. The 
solution was then filtered through a PTFE filter disc (0.45 μm pore size) into a clean vial 
which was covered with parafilm and left to stand at room temperature. The parafilm was 
punctured with one needle-sized hole to allow slow evaporation of solvent. Small rod-
shaped crystals were observed on the bottom of the vial after two days. A single crystal of 
dimensions                mm was selected for X-ray diffraction.  
 
6.2.1.1.2 Structure Solution and Refinement  
 
All non-hydrogen atoms were refined with anisotropic temperature factors apart from some 
of the atoms of the disordered DMSO solvent molecule. The hydrogen atom located on the 
propionic acid group was located in the difference map and refined independently with a 
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simple bond length constraint. There is disorder displayed on the porphyrin pyrrole rings 
by the vinyl and methyl substituents. Each of the vinyl groups is disordered over two 
positions with site occupancy factors (s.o.f’s) of 0.66 and 0.34. One of the DMSO solvent 
molecules is also disordered over two positions with s.o.f.’s of 0.92 and 0.08. The oxygen 
and carbon atoms of the minor component of the disorder were modelled isotropically and 
hydrogen atoms were not placed on the carbon atoms.  
 
6.2.1.2 The Crystal Structure of β-Haematin DMSO Solvate: Crystallisation from 
Amodiaquine Free Base  
 
6.2.1.2.1 Crystallisation Preparation 
 
A 3.8 mM stock solution of Fe(III)PPIX was prepared by dissolving Fe(III)PPIX (5.0 mg, 
7.6 μmol) in 2.0 mL DMSO. A 2.5 mM stock solution of AQ free base (AQfb) was 
prepared by dissolving 1.8 mg (5.06 μmol) in 2.0 mL DMSO. The crystallisation medium 
was prepared by adding 1.0 mL of Fe(III)PPIX stock solution to 1.0 mL of the AQ stock 
solution in a small 5 mL glass vial. Hence the solution contained approximately 0.6 mol 
equiv of AQfb relative to Fe(III)PPIX. The mixture was stirred at 100 
o
C for 30 min and 
then
 
covered with parafilm and left to stand at room temperature. The parafilm was 
punctured with one needle-sized hole to allow slow evaporation of solvent. Small rod-
shaped crystals were observed on the bottom of the vial after one day. A single crystal of 
dimensions                mm was selected for X-ray diffraction.  
The free base form of AQ was prepared from an aqueous solution of the salt, using 
concentrated NaOH in order to yield a precipitate of the neutral species. The free base 
form of AQ was recovered by drying the precipitate in the presence of phosphorus 
pentoxide for 3 to 7 days. 
 
6.2.1.2.2 Structure Solution and Refinement 
 
All non-hydrogen atoms were refined with anisotropic temperature factors. The hydrogen 
atom located on the propionic acid group was located in the difference map and refined 
independently with a simple bond length constraint. There is disorder displayed on the 
porphyrin pyrrole rings by the vinyl and methyl substituents. Each of the vinyl groups is 
disordered over two positions with s.o.f’s of 0.66 and 0.34, respectively. The S atom of one 
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of the DMSO solvent molecules is also disordered over two positions with s.o.f.’s of 0.93 
and 0.07, respectively.  
 
6.2.1.3 The Crystal Structure of Haemin 
 
6.2.1.3.1 Crystallisation Preparation 
 
A solution containing 0.806 mM AQ (salt form) and 1.59 mM haemin was prepared in 4.0 
mL acetonitrile and 0.8 mL MeOH by dissolving AQ (1.8 mg, 3.87 μmol) and haemin (5.0 
mg, 7.66 mmol). After stirring the solution for 30 minutes at 50 
o
C, it was filtered through 
a PTFE filter disc (0.45 μm pore size) into a clean glass vial which was covered with 
parafilm and left to stand at room temperature. The parafilm was punctured with one 
needle-sized hole to allow slow evaporation of solvent. Small triangular-shaped crystals 
were observed on the bottom of the vial after two weeks. A single crystal of dimensions 
                mm was selected for X-ray diffraction.  
 
6.2.1.3.2 Structure Solution and Refinement 
 
All non-hydrogen atoms were refined with anisotropic temperature factors. The hydrogen 
atom located on the propionic acid group was located in the difference map and refined 
independently with a simple bond length constraint. There is disorder displayed on the 
porphyrin pyrrole rings by the vinyl and methyl substituents. The vinyl group is disordered 
over two positions with s.o.f’s of 0.52 and 0.48, respectively. The one acetonitrile solvent 
molecule and one water molecule which could be modelled were assigned s.o.f’s of 0.5 
each. The acetonitrile molecule was refined with simple bond length constraints and 
hydrogen atoms were not placed on the carbon atom of the acetonitrile molecule or the 
water molecule. There are additional solvent and/or water molecules in the structure, 
located in voids within and between the layers, which could not be unambiguously 
modelled. This structure was therefore analysed using SQUEEZE,
165
 which showed a total 
void volume of 823.2 Å
3
 and an electron count of 265 electrons. 
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6.2.2 EXAFS 
 
6.2.2.1 Sample Preparation 
 
The Fe Kα-edge EXAFS spectra were collected at the X-ray absorption spectroscopy 
(XAS) beamline at the Australian synchrotron. The β-haematin DMSO solvate crystals 
were prepared in advance according to the procedure described above. In order to 
investigate the solution species, it was necessary to increase the amount of haemin and 
drug relative to the initial crystallisation conditions so that a good quality signal could be 
detected. A final Fe(III)PPIX concentration of 10 mM and a final CQfb concentration of 
20 mM, were used. The concentrated solution of the two species was prepared immediately 
before the EXAFS experiment was conducted and filtered through a PTFE filter disk (0.45 
μm pore size) to remove undissolved solid. In the case of the crystals, they were placed in 
the sample holder with as much mother liquor removed as possible. All samples were flash 
frozen in liquid nitrogen and the cryogenic temperature of   18K was maintained for the 
duration of the measurement to limit thermal disorder and avoid sample degradation. 
Spectra were collected from several locations within the sample to ensure sample 
homogeneity and to limit sample damage due to continuous exposure to the X-ray beam.  
 
6.2.2.2 Data Analyses 
 
The raw EXAFS scans collected by the 100-channel Ge detector were merged using the 
AVERAGE program.
159
 Data processing and background removal were achieved with 
ATHENA and AUTOBK respectively, while fitting of experimental data to the 
corresponding model was done with ARTEMIS.
160,161
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6.3 Results 
 
6.3.1 β-Haematin DMSO Solvate Crystal 
 
Crystals of the β-haematin DMSO solvate species were obtained from two separate 
crystallisation environments, one containing CQ free base (CQfb) and the other AQ free 
base (AQfb). Fe(III)PPIX was prepared in the presence of approximately 2 mol equivalent 
of CQfb in a DMSO solution in the one case and in the presence of approximately 0.6 mol 
equivalent of AQfb in DMSO solution in the other case. Both crystallisation solutions 
yielded small rod-shaped crystals, which proved to be unstable when the mother liquor was 
removed completely, collapsing into a tarry amorphous material. After analysing the single 
crystal X-ray diffraction data in both cases, the species in the solid state was determined to 
be a DMSO solvate of β-haematin. In both cases, the structure was shown to belong to the 
triclinic space group P ̅. The repeating unit in both crystal structures is a centrosymmetric 
µ-propionato coordination dimer of Fe(III)PPIX (Figure 6.1). The structural refinement 
parameters are summarised in Table 6.1 and compared with the structural refinement 
parameters of β-haematin.35 
 
Figure 6.1 The µ-propionato dimer of Fe(III)PPIX, observed in the β-haematin DMSO solvate 
structure determined by single crystal X-ray diffraction. The crystals which yielded this structure 
were grown in the presence of either CQfb or AQfb, in DMSO solvent. The hydrogen bond (O3—
H3····O6) between the free propionic acid group of Fe(III)PPIX and an included DMSO molecule 
is indicated with a dashed red line. Ellipsoids are drawn at 50% probability level and non-relevant 
solvent molecules and hydrogen atoms have been omitted for clarity. In the case of the disordered 
vinyl and methyl groups, only the position with highest occupancy has been shown for clarity. 
Atom colour labelling: grey – C, cyan – Fe, dark blue – N, red – O; white – H and purple – S. 
O3
H3
O6
O4
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Table 6.1 Experimental and refinement parameters for β-haematin DMSO solvate and β-haematin.  
 β-haematin DMSO 
solvate (CQfb)* 
β-haematin DMSO 
solvate (AQfb)* 
β-haematin# 
Molecular 
formula 
[C34H31FeN4O4.3(C2H6OS)]2 [C34H31FeN4O4.3(C2H6OS)]2 [C34H31FeN4O4]2 
Formula weight / 
g mol
-1
 
849.96 843.81 615.50 
Crystal system Triclinic Triclinic Triclinic 
Space group P ̅ P ̅ P ̅ 
a (Å) 9.7395(6) 9.7426(15) 12.196(2) 
b (Å) 13.1930(7) 13.196(2) 14.864(2) 
c (Å) 17.621(1) 17.635(3) 8.040(1) 
α 110.641(3) 110.646(4) 90.22(1) 
β 99.147(3) 99.110(4) 96.80(1) 
γ 100.167(3) 100.144(4) 97.92(1) 
V(Å
3
) 2024.5(2) 2027.7(5) 1416.0(3) 
Z 2 2 2 
Temperature (K) 100 100 Room Temp 
µ (mm
-1
) 2.369 0.580 - 
Independent 
reflections 
6892 7152 - 
Rint 0.0884 0.1220 - 
Goodness of fit, S 1.073 0.997 - 
Final R indices 
[I˃2σ(I)] 
R1 = 0.0463 
wR2 = 0.1241 
R1 = 0.0674 
wR2 = 0.1978 
- 
*This study. Structures determined by single crystal X-ray diffraction 
#
From Pagola et al. Structure determined by Rietveld refinement of powder X-ray diffraction data. 
35
 
 
 
Refinement of the β-haematin DMSO solvate crystal structures reveal that three DMSO 
solvent molecules are included in the crystal packing per molecule of Fe(III)PPIX. Two of 
the DMSO molecules simply occupy the free space between adjacent columns of stacked 
µ-propionato dimers, and are not involved in hydrogen bonding. The third DMSO 
molecule is hydrogen-bonded to the free propionic acid group of each Fe(III)PPIX 
molecule (Figure 6.1), for which the hydrogen bond geometries are reported in Table 6.2. 
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Both CQfb and AQfb, which were present in the crystallisation media, are not observed in 
the crystal structures. 
Table 6.2 Hydrogen bond geometry in the β-haematin DMSO solvate crystal structure. 
Species D―H∙∙∙∙A D―H∙∙∙∙Å  H∙∙∙∙A/Å D―H∙∙∙∙A/ Å D―H∙∙∙∙A/
 o
 
From CQfb O3―H3∙∙∙∙O6 1.000(5) 1.56(2) 2.531(4) 162(6) 
From AQfb O3―H3∙∙∙∙O6 1.00 1.54 2.537 175.2 
 
 
As a result of the solvent included in the structures, the unit cell parameters for both β-
haematin DMSO solvate crystals are larger when compared to those reported for β-
haematin, which was determined to be void of solvent.
35
 Despite the presence of solvent 
molecules in the β-haematin DMSO solvate crystals however, the external morphology of 
the crystals observed by scanning electron microscopy (SEM), is very similar to the 
observed growth form of haemozoin (Figure 6.2).
179,180
  
 
Figure 6.2 SEM micrographs of β-haematin DMSO solvate crystals and haemozoin. β-haematin 
DMSO solvate crystals grown in the presence of (a) CQfb and (b) AQfb. (c) Haemozoin crystals 
from P. falciparum, reproduced from reference.
184
 Scale bar represents 20 µm, 10 µm and 200 nm 
for (a), (b) and (c) respectively. 
 
An interesting observation is that the crystals grown in the presence of CQfb and AQfb do 
not show any signs of having tapered ends as has been reported in the presence of 10% CQ 
(mol/mol Fe(III)PPIX) in DMSO-MeOH and CHCl3.
180
 
The infrared spectrum of the bulk material confirmed that the single crystal selected for 
analysis was representative of the bulk sample (Figure 6.3). The crystal grown from the 
solution containing AQfb had a significant amount of mother liquor present and therefore 
the absorbance bands are not so intense (Figure 6.3 (b)). The bands attributed to 
coordination of the propionate group to the iron centre appear at 1205 and 1651 cm
-1
, 
(a) (b) (c)
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shifted to lower wavenumbers relative to their characteristic positions of 1211 and 1664 
cm
-1
 respectively, in β-haematin. This is also the case for the band at 1703 cm-1, which is 
assigned to the carbonyl stretch of the free carboxylic acid groups in the crystals grown in 
the presence of CQfb. The use of DMSO as the crystallisation medium for these crystals, 
and the fact that it is included in the structure of the β-haematin DMSO solvate and 
participates in hydrogen bonding to the free propionic acid group, may account for these 
observed differences in the IR spectra. A study by Nie et al.
185
 provides some explanation. 
Making use of ab initio computational studies, the authors demonstrated that there is a 
correlation between the C=O stretching frequency in hydrogen-bonded carboxylic acid 
moieties and the hydrogen bond strength. They showed that the stronger the hydrogen-
bonding interactions, the larger the red shift in the C=O stretching frequency. Using 
Gaussian03 for structural optimisation and energy calculations in the presence of a 
dielectric medium, the frequencies were also shown to be sensitive to the dielectric 
constant of the environment, where a hydrogen-bonding interaction is expected to remain 
strong in a medium with a dielectric constant between 1 and 5.6. Interestingly, the 
characteristic peaks of the µ-propionato coordination dimer are not visible in the IR 
spectrum of dried crystals (i.e. when no solvent is present). This points to the instability of 
the crystals when removed from the crystallisation medium. Due to this instability, all 
attempts to use powder X-ray diffraction to confirm that the bulk sample has the same 
structure as the single crystal were unsuccessful. In each case the crystals rapidly collapsed 
into a tarry substance that yielded an amorphous solid when dry. The instability of these 
crystals probably arises from rapid desolvation or absorption of water from the 
atmosphere.  
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Figure 6.3 ATR-IR spectra of the β-haematin DMSO solvate crystals (a) from CQfb and (b) from 
AQfb. A sample of the bulk material was removed from the mother liquor, excess solvent was 
removed manually and the spectrum was recorded immediately in attenuated total reflectance 
(ATR) mode (black solid line). Peaks arising from DMSO have been highlighted in grey. These do 
not, however, interfere with the characteristic IR peaks attributed to µ-propionato coordination at 
1205 and 1651 cm
-1
, which correspond to the coordinated carboxylate C=O and C─O stretches 
respectively.
30
 The peak at 1703 cm
-1
 in the spectrum of the material from CQfb corresponds to the 
C=O stretch of the free carboxylic acid group. For the crystals grown from AQfb, this peak is 
included in the broad peak centered at 1651 cm
-1
. The ATR-IR spectrum of dried β-haematin 
DMSO solvate crystals is shown for comparison in (a) (solid grey line).  
 
6.3.1.1 Disorder in the Positions of the Methyl and Vinyl Substituents 
 
The vinyl and methyl substituents on the pyrrole rings B and C (Figure 6.4) are disordered. 
This disorder has been modelled over two sites, labeled as α and β for the upper molecule 
of the μ-propionato dimer, and γ and δ for the lower molecule. The α and γ positions are 
shown in green while the β and δ positions are shown in orange. In the refinement process, 
the site occupancies of the two vinyl groups at each position (i.e., the two α, the two β, the 
two γ, and the two δ vinyl groups) were set equal to each other, while the sum of the site 
occupancies of the α and β vinyl groups and the γ and δ vinyl groups was set equal to 1.0. 
In this way, the site occupancies of the vinyl substituents refined to 0.66 for the α and γ 
positions, and 0.34 for the β and δ positions. The result was the same for both β-haematin 
DMSO solvate structures, irrespective of whether the crystals were grown in CQfb or 
AQfb. 
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Figure 6.4 Illustration of the vinyl disorder in the single crystals of the β-haematin DMSO solvate. 
The site occupancies of the α and γ positions (shown in green) refined to 0.66, while the site 
occupancies of the β and δ position (shown in orange) refined to 0.34. Atom colour labelling for 
the porphyrin: grey – C; blue – N; red – O; cyan – Fe. 
 
6.3.2 Comparison of Crystal Packing in β-Haematin DMSO Solvate and β-
Haematin  
 
The structure of haemozoin (β-haematin) was solved from powder X-ray diffraction 
(PXRD),
35
 and the structural information was accessed via the Cambridge Structural 
Database (reference code XETXUP).
84
 We were able to compare the structural similarities 
between the β-haematin DMSO solvate, solved with SCD, and β-haematin solved from 
PXRD, by viewing the data through XSEED.
143
  
Firstly, an overlay of the porphyrin cores of the β-haematin DMSO solvate and β-
haematin
35
 show that there is a close agreement between the structures of the repeating 
units (Figure 6.5).  
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Figure 6.5 An overlay of the porphyrin core as present in the μ-propionato dimer of the β-haematin 
DMSO solvate (red) and β-haematin35 (green). 
 
While the structural features of the repeating µ-propionato dimer and the external crystal 
morphology of the β-haematin DMSO solvate (Figure 6.2) appear to be almost 
indistinguishable from β-haematin,179,180 examination of the crystal packing reveals 
interesting differences. The unit cell of each structure contains two molecules of 
Fe(III)PPIX, which are related to one another through a centre of inversion. In the case of 
the β-haematin DMSO solvate crystals, the unit cell contains a π-π dimer in which the 
unligated faces of the two Fe(III)PPIX molecules interact with one another (Figure 6.6), 
with three solvent molecules included in the crystal packing per molecule of Fe(III)PPIX. 
In contrast to this, the unit cell of β-haematin, was placed so as to contain a µ-propionato 
dimer of Fe(III)PPIX, Figure 6.7, and no solvent molecules are present in the crystal 
packing.35  
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Figure 6.6 Crystal packing of β-haematin DMSO solvate viewed along the crystallographic b-axis. 
The unit cell (outlined in grey) contains a pair of Fe(III)PPIX molecules in which the two Fe atoms 
are separated by an interdimer distance of 5.380 Å (i). Packing of the Fe(III)PPIX molecules along 
the a-axis is brought about by μ-propionato–Fe coordination resulting in the formation of a 
centrosymmetric μ-propionato dimer in which the two Fe atoms are separated by an intradimer 
distance of 8.982 Å (ii). Atom colour labelling: grey – C; white – H; blue – N; red – O; cyan – Fe; 
purple –S. 
 
c
0
a
(i)
(ii)
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Figure 6.7 Crystal packing of β-haematin viewed along the crystallographic a-axis. The unit cell 
(outlined in grey) contains a µ-propionato dimer in which the two Fe atoms are separated by an 
intradimer distance of 9.047 Å (i). Stacking of the dimers along the b-axis by means of non-
covalent (π-π) interactions between the unligated Fe(III)PPIX faces, results in the two Fe atoms 
being separated by an interdimer distance of between 7.859 and 8.040 Å (ii). Atom colour 
labelling: grey – C; blue – N; red – O; cyan – Fe; purple –S. 
 
When considering only the stacked (π-π) dimer, the metal centres are offset relative to one 
another. For the β-haematin DMSO solvate dimers, there is considerable overlap of the 
porphyrin cores (Figure 6.8 (a)). However, given the larger offset between the porphyrin 
planes, there is much less lateral overlap between the porphyrin cores in β-haematin 
(Figure 6.8 (b)). The observed Fe–Fe distance between adjacent µ-propionate dimers 
(referred to as the interdimer distance) for the β-haematin DMSO solvate is 5.380 Å for 
both the CQfb and AQfb structures (Figure 6.8 (a)), while an interdimer Fe-Fe distance of 
between 7.859 and 8.040 Å was measured for β-haematin (Figure 6.8 (b)).  
b
c0
(ii)
(i)
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Figure 6.8 A view down the Fe–O bonds of two adjacent μ-propionato dimers. (a) In the β-
haematin DMSO solvate, the two porphyrin cores are laterally shifted relative to one another, with 
an observed interdimer Fe–Fe distance of 5.380 Å. (b) The corresponding view in β-haematin.35 In 
this case, the interdimer Fe–Fe distances vary between 7.859 and 8.040 Å. For clarity the porphyrin 
at the back has been shaded green. Atom colour labelling of the front porphyrin: grey – C; blue – 
N; red – O and cyan – Fe. 
 
In the β-haematin DMSO solvate structure, stacked Fe(III)PPIX pairs interact with one 
another through µ-propionate-Fe coordination along the a-axis, resulting in formation of µ-
propionato dimers in which the observed intradimer Fe–Fe distance is 8.982 Å and 8.991 
Å, respectively (Figure 6.9 (a)). Given the geometrical constraints of the µ-propionato 
dimer, it was not unexpected that a very similar intradimer Fe-Fe distance of 9.047 Å is 
observed in the β-haematin structure (Figure 6.9 (b)). These dimers  -stack along the b-
axis. 
 
Figure 6.9 A view down the Fe―O bonds of the μ-propionato dimer of Fe(III)PPIX in (a) the β-
haematin DMSO solvate and (b) the β-haematin35 structures. The intra-dimer Fe-Fe distances are 
8.982 Å and 9.047 Å, respectively. The porphyrin molecule at the back has been shaded green for 
clarity. Atom colour labelling of the front porphyrin: grey – C; white – H; blue – N; red – O; cyan 
– Fe and purple –S. 
(a) (b)
(a) (b)
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6.3.3 The Crystal Structure of Haemin  
 
Crystals of haemin (Cl-Fe(III)PPIX) were obtained by dissolving haemin in the presence 
of approximately 0.5 mol equivalents of amodiaquine dihydrochloride dihydrate (AQ) in a 
5:1 (v:v) solution of acetonitrile: methanol. After two weeks, small triangular-shaped 
crystals were observed on the bottom of the vial. A single crystal of dimensions      
           mm was selected for X-ray diffraction. The asymmetric unit for haemin is 
shown in Figure 6.10. The crystal and structural refinement parameters are reported in 
Table 6.3 and compared to those determined previously for α-chlorohaemin.82 Despite the 
inclusion of the antimalarial compound, analysis of the crystals by SCD showed that they 
contained only haemin. At first this was not considered interesting since the structure of 
haemin ( -chlorohaemin) has been known since 1965,82 however, having compared the 
two structures, there are notable differences.  
 
 
 
Figure 6.10 The haemin structure. Solvent molecules and non-relevant H atoms have been omitted 
for clarity. In the case of the disordered vinyl and methyl substituents, only the position with the 
highest site occupancy has been shown for clarity. Atom colour labelling: grey – C, cyan – Fe, dark 
blue – N, red – O; white – H and yellow – Cl.  
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Table 6.3 The crystal data, experimental and refinement parameters for haemin and α-
chlorohaemin. 
 Haemin* α-Chlorohaemin# 
Molecular formula C34 H28 N4 O4 Cl1 Fe1 C34 H18 N4 O4 Cl1 Fe1 
Formula weight / g mol
-1
 684.44 637.84 
Crystal system Monoclinic - 
Space group C 2/m P ̅ or P1 
a (Å) 17.3355(15) 11.494 
b (Å) 23.005(2) 14.097 
c (Å) 11.5284(11) 10.854 
α 90.00 98.56 
β 122.195(5) 108.48 
γ 90.00 107.48 
V(Å
3
) 3890.7(6) 1529.99 
Z 1 2 
Temperature(K) 100 173 
µ (mm
-1
) 0.497 - 
Independent Reflections 3667 - 
Rint 0.2295 - 
Goodness of fit, S 1.030 - 
Final R indices [I˃2σ(I)] R1 = 0.0815 
wR1 = 0.2310 
- 
*This study. Structure determined by SCD. 
#
From Koenig. Structure determined by SCD.
82
 
 
 
Intermolecular hydrogen bonding between the propionic acid group of adjacent 
Fe(III)PPIX molecules is observed. Specifically, carboxylic acid moieties from adjacent 
Fe(III)PPIX molecules hydrogen bond to form the carboxylic acid dimer motif as shown in 
Figure 6.11. The hydrogen bonding geometries are reported in Table 6.4 and the crystal 
packing is outlined in section 6.3.4. 
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Figure 6.11 The hydrogen bonding observed in the crystal structure of haemin. The atoms involved 
in hydrogen bonding and the Fe(III) centre are labelled. The hydrogen bonds between the propionic 
acid group of adjacent Fe(III)PPIX molecules are indicated with dashed red lines. Solvent 
molecules and non-relevant H atoms have been removed for clarity. Atom colour coding: grey – C, 
cyan – Fe, dark blue – N, red – O; white – H and yellow – Cl.  
 
Table 6.4 Hydrogen bond geometry in haemin. 
D―H∙∙∙∙A D―H∙∙∙∙Å  H∙∙∙∙A/Å D―H∙∙∙∙A/ Å D―H∙∙∙∙A/
 o
 
O2―H2∙∙∙∙O1A 0.986 1.697 2.636 157.84 
 
 
6.3.3.1 Comparison Between Haemin and α-Chlorohaemin 
 
Crystals of α-chlorohaemin formed on the surface of a dialysis tube which was filled with 
a concentrated aqueous solution of NaCl, coated with mineral oil and perforated with 
pinholes, before being placed in test tube containing dissolved haemin in 1.0 mL pyridine, 
1.4 mL tetrachloroethane and 14 mL of glacial acetic acid and incubated at 120 
o
C.
82
 Even 
though a structure for haemin was solved in 1965,
82
 it is known that the conformation 
adopted by porphyrins may be strongly influenced by the crystal packing forces.
186
 As a 
result of the different solvents and environments used to grow the crystals of haemin (this 
work) and α-chlorohaemin (previous study), the unit cell parameters for haemin are 
notably different to the unit cell parameters reported for  -chlorohaemin (Table 6.3).  
Comparing the structure of haemin to the published structure of  -chlorohaemin,82 obvious 
differences in the packing of the porphyrins can be seen by simply comparing the adopted 
conformations of two adjacent porphyrins. Viewed from the side, the porphyrin core of 
haemin is planar (Figure 6.12 (a)), while that of α-chlorohaemin is noticeably domed 
(Figure 6.12 (b)).
82
 Given that the closest contact between adjacent porphyrin cores at a 
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distance of approximately 3.54 and 3.465 Å respectively, some π-stacking is likely 
between the two aromatic porphyrin macrocycles. Interestingly, Fe(III)PPIX has been 
shown to exist in aqueous solution as a π-π dimer, with a proposed structure similar to the 
structures shown below.
79
 This π-π dimer (where the axial ligand is H2O) is thought to be 
the precursor in the formation of β-haematin.73 Therefore, the structure of this species is of 
interest in understanding the mechanism of β-haematin formation, and the π-π dimers in 
haemin and α-chlorohaemin (Figure 6.12) provide the most accurate (SCD data) structural 
interpretations to support this model. In the aqueous environment, the axial ligand Cl of 
haemin would be substituted by either H2O or HO
-
.
79
 In the parasite’s digestive vacuole, 
which has an estimated pH of 4.8, H2O would be expected to be the axial ligand.  
 
Figure 6.12 Conformation of π-π dimers. A view from the side of two haemin molecules stacking 
on top of each other with the unligated faces facing one another and the axial ligands directed 
outward, for (a) haemin and (b) α-chlorohaemin82. The planar and domed conformations adopted 
by the Fe(III)PPIX molecules is observed for the two structures respectively. Atom colour coding: 
C – grey; N – blue; O – red; Fe – cyan and Cl – yellow. 
 
An overlay of the porphyrin cores in the two structures, viewed down the Fe-Cl bonds 
(Figure 6.13), shows that there is a much greater overlay in haemin compared to α-
chlorohaemin. The resulting interdimer Fe-Fe distance is 4.592 Å in haemin compared to 
6.666 Å in α-chlorohaemin. 
 
(a) (b)
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Figure 6.13 A view down the Fe—Cl bonds of (a) haemin and (b) α-chlorohaemin82. The 
interdimer Fe-Fe distance between two π-stacked porphyrins is 4.597 and 6.666 Å, respectively. 
These Fe-Fe distances may be more easily appreciated from the side view shown in Figure 6.12. 
The porphyrin molecule at the back has been shaded green for clarity. Atom colour coding in the 
front porphyrin: C – grey; N – blue; O – red; Fe – cyan and Cl – yellow. 
 
Closer inspection of the packing of haemin viewed along the crystallographic c-axis 
reveals large channels filled with disordered solvent molecules. 
 
Figure 6.14 Crystal packing of haemin viewed down the crystallographic c-axis as indicated by the 
unit cell. Disordered acetonitrile and water molecules are shown in light blue (space-filling). Atom 
colour coding: C – grey; H – white; N – blue; O – red; Fe – cyan and Cl – yellow. 
(a) (b)
a
b
0
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The π-π stacking observed in haemin is best appreciated when viewed along the 
crystallographic b-axis (Figure 6.15).  
 
Figure 6.15 Crystal packing of haemin viewed down the crystallographic b-axis indicated by the 
unit cell. Solvent molecules and non-relevant hydrogen atoms have been removed for clarity. Atom 
colour coding: C – grey; H – white; N – blue; O – red; Fe – cyan and Cl – yellow. 
 
The difference in the packing of haemin and α-chlorohaematin can be appreciated when 
looking at comparative views of the packing of the latter species (Figure 6.16) down the b-
axis and down the c-axis. When considering the ligated faces of the porphyrins in the 
packing diagrams, the atoms surrounding the Cl atom in the α-chlorohaemin structure are 
packed closer together. Therefore, comparing distances between Cl atoms in the crystal 
packing, the observed distances between two closest packed Cl atoms is 6.237 Å in α-
chlorohaemin compared to 7.807 Å in haemin. 
a
c
0
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Figure 6.16 The crystal packing of α-chlorohaemin viewed down the crystallographic (a) b-axis 
and (b) c-axis as indicated by the unit cell. Atom colour coding: C – grey; N – blue; O – red; Fe – 
cyan and Cl – yellow. 
  
a
c 0
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b
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6.3.4 EXAFS 
 
X-ray absorption spectroscopy was used to investigate the Fe(III)PPIX species in the 
crystallisation medium of β-haematin DMSO solvate in order to determine whether the 
species observed in the solid state also exists in solution. EXAFS is a very powerful tool 
that can give information about the local structure around an absorbing atom. The location 
and distance between atoms relative to an absorbing atom within a molecule can be 
determined, and can also provide information about disorder. Unfortunately, EXAFS is not 
suitable to study drug-treated parasite samples. Due to the high concentration of iron in 
haemoglobin, this would overpower the signal arising from any Fe(III)PPIX interacting 
with CQ. In this study, crystal of the β-haematin DMSO solvate and the crystallisation 
medium containing CQfb were investigated to study the interaction between Fe(III)PPIX 
and CQ at much higher concentrations.  
As mentioned previously, a reasonable starting model of the atoms around the absorbing 
Fe atom is needed to analyse EXAFS data. As an obvious starting point, the single crystal 
diffraction data determined for the β-haematin DMSO solvate was used to generate 
coordinates for these atoms from which a model was built to account for atoms in a sphere 
of ≤ 5.0 Å around the central Fe atom of one of the porphyrin molecules in the µ-
propionato dimer. These included the four nitrogen atoms directly bonded to the Fe centre, 
the α and meso carbon atoms, and the β-carbon atoms (refer back to Figure 2.13 in section 
2.5.4). Atoms anticipated to be involved in coordination to the Fe centre, namely those of 
the propionate group of Fe(III)PPIX involved in coordination to form the µ-propionato 
dimer, as well as atoms of DMSO, CQfb and H2O which could compete in solution and 
preferentially coordinate to the Fe(III) centre in the crystallisation medium, are referred to 
as axial atoms (a.a.). Atoms involved in backscattering from a second Fe(III)PPIX 
molecule as a result of π-π interactions or stacking between adjacent Fe(III)PPIX 
molecules are labelled as atoms outside the ring (a.o.). These atomic positions based on the 
known crystal structure were used to compare to the atomic positions determined from the 
EXAFS refinement, and were used to rationalise whether the solid-state structure is 
represented in solution or not.  
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6.3.4.1 EXAFS of β-Haematin DMSO Solvate  
 
The EXAFS spectra of the β-haematin DMSO solvate crystallisation medium and the 
crystals of β-haematin DMSO solvate were fitted to a starting model which was based on 
the SCD structure of the β-haematin DMSO solvate. Atoms involved in the EXAFS 
refinement are indicated in Figure 6.17. The EXAFS oscillations χ(q) and the 
corresponding Fourier transforms obtained for the crystallisation medium and the crystals 
respectively are shown Figure 6.19.  
 
Figure 6.17 The µ-propionato dimer as observed in the crystal structure of β-haematin DMSO 
solvate. The atoms considered in the EXAFS model refinement are labelled. Atom colour labelling: 
grey – C, cyan – Fe, dark blue – N, red – O and white – H. 
 
Due to the fact that some mother liquor remained in the sample of crystals of the β-
haematin DMSO solvate, some scattering from partner Fe(III)PPIX molecules was also 
considered in the model. As expected, there was very good agreement between the 
experimental spectrum of the crystals of β-haematin DMSO solvate and the model based 
on the SCD. In the case of the crystals of β-haematin DMSO solvate, the R factor for the 
best fit of the experimental data to the model was 0.029. In the case of the crystallisation 
medium however, the fit to the SCD model was poor and other models of Fe(III)PPIX, 
including cases with DMSO and CQfb as ligands, were considered. For this purpose the 
model of the local environment around the Fe centre was modified assuming the absence 
or existence of additional atoms. All plausible models were considered before the best fit 
was selected.  
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In an independent attempt to rationalise which Fe(III)PPIX species might exist in the 
crystallisation medium, a UV-vis spectrum of the crystallisation medium was collected. 
The concentration of Fe(III)PPIX used in the crystallisation medium was too high to obtain 
a meaningful UV reading, and therefore the concentrations of both Fe(III)PPIX and CQfb 
were adjusted to             mM and            mM, respectively for the 
investigation of the Soret band, Figure 6.18 (a), and            mM and            
mM, respectively to investigate the charge transfer and Q bands, Figure 6.18 (b). Both 
solutions contained approximately 2 mol equiv of CQfb relative to Fe(III)PPIX. In the UV 
spectra obtained, the sharp and intense absorbance peak close to 400 nm indicates the 
presence of a monomeric Fe(III)PPIX species.
155
 No change in the speciation of 
Fe(III)PPIX was observed even after 10 days. While providing some insight, the low 
Fe(III)PPIX concentration used compared to the EXAFS study, may influence the 
Fe(III)PPIX speciation. 
 
Figure 6.18 The UV-vis spectrum of the crystallisation medium of β-haematin DMSO solvate. (a) 
The concentrations of Fe(III)PPIX and CQfb were             mM and            mM 
respectively, to investigate the Soret band. (b) The concentration of Fe(III)PPIX and CQfb were 
           mM and            mM respectively, to investigate the charge transfer and Q 
bands. The soret band in the spectrum is characteristic of monomeric Fe(III)PPIX, suggesting that 
this is the species present in solution. 
 
According to the UV study (Figure 6.18), the speciation of Fe(III)PPIX in the presence of 
CQfb in DMSO is consistent with a monomeric Fe(III)PPIX species. However, since the 
concentration of Fe(III)PPIX in the EXAFS experiment was increased to 10 mM compared 
to 0.38 mM in the crystallisation experiment and 7.6 × 10
-3
 mM in the UV experiments (in 
order to record a spectrum), it was possible that other species such as a π-π dimer or even 
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the µ-oxo dimer of Fe(III)PPIX could have been in the crystallisation solution environment 
owing to aggregation. Therefore these species were also considered together with 
monomeric Fe(III)PPIX.  
If Fe(III)PPIX is monomeric, it is reasonable to consider the case in which DMSO could 
coordinate to form a 6-coordinate Fe(III)PPIX species. Given that the DMSO solvent was 
not dried before use, water is also a possible axial ligand along with the CQfb present in 
the crystallisation solution environment. Even though no drug molecules were observed in 
the SCD data, Fe(III)PPIX-drug moieties in the crystallisation medium were considered. 
Despite these other possibilities, the 6-coordinate monomeric Fe(III)PPIX with two DMSO 
molecules coordinating to the Fe centre, through either the oxygen or sulphur atom was 
considered the likely species. However, modelling did not refine with acceptable values of 
interatomic distances, r, or the statistical parameters R, and χ2. 
The µ-oxo dimer between two Fe(III)PPIX molecules was also considered. Again this 
model did not refine with acceptable values of the Fe-Fe distance and R and χ2 fitting 
indices. 
The model proposed to exist in aqueous solution comprises two 5-coordinate Fe(III)PPIX 
molecules interacting non-covalently through their unligated faces, with the axial ligand 
pointing outward being either H2O or HO
-
.
79
 Judging from the R and χ2 values, 0.014 and 
1.06 respectively, there is excellent agreement of the experimental data to this model. 
Although a somewhat surprising result given what is known about Fe(III)PPIX speciation 
is solution, the π-π dimer has been proposed to be one of the precursor steps in the 
formation of β-haematin.73  
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Figure 6.19 EXAFS spectra. The Fe Kα-edge k
3
-weighted experimental (blue) and the best fit (red) 
spectra (a and d), the corresponding Fourier transform (b and e) and the corresponding Fourier 
transform with phase correction (c and f), for crystals of β-haematin DMSO solvate (a, b and c) and 
the corresponding crystallisation medium (d, e and f). The R factor for the best fit to the model is 
0.029 in the case of the crystals of the β-haematin DMSO solvate fitted to the SCD data as a model, 
and 0.014 for the crystallisation solution fitted to a model of a π-π dimer with the axial ligand being 
either H2O or HO
-
 pointing outward. 
 
(c)
(e)(b)
(f)
(a) (d)
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The EXAFS oscillations χ(q), refined for the crystals of β-haematin DMSO solvate and the 
corresponding Fourier transforms spectra (Figure 6.19), indicate that there is good 
agreement between the model built from the SCD data of the β-haematin DMSO solvate 
and the fitted EXAFS. This is the same in the case of the crystallisation medium, where a 
model was built based on the π-π dimer of Fe(III)PPIX with H2O or HO
-
 as the axial 
ligand.  
In the case of the β-haematin DMSO solvate crystal, the EXAFS oscillation spectrum 
(Figure 6.19 (a)) shows differences in the shape between the model and the experimental 
results in the ranges 2.5–4.5 Å-1 and an increase in the peak intensity at 6.2 Å-1 for the 
experimental data. This could be as a result of the mother liquor that was present in the 
sample. The Fourier transformed spectrum shows similarities for the resolved atomic 
coordination spheres (Figure 6.19 (b)), again the small differences in the spectrum of the 
experimental and best fit to the model could be attributed to mother liquor present in the 
sample collection. The first peak from 1.4 to 2.4 Å, present in the Fourier transformed 
spectrum with phase corrections (Figure 6.19 (c)), is attributed to the scattering 
contributions from the axial oxygen (as a result of propionate coordination from a partner 
Fe(III)PPIX) and the four pyrrolic nitrogen atoms of Fe(III)PPIX. From Table 6.5 the 
distances assigned to the scattering atoms agree with the distance at which they will 
contribute to the peak observed in the spectrum in Figure 6.19 (c). The EXAFS data for the 
crystallisation medium indicate that the Fe(III)PPIX species present in solution prior to β-
haematin DMSO solvate crystallisation is a π-π dimer with either H2O or HO
-
 as the axial 
ligand. From the EXAFS oscillation spectrum (Figure 6.19 (d)) there are minor differences 
in the range of 3.5–6 Å-1, which is expected since molecules in solution are able to move 
more freely. The Fourier transformed spectrum for the crystallisation medium shows a 
good fit to the predicted model. Therefore, the precursor to the formation of β-haematin is 
proposed in Figure 6.20. 
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Figure 6.20 Proposed precursor to β-haematin DMSO solvate formation. (a) The π-π dimers 
predicted by EXAFS to be in the crystallisation medium of β-haematin DMSO solvate. (b) In order 
to form the µ-propionato linkages in the crystal structure of β-haematin DMSO solvate, the π-π 
dimers need to shift laterally, forming the µ-propionato dimer via propionate coordination and loss 
of the axial H2O or HO
-
 molecule. 
 
The refined EXAFS parameters are shown in Table 6.5.  
 
 
(a) (b)
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Table 6.5 Refined EXAFS parameters of β-haematin DMSO solvate crystallisation solution and crystals of β-haematin DMSO solvate.  
 β-haematin DMSO solvate (SCD)# β-haematin DMSO Solvate Crystal EXAFS β-haematin DMSO Solvate Crystallisation 
Medium EXAFS 
E0(eV) - 2.8(1.6) 9.5(5) 
So
2
 - 0.8(1) 1.000(1) 
nind - 20.2 25.15 
nvar - 16 10 
R  0.029 0.013 
2 - 2.59 1.06 
    
EXAFS 
labelling
##
 
Atom in 
SCD 
Distance  
from Fe (Å) 
Average Atom (X) N(X) Distance 
from Fe (Å) 
   (Å2) Atom (X) N(X) Distance 
from Fe (Å) 
   (Å2) 
N1 N1 2.064  N1 1 2.020(7) 0.006(4) N1 1 2.07(6) 0.0045(4) 
N2 N2 2.063  N2 1 2.061(7) 0.006(4) N2 1 2.11(6) 0.0045(4) 
N3 N3 2.057  N3 1 2.046(7) 0.006(4) N3 1 2.10(6) 0.0045(4) 
N4 N4 2.055  N4 1 2.036(7) 0.006(4) N4 1 2.09(6) 0.0045(4) 
C2 C1α 3.079 3.085 C2 4 3.07(4) 0.004(2) C2 4 3.1(1) 0.0008(7) 
C2 C4 α 3.101         
C2 C6 α 3.088         
C2 C9 α 3.072         
C3 C11 α 3.089 3.089 C3 4 3.04(4) 0.004(2) C3 4 3.07(7) 0.0008(7) 
C3 C14 α 3.091         
C3 C16 α 3.094         
C3 C19 α 3.080         
C5 C2 β 4.314 4.313 C5 4 4.32(9) 0.004(5) C5 4 4.25(1) 0.008(7) 
C5 C3 β 4.319         
C5 C7 β 4.314         
C5 C8 β 4.306         
C4 C12 β 4.323 4.314 C4 4 4.32(9) 0.004(5) C4 4 4.3(1) 0.0008(7) 
C4 C13 β 4.314         
C4 C17 β 4.311         
C4 C18 β 4.311         
C6 C5 meso 3.45 3.443 C6 4 3.47(9) 0.004(5) C6 4 3.5(1) 0.006(3) 
C6 C10 meso 3.43         
C6 C15 meso 3.445         
C6 C20 meso 3.445         
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Tabel 6.5 Continued from previous page 
 
EXAFS 
labelling
##
 
Atom in 
SCD 
Distance  
from Fe (Å) 
Average Atom (X) N(X) Distance 
from Fe (Å) 
   (Å2) Atom (X) N(X) Distance 
from Fe (Å) 
   (Å2) 
 Fe(III)PPIX           
O1 O1 a.a. 1.892  O1 1 1.97(4) 0.006(5)     
C7 C30 a.a. 3.037  C7 1 3.10(5) 0.004(2)     
O2 O2 a.a. 4.056  O2 1 4.05(2) 0.006(4)     
C8 C29 a.a. 3.520  C8 1 3.8(2) 0.004(5)     
Fe Fe o.r.       Fe 1 4.6(-1) 0.007(0.01) 
Cp1    Cp1 6 3.83(4) 0.003(5) Cp1 3 3.8(4) 0.010 (3) 
Cp2 C15 o.r. 3.811 4.163 Cp2 4 4.5(2) 0.005(7) Cp2 4 4.6(3) 0.004(0.01) 
Cp2 C16 o.r. 3.98          
Cp2 N4 o.r. 4.438          
Cp2 C17 o.r. 4.4          
Cp2 C14 o.r. 4.186          
Cp3 N3 o.r. 4.644 4.71 Cp3 2 4.73(8) 0.003(.01) Cp3 6 4.8(1) 0.004(5) 
Cp3 C13 o.r 4.769          
Cn    Cn 4 3.96(-7) 0.003(6) Cn 2 3.8(-2) 0.010(3) 
 H2O
*
           
oh O a.a.       oh 1 2.5(-2) 0.001(2) 
            
#
The model was built from the SCD data of the β-haematin DMSO solvate determined in this work. The atoms used to model distances from the Fe 
centre of the porphyrin are included to compare with the distances refined in the EXAFS data. 
##
 If atoms have the same EXAFS labelling it indicates that the atoms were refined at the same distance from the absorbing atom. 
*
 In the crystallisation solution, coordination to the Fe(III) centre through H2O or HO
-
 was also modelled. 
**
Abbreviations: atoms marked a.a. - axial atoms belonging to the propionate side chains of the second Fe(III)PPIX coordinating to the Fe(III) centre 
to form the µ-propionato dimer. Atoms marked o.r. – atoms outside the Fe(III)PPIX ring, belonging to the partner porphyrin which is involved in 
 -  stacking in the crystal structure.  ,   and meso labels indicate the atoms respective position in the Fe(III)PPIX ring. 
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6.3.4.1 1H Nuclear Magnetic Resonance Spectroscopy 
 
In order to further investigate the Fe(III)PPIX species present in solution prior to 
crystallising out as β-haematin DMSO solvate crystals, 1H NMR spectra of the 
crystallisation solution used in the EXAFS experiment, with and without CQfb were 
recorded in DMSO-d6 (Figure 6.21). With only Fe(III)PPIX dissolved in DMSO, a 
spectrum consistent with that reported for a high-spin six coordinate species is observed 
(Figure 6.21 (a)). When the CQfb is added to the solution, the peaks in the 40-70 ppm 
region are still observed in the base line (Figure 6.21 (b)), but when the solution was 
spiked with D2O, no peaks were observed in this region.
 
 
Figure 6.21 (a) The 
1
H NMR spectrum of Fe(III)PPIX in DMSO-d6. Peaks are assigned based on 
the spectrum reported by Budd et al,
81
i methyl groups, ii vinyl α-CH, iii porphyrin meso H, iv 
propionic acid COOH group, v propionyl β-CH2 and vi cis and trans vinyl β-CH2. Asterisks 
indicate solvent signals. (b) The 
1
H NMR spectrum of Fe(III)PPIX and CQfb in DMSO- d6.  
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6.3.4.2 Haemin Structure Compared to EXAFS Data of Fe(III)PPIX π-π Dimers  
 
In unpublished work by our collaborator, Dr. Victor Streltsov, at the CSIRO in Australia, 
X-ray absorption spectroscopy (XAS) was used to study aggregated Fe(III)PPIX in 
aqueous suspension. Analysing the XAS data confirmed that the samples contained a 
substantial amount of π-π dimers as was proposed for the Fe(III)PPPIX species to exist in 
aqueous solution.
79
 Therefore, it was proposed that crystallisation of β-haematin may be 
initiated by the formation of π-π dimers. The distances calculated in this EXAFS 
investigation were compared to the distances in the crystal structure of both haemin and α-
chlorohaemin in Table 6.6. The numbering of the EXAFS is the same as in Figure 2.13, 
section 2.5.4. 
Table 6.6 The best fit of EXAFS for Fe(III)PPIX with the distance from the Fe (Å) centre, 
comparing with the same distances observed in the crystal structure of haemin and α-chlorohaemin.  
EXAFS labelling
#
 EXAFS* Haemin  -Chlorohaematin 
 Distance from Fe (Å) Distance from Fe (Å) Distance from Fe (Å) 
N, N=4 2.055 (4) 2.055 2.056 
  , N=8 3.08 (2) 3.086 3.091 
     , N=4 3.46 (3) 3.433 3.456 
  , N=8 4.27 (5) 4.304 4.313 
Fe, N=1 4.50 (3) 4.597 6.666 
##
Cp1 N=3 3.80 (5) 4.139 (N=2) 3.898 (N=2) 
##
Cp2 N=2 3.90 (5) 4.246 (N=4) 4.356 (N=2) 
##
Cp3 N=6 4.68 (3) 4.783 (N=2) 4.828 (N=3) 
*Data collected by Dr Victor Streltsov. 
# 
 EXAFS labelling is the same as in Table 6.5, N indicates the number of atoms at the same distance from 
the Fe centre. 
## 
Is the labelling for atoms back scattered from an partner Fe(III)PPIX molecule. Same meaning as in Tabel 
6.5. 
 
 
The distances of scattering atoms from the Fe(III) centre in Fe(III)PPIX in the EXAFS data 
were compared to the distances in the crystal structures of haemin and α-chlorohaemin. 
The distance to the Fe centre of the adjacent Fe(III)PPIX moiety, as a result of π-stacking 
is highlighted in light grey (Table 6.6). The crystal structure of haemin determined in this 
work (where crystals were grown from a acetonitrile-methanol solvent system) showed a 
Fe to Fe distance of 4.597 Å compared to the Fe to Fe distance of 6.666 Å in the case of α-
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chlorohaemin which is closer to the structure observed in aqueous solution with a distance 
of 4.50 Å between the Fe centres (Table 6.6, highlighted in light grey). Therefore the 
haemin SCD structure presented in this work is the closest structure (to date) to represent 
the back to back π-π structure believed to exist in aqueous solution with the only difference 
being that the position occupied by the axial ligand is Cl as opposed to H2O/HO
-
.
79
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6.4 Discussion 
 
When the crystal structure of β-haematin was solved from powder X-ray diffraction in 
2000,
35
 it came as a surprise that it was not in fact a polymer but rather a cyclic dimer of 
Fe(III)PPIX in which the propionic acid groups linked these dimers through hydrogen 
bonding. It is recognised that the information which can be obtained from powder X-ray 
diffraction is far less than from SCD. There are limitations of the PXRD technique when 
applied to a large organic molecule like Fe(III)PPIX which has 43 non-hydrogen 
atoms.
35,42
 However, growing crystals of a suitable size for SCD has not been 
accomplished to date. The material which was used in the PXRD study was prepared from 
a solution containing haemin and 2,6-lutidine, where it seems reasonable that the base 
facilitated the dehydrohalogenation reaction necessary to yield a propionate which is then 
free to coordinate to the Fe(III) centre of a partner molecule and vice versa. 
45
 
In the current study, several attempts to grow single crystals of 4-aminoquinoline 
antimalarial drugs, in particular CQ given its success in clinical treatment, complexing 
with Fe(III)PPIX were undertaken without success. However, a experiment in which we 
used the free base of CQ (CQfb) in place of the salt yielded single crystals of β-haematin 
that were suitable for analysis by SCD. The crystal structure of the β-haematin DMSO 
solvate is the closest Fe(III)PPIX analogue (to date) of β-haematin. Even though it has 
been crystallised as its DMSO solvate, the structures still provide conclusive insight into 
the molecular nature of the synthetic counterpart of haemozoin. The repeating unit is 
confirmed to be a µ-propionato coordination dimer of Fe(III)PPIX, as we have come to 
appreciate for β-haematin based on the original PXRD structure determination.35 The 
porphyrin planes are laterally shifted in two dimensions relative to one another, which 
results in an intradimer Fe-Fe distance of 8.982 and 8.991 Å for the species grown from 
CQfb and AQfb, respectively. These values agree closely with the intradimer distance 
reported for β-haematin (9.047 Å), which is not surprising given the geometric constraints 
imposed upon formation of the centrosymmetric dimer. We also showed that the geometry 
of the porphyrin core within the dimers determined by SCD and PXRD are in very good 
agreement (Figure 6.5). When comparing the five-coordinate species, the Fe(III)‒O bond 
lengths in the two structures solved from SCD are 1.891(2) Å and 1.886(2) Å, respectively 
and 1.893 Å for the PXRD structure. The metal centre resides 0.42 Å out of the mean 
porphyrin plane for both β-haematin DMSO solvate structures and only slightly further 
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(0.47 Å) in the case of β-haematin. As mentioned in the introduction, section 1.5.1, Bohle 
and Dodd
46
 recently reported the SCD structure of a propionate-linked dimer as found in 
haemozoin. This cyclic dimer of Ga(III)PPIX, in which the propionate side chain of one 
protoporphyrin unit coordinates to the Ga(III) centre of the second and vice versa, has a 
Ga(III) centre and is six-coordinate with a pyridine ligand bound trans to the propionate. 
The free propionic acid forms an intradimer hydrogen bond with its partner propionate of 
the same porphyrin unit. With the obvious dissimilarities between β-haematin and the 
Ga(III)PPIX species, the crystal structure of the β-haematin DMSO solvate determined in 
this work is able to provide far greater insight into the structure of β-haematin and 
therefore haemozoin. 
Due to the enantio-facial symmetry of Fe(III)PPIX, isomers of the µ-propionato dimer can 
form upon coordination due to the random choice of face via which the incoming 
propionate ligand binds the iron centre. Straaso and co-workers have proposed four 
different Fe–O cyclic stereoisomers relevant to β-haematin, which differ in the site 
occupancies of the vinyl and methyl substituents.
41
 There are two achiral centrosymmetric 
dimers labelled cd ̅1 and cd ̅2, and two chiral noncentrosymmetric enantiomers labelled 
cd2(+) and cd2(-) (Figure 6.22). 
 
 
Figure 6.22 A schematic representation of the four isomers of the β-haematin µ-propionato 
dimer.
41
 The two achiral centrosymmetric dimers, (a) and (b) have been termed cd ̅1, and cd ̅2, 
respectively, while the two chiral non-centrosymmetric dimers, (c) and (d) have been termed 
cd2(+) and cd2(-), respectively. The vinyl substituents shown in green occupy the α (top porphyrin 
and γ (bottom porphyrin) sites, while those shown in orange occupy the β (top porphyrin) and δ 
(bottom porphyrin) sites. Atom colour coding: C – grey; N – blue; O – red; Fe – cyan and vinyl 
groups – green and orange. Redrawn from reference.41 
(a) (b) (c) (d)
)/(  )/(  )/(  )/( 
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In these four isomers, the vinyl substituents are located at the α/γ, β/δ, α/δ and β/γ 
positions, respectively. The authors proposed that a major phase of β-haematin exists, and 
that it primarily consists of cd ̅1, and the minor phase of cd ̅2, with cd2(+) and cd2(-) 
included in both, giving rise to the disorder. Alternatively it has been proposed that there is 
only one single phase and that disorder is caused by the presence of all four isomers.
42
 The 
latter authers also state that powder X-ray diffraction cannot distinguish between the 
vinyl/methyl disorder and that SCD would provide insight into resolving the issue.  
In the β-haematin DMSO solvate crystals grown from either CQfb or AQfb, there is no 
evidence of major and minor phases. Rather, IR analysis suggests a homogenous (single 
phase) sample. The single crystals selected for analysis out of both samples display 
disorder in the positions of the vinyl and methyl substituents, and we consider 
combinations of the four stereoisomers to be the most likely explanation. The observed  , 
 , γ and δ site occupancies of 0.66, 0.34, 0.66 and 0.34 were obtained for both structures. 
These values can be rationalised by considering various ratios of the four isomers. For 
example, the observed site occupancies may arise due to 0.66 cd ̅1 and 0.34 cd ̅2 (with no 
contribution from cd2(+) and cd2(-)). On the other hand 0.33 cd ̅1 and 0.33 each of cd2(+) 
and cd2(-), would give the same result. Taking into account that for the overall structure to 
remain centrosymmetric, a requirement of the space group P  ̅ , equal contributions of 
cd2(+) and cd2(-) must be included, many more ratios are in fact possible. Essentially, the 
contribution of cd ̅1 can vary from 0.66 to 0.34, while that of cd ̅2 can vary from 0.34 to 0. 
At the same time, contributions from both cd2(+) and cd2(-) can range from 0 to 0.33 (i.e. 
their contribution increases while that of cd  ̅ 1 and cd  ̅ 2  decreases). In the original 
proposed structure of β-haematin, the sites at α and γ were fully occupied while the β and δ 
sites were empty.
35
 The β-haematin DMSO solvate structure highlights the value of SCD 
analysis over PXRD, and provide insight into this disorder. SCD cannot, however, shed 
light on which ratio of the four isomers accounts for the observed site occupancies. 
Furthermore, whether the disorder issue is relevant or present at all in the parasite still 
remains questionable.  
In the SCD structure of the β-haematin DMSO solvate, an intramolecular hydrogen bond is 
observed between the free propionic acid group of each molecule of Fe(III)PPIX and an 
included molecule of DMSO. Bohle and co-workers have reported the same interaction in 
the PXRD structure of the Fe(III) mesoporphyrin IX analogue of β-haematin, prepared 
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from a DMSO solution containing 2,6-lutidine.
47
 When compared to the structures of β-
haematin
35
 and haemozoin,
36
 both solved from PXRD data by means of Rietveld 
refinement (and maximum-entropy-based fitting in the case of haemozoin), it is interesting 
to note that neither of these structures contain solvent molecules. In both structures, the µ-
propionato dimers of Fe(III)PPIX hydrogen bond through their free carboxylic acid groups 
to form a common supramolecular homosynthon, the carboxylic acid dimer (Figure 6.22 
(a)).
187
  
A detailed study on the hierarchy of supermolecular synthons by Zaworotko and co-
workers
187
 reported that out of 5690 entries in the Cambridge Structural Database (CSD) 
that had at least one carboxylic acid moiety present, only 34% included homosynthons (the 
dimer accounting for 31% of these entries and the catemer the remaining 3%). This 
indicates that heterosynthons are preferred in the presence of a competing hydrogen 
bonding moiety. In structures in which no other hydrogen bonding partners (donors or 
acceptors) are present, the authors showed that the characteristic carboxylic acid dimer 
accounts for 93%.
187
 In the case of the β-haematin DMSO solvate, we see that the 
heterosynthon is preferred. However, closer inspection reveals that a cyclic dimer like 
motif is still more-or-less preserved (Figure 6.23 (b, c)). 
 
Figure 6.23 (a) The carboxylic acid dimer, present in the structure of haemozoin. (b) The preserved 
dimer structure in β-haematin DMSO solvate. (c) Interactions between the DMSO solvent and the 
free carboxylic acid group in the µ-propionato dimer of Fe(III)PPIX as found in the β-haematin 
DMSO solvate crystal are shown, with the atoms involved in the hydrogen bonded “dimer” 
labelled. 
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Hydrogen bonding is a well-known intermolecular interaction X-H∙∙∙A, with X being the 
donor and A the acceptor. This interaction can be classified as very strong, strong and 
weak depending on the contact distances between atoms.
188
 The O3—H3····O6 hydrogen 
bond in the crystal structure of the β-haematin DMSO solvate is considered to be a strong 
interaction with a distance of 2.531 Å between O3 and O6. If we consider the Cmethyl atom 
of the solvent to be a hydrogen bond donor, then the resulting hydrogen bond is considered 
to be much weaker, with the distance between C37 and O4 in the crystal structure being 
3.393 Å, and the bond angle 28.97
o 
(Figure 6.23).  
Each β-haematin DMSO solvate crystal contains three molecules of solvent (DMSO) per 
molecule of Fe(III)PPIX. As mentioned in the introduction, it is interesting that malaria 
pigment is able to reversibly absorb up to 14% of its mass in water (a mol ratio of 4.78 
H2O molecules compared to Fe(III)PPIX).
189
 PXRD data has shown that upon hydration, 
samples of haemozoin become more ordered, which suggests that water molecules may be 
present in haemozoin and β-haematin, where they contribute to the crystallinity. Even 
though it is still unclear where the water that is absorbed resides in the crystal, the 
possibility that we could exchange the DMSO in the β-haematin DMSO solvate structure 
for water was considered. However, all attempts to do so with either water or methanol 
were not successful. Since the original structural interpretation of β-haematin did not show 
any solvent molecules, the role played by the solvents (DMSO or water) is yet to be fully 
appreciated. It may well have great implications for our understanding of the biological 
target haemozoin, proposed to grow at a lipid-water interface,
60
 however, further evidence 
is still required in order to substantiate this. 
The fact that β-haematin DMSO solvate crystals were grown in the presence of inhibitor 
drugs, CQfb or AQfb, is interesting and brings up a few questions. How is it possible for β-
haematin DMSO solvate to grow in the presence of an inhibitor? And what role is the drug 
molecule playing? At first one would assume that in the absence of another base, CQfb or 
AQfb would simply act as the base which is required for overall dehydrohalogenation. 
However looking at the kinetic effect of CQ and AQ on the rate of β-haematin formation 
investigated in this work (Chapter 5), and previously demonstrated in aqueous acetate 
medium,
71,137
 suggests that CQ and AQ, in addition to acting as a base in the crystallisation 
medium, may also be acting kinetically to slow down the rate of β-haematin, thereby 
enabling the formation of single crystals of β-haematin DMSO solvate. 
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The crystal structure of haemin shown in this work gives us valuable insight into the 
structure of a π-π dimer. In this structure, disorder in the vinyl occupancies was also found. 
The observed α and    site occupancies are 0.48 and 0.52, respectively. In the α-
chlorohaemin it was only mentioned that the vinyl group may be on either the α or β 
position, but not on both at once.
82
 Another related structure which has been used to model 
the π-π dimer previously is that of the aqua-iron(III)octaethylporphyrin perchlorate 
(Fe(OEP)(H2O))ClO4 (Figure 6.24).
83
 However this structure has only ethyl groups located 
around the porphyrin with no methyl, vinyl or propionic acid groups as found in 
Fe(III)PPIX, and the interdimer Fe–Fe distance of stacking molecules in 
(Fe(OEP)(H2O))ClO4 is 5.083 Å, compared to 4.592 Å and 6.666 Å for haemin and α-
chlorohaemin respectively.  
 
Figure 6.24 The SCD structure of aqua-iron(III)octaethylporphyrin perchlorate (a) side view, (b) 
top view. The structure was extracted from the Cambridge Structural Database,
84
 (reference code 
HECZUK) and displayed in XSEED.
143
 
 
Haemin being able to form in the presence of AQ is interesting, since it has been proposed 
that 4-aminoquinoline antimalarials promote µ-oxo dimer formation.
122
 Comparing the 
method used to grow the crystals which yielded the haemin structure, namely a solution of 
acetonitrile/methanol AQ present in its salt form, to the method used to grow β-haematin 
DMSO solvate, where AQfb was used in the DMSO crystallisation medium, not one of the 
crystal structures have the drug molecule included in the crystal structure. The results 
indicate that the protonation state of the drug can influence Fe(III)PPPIX speciation. 
Utilizing the ability of the EXAFS to model the local atomic structure around the Fe centre 
of Fe(III)PPIX, the species of Fe(III)PPIX present in solution prior to β-haematin DMSO 
solvate crystallisation has been investigated in the current work. It is shown that in this 
(a) (b)
Stellenbosch University  http://scholar.sun.ac.za
Chapter 6 – SCD of β-Haematin DMSO Solvate and Haemin 
223 
 
environment, the species present in solution prior to crystal formation is a back to back (π-
π) dimer of Fe(III)PPIX with the unligated faces facing one another and either H2O or HO
-
 
as the axial ligand directed outwards. The distance of the offset π-π dimers Fe centres in 
solution is 4.6 Å, therefore it does not appear that the µ-oxo dimer is formed in the 
presence of the CQfb and the EXAFS data indicate no interaction between CQ and the 
Fe(III) centre of Fe(III)PPIX. A similar investigation of mesohaematin anhydride 
(synthetic analogue of haemozoin) to probe the structure in the presence and absence of 
CQfb was carried out by Walczak et al.
162
 In contrast to their findings where the authors 
contributed the additional features in the EXAFS spectra at 2.5 Å to a CQ-
ferrimesoporphyrin IX complex (refer back to Figure 1.19, section 1.5.1), our results for 
the EXAFS spectrum of the β-haematin DMSO solvate crystals do not support the 
formation of a CQ-Fe(III)PP IX complex. 
Since an understanding of the speciation of Fe(III)PPIX in solution has direct implications 
for understanding the nucleation and formation of haemozoin, this SCD data of the π-π 
dimer and the β-haematin DMSO solvate gives us structural insight into the proposed 
formation of haemozoin at the lipid-water interface.
73,79
 Therefore, the formation of the 
haemozoin precursor dimer (exemplified by the β-haematin DMSO solvate structure), 
Figure 6.25, only requires that the π-π dimer of Fe(III)PPIX in aqueous solution simply 
changes in a lateral shift of the two porphyrins when entering the lipid environment to 
adopt the correct conformation to coordinate. This model is supported in the crystal growth 
mechanism of the β-haematin DMSO solvate. The EXAFS data suggest that Fe(III)PPIX 
starts out as a back to back π-π dimer in the crystallisation solution, and provides us with 
valuable insight in understanding the formation of β-haematin from Fe(III)PPIX. 
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Figure 6.25 The proposed mechanism of the formation of haemozoin at the lipid water interface. 
Starting in the aqueous where Fe(III)PPIX is proposed to exist as a π-π dimer (1) supported by the 
structure of haemin. When the π-π dimer enters the lipid environment, the formation of the 
haemozoin precursor dimer (2) only requires the coordination of the positively charge propionate to 
coordinate to the negatively charged Fe centre to form the haemozoin dimer (3), supported by the 
structure of β-haematin DMSO solvate dimer. In order to form haemozoin, all that is required is the 
loss of the H2O and the hydrogen bonding between the haemozoin dimers (4). 
 
6.5 Conclusions 
 
To develop new antimalarial drugs, it is imperative to understand the crucial pathway of 
haemozoin formation. The crystals of the β-haematin DMSO solvate reported in this work 
are the first Fe(III)PPIX model of haemozoin to be studied by SCD. These crystals provide 
the most accurate structural insight to date for a Fe(III)PPIX model of haemozoin and the 
 -  dimer predicted in aqueous solution. Though the crystallisation environment does not 
represent that of the parasite, it is still very relevant in gaining deeper insight into the 
nucleation and formation of β-haematin. The EXAFS results indicate that the back to back 
π-π dimer of Fe(III)PPIX is present in solution as the precursor to the formation of the β-
haematin DMSO solvate. This π-π dimer can be thought of as the building block in the 
nucleation initiation of β-haematin DMSO solvate crystals and the crystal structure of 
haemin provides the insight into the molecular structure of the precursor. These SCD 
structures may aid in probing Fe(III)PPIX drug interactions in the design of novel 
antimalarial drugs. 
+
+- -
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7 Overall Conclusion and Future Work 
 
7.1 Overall Conclusion 
 
Haemozoin, the characteristic pigment observed in the blood of victims suffering from 
malaria, still remains a validated drug target for quinoline antimalarial drug 
development.
55,190
 With widespread resistance to drugs currently used in treatment, there 
are extensive attempts to design novel haemozoin inhibitors. Given that the large majority 
of quinoline antimalarials have been shown to inhibit the formation of synthetic haemozoin 
(β-haematin), this process has been the focus of the current study. Understanding the 
pharmacophore of quinolines, as well as how β-haematin formation is mediated and 
inhibited, were the main objectives. In particular, the work in this dissertation gives insight 
into the different interactions which are possible between ferrihaem (Fe(III)PPIX), be it in 
solution or the solid-state (β-haematin), and clinically-relevant quinoline antimalarial 
drugs.  
Prior to this study, very little structural information existed to conclusively demonstrate 
how antimalarial drugs interact with Fe(III)PPIX, either in its free form or as haemozoin. 
The structures of the QD-Fe(III)PPIX, QN-Fe(III)PPIX and MQ-Fe(III)PPIX complexes 
determined in this work by single crystal X-ray diffraction provide detailed insight into the 
key interactions formed between the drug molecule and Fe(III)PPIX, at least in the case of 
the quinoline methanol antimalarial drugs. By targeting free Fe(III)PPIX in solution, which 
is a precursor to β-haematin formation, the three structures provide conclusive 
experimental evidence for a three-point binding mode which includes direct coordination 
of the drug to the Fe(III) centre through their benzylic alcohol functional group, π-stacking 
between drug and porphyrin aromatic systems, and finally intramolecular hydrogen bond 
formation. In the case of the Cinchona alkaloids (QD and QN), this was observed between 
the porphyrin propionate group and the protonated quinuclidine nitrogen atom of the drug, 
while in the MQ complex, a network of intramolecular hydrogen bonding between the 
propionate and propionic acid side chains of Fe(III)PPIX, with further two between each of 
these groups and the piperidinium nitrogen atom of the drug was observed. The 
intramolecular hydrogen bonds are proposed to play an important part in stabilising these 
crystal structures, and are in fact considered fundamental to be able to rationalise activity. 
It has been shown computationally, that the ease by which the active and inactive 
Cinchona alkaloids form this intramolecular hydrogen bond is directly correlated to their 
Stellenbosch University  http://scholar.sun.ac.za
Chapter 7 – Overall Conclusions and Future Work 
226 
 
biological and β-haematin inhibitory activity.85 Given that the intramolecular hydrogen 
bond was observed in the QD-Fe(III)PPIX crystals which were grown from a solvent 
system rich in hydrogen bonding partners (3:7 DMSO-methanol), this support a previous 
hypothesis that QD may be suitably pre-organised given its stereochemical configuration.
89
 
It has long been thought that stereochemical effects are the key to the greater activity of 
QD compared to QN. However, this current study has provided conclusive evidence in 
favour of a proposal that it is not the stereochemistry of the drug alone which is important, 
but rather the impact of the drug’s stereochemistry on its ability to form the key 
interactions with Fe(III)PPIX described above. The EXAFS data indicate that the 
coordination complexes are also present in solution, however, due to the distance of the 
atoms involved in intramolecular hydrogen bond formation from the Fe centre exceeding 
the analysed coordination sphere, we are not in a position to comment on whether the 
intramolecular hydrogen bonds persist in solution or not. Given that the coordination 
complexes do exist in solution, we propose that this mode of interaction may contribute to 
the antimalarial action of these drugs, since binding to free Fe(III)PPIX would limit 
haemozoin formation. 
Due to increasing interest in the lipid-mediated mechanism of β-haematin formation, and 
the fact that drug activity is likely to take place in this non-aqueous environment, a 
biomimetic system was used in this study to model the lipid-water interface. Drug activity 
was investigated under conditions that are more biologically-relevant than previous assays, 
and experimentally-determined IC50 values for CQ, AQ, QN and QD show excellent 
correlation with biological data determined against CQ-sensitive parasite strains, 3D7 and 
HB3. The lipid-water interface system was also used to investigate the effect of quinoline 
antimalarial drugs on the kinetics of β-haematin formation. Previous studies performed 
under non-biological conditions have shown that quinoline antimalarial drugs decrease the 
rate at which β-haematin is formed, rather than thermodynamically inhibit its formation. 
The kinetic investigation of β-haematin formation under biomimetic (lipid-water interface) 
conditions in the presence of antimalarial drugs shows that at low concentration of both 4-
aminoquinoline and quinoline methanol compounds, a decrease in the rate at which β-
haematin is formed is effected by the drug. However, as the drug concentration is 
increased, a decrease in the final yield of β-haematin is observed. This dual mode of action 
has not been considered before by other investigators. In order to explain the exponential 
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kinetics of β-haematin formation observed in the presence of lipid, a model was developed 
in an attempt to explain these observations.  
The kinetic model is based on the Avrami model,
69,70
 and incorporates the premises of the 
Langmuir isotherm.
182,183
 The experimental data strongly support a mechanism of 
antimalarial drug action by adsorption to the growing face of β-haematin, and the strength 
of interaction between a drug and the surface is measurable (log Kads). At significantly high 
drug concentration, precipitation of Fe(III)PPIX was included to account for the observed 
decrease in yield of β-haematin, and it is possible that a Fe(III)PPIX-drug complex is 
formed. The kinetic model provides a basis for furthering our understanding of β-haematin 
inhibition processes under biomimetic conditions, although it is recognised that a kinetic 
model cannot necessarily predict a mechanism. 
Finally, the single crystal X-ray diffraction structures of the β-haematin DMSO solvate and 
haemin determined in this study provide the most accurate structural insight to date for a 
Fe(III)PPIX model of haemozoin and the π-π dimer predicted in protic solution. Based on 
the reported EXAFS data, a model in support of the π-π dimer with the outward axial 
ligands being either H2O of HO
-
 is postulated to be the precursor species in the formation 
of β-haematin. Furthermore, the inclusion of a free base species that is also antimalarially 
active supports the kinetic data which indicate that a reduction in the crystal growth rate is 
achieved in the presence of a β-haematin inhibitor. 
Overall, this body of work provides valuable structural insight into the possible mode of 
inhibition, by quinoline antimalarials as well as structural insight into the proposed target, 
β-haematin (Figure 7.1), and thus contributes to the growing literature which may inform 
the rational design of novel antimalarial haemozoin inhibitors.  
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Figure 7.1 The main conclusions reached from this study. For a description of the proposed route 
of haemozoin formation (1-4) and inhibition (5 and 6), refer back to Figure 1.34 and Figure 1.50, 
respectively. (7) The SCD structure of haemin provides structural insight into the π-π dimer shown 
to exist in aqueous solution. (8-10) The Fe(III)PPIX-drug complexes shown, inhibit haemozoin 
formation via coordination, π-π interactions and intramolecular hydrogen bonding. (11) The β-
haematin DMSO solvate SCD structure provides the most accurate structural insight to date of a 
Fe(III)PPIX model of haemozoin. (12) The kinetic model developed provides essential insight for 
furthering our understanding of β-haematin inhibition processes under biomimetic conditions. The 
data strongly support a mechanism of antimalarial drug action by adsorption to the growing face of 
haemozoin, as well as precipitation of haematin at high drug concentration, possibly as a 
Fe(III)PPIX-drug complex (8-10). 
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7.2 Future Work 
 
The elucidation of the crystal structures of the quinoline methanol antimalarial drug (QN, 
QD and MQ) complexes of Fe(III)PPIX indicate that drug activity may involve three key 
interactions. The intramolecular hydrogen bond is thought to be the key interaction for 
determining activity, at least when considering the active and inactive Cinchona alkaloids. 
An understanding of how antimalarial compounds interact with Fe(III)PPIX, specifically 
within the food vacuole of the malaria parasite, has important implications in future drug 
development. In order to address the biological relevance of the complexes obtained in this 
work, the following studies are proposed: 
 Investigate drug-treated parasites spectroscopically in an attempt to characterise 
and locate the Fe(III)PPIX-drug species as they occur in vivo. One technique which 
may offer insight in this regard may be Resonance Raman Spectroscopy (RRS), 
due to its high sensitivity and selectivity. Webster et al.
191
 have shown that RRS is 
able to resolve structural changes in haemozoin after incubation with CQ in 
infected erythrocytes. This technique has important implications for monitoring the 
effect of antimalarials on their proposed target Fe(III)PPIX, and may thus be the 
link between the crystal structures and their biological relevance in vivo.  
 Continue ongoing experimental efforts to crystallise Fe(III)PPIX complexes with 
the inactive Cinchona alkaloids, namely 9-epiquinidine and 9-epiquinine. 
 An EXAFS investigation of the crystallisation solutions of QD-Fe(III)PPIX and 
QN-Fe(III)PPIX complexes, in which the active alkaloids are replaced with the 
inactive alkaloids (EQN and EQD), may provide insight into whether the inactive 
compounds coordinate to the Fe centre or not. If coordination does take place, 
intramolecular hydrogen bonding would not be expected,
85
 and the protonated 
quinuclidine nitrogen atom, and propionate group would most likely be involved in 
hydrogen bonding to solvent molecules. This may be the reason for our 
unsuccessful attempts to date to crystallise these complexes. 
 Use the Fe(III)PPIX-drug complexes as a scaffold for synthesising novel new 
antimalarial haemozoin inhibitors, based on the interactions shown to exist in the 
solid state, and test their antimalarial activity against P. falciparum. 
In this work, the lipid-water interface system was validated as a means to investigate the 
inhibition activities of quinoline antimalarial drugs. One drawback of the system is the fact 
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that only aqueous soluble drugs can be tested using the current approach. In the same 
system, the observed kinetics of β-haematin formation in the presence of quinoline 
antimalarial drug led to the development of a kinetic model, which proposes that the 
biologically-relevant mode of drug action is when inhibitor molecules adsorb onto the 
crystal surface. To investigate the relevance of the adsorption onto β-haematin crystals, and 
to further modify the procedures so that non-aqueous soluble compounds can be studied 
using the lipid-water interface, the following studies are proposed: 
 Develop the methodology of the lipid-water interface assay further in order to be 
able to investigate drugs not soluble in the aqueous medium. It is necessary to 
investigate means of testing the activities of aqueous insoluble compounds such as 
mefloquine (MQ), lumefantrine (Lf) and halofantrine (Hf) using the lipid-water 
interface assay. One solution may be to incorporate these and other such drugs into 
the Fe(III)PPIX-lipid premix, which is prepared in a 1:9 (v/v) acetone:methanol 
solution (as was attempted for MQ). The total volume of the premix is only 200 μL 
which means that the active compound is essentially added directly to the 
interface, whereas previously it was necessary to first concentrate the drug at the 
interface out of the bulk aqueous phase (5 mL). Since we have already shown in 
this study that incubation time has a significant impact on the IC50 value, this 
would need to be carefully investigated. 
 Making us of LynxTag-CQ, where a fluorescent marker was successfully tagged to 
CQ, 
192,193
 attempts to visualise CQ adsorbed to β-haematin crystals may provide 
definitive insight into the mechanism of drug action. By using the fluorescent-
labelled CQ in inhibition studies, the result may possibly confirm adsorbance of 
CQ onto the growing crystal surface of β-haematin (haemozoin), by use of 
fluorescence microscopy. 
Based on the crystal structure of β-haematin DMSO solvate, solvent in the crystal is 
relevant in stabilising the structure. To investigate how the β-haematin DMSO solvate 
crystal may be used in drug development, and to further probe the relevance of solvent, if 
any, in haemozoin crystal formation, the following studies are proposed: 
 Since it has been possible to predict the face of β-haematin that would most likely 
support drug adsorption,
40
 it should also be possible to compute the attachment 
energies for the different faces of the DMSO solvate crystal and hence use their 
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structure as a model in the rational design of novel probes for controlling the 
crystallisation process. 
 Since the original structure interpretation of β-haematin does not show any 
included solvent molecules, the role played by solvents (DMSO or water) is yet to 
be fully appreciated. Therefore, attempts to crystallise β-haematin from other 
solvents are ongoing and may aid in furthering our understanding of the role 
played in the structure of malarial pigment. 
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Appendix I – Derivation of the Kinetic Model 
 
The Avrami equation (eq. 1), has been used to model crystallisation processes, that is how 
solids transform from one phase into another at a constant temperature. It specifically 
describes the kinetics involved in crystallisation.
69,70
 
  
  
     
 
 (1) 
In the above equation,   is the mass of Fe(III)PPIX remaining at time t compared to the 
initial mass  , z is an empirical rate constant, and n is a constant known as the Avrami 
constant, which is usually an integer ranging between 1 and 4.  
The Langmuir isotherm (eq. 2), where the extent of monolayer coverage of a solid surface 
 , is related to the partitioning of an adsorbant between the gas phase and the adsorbed 
state as a function of applied pressure P of the adsorbing reactant and the equilibrium 
adsorption constant Kads.
182 
  
    [ ]
      [ ]
 (2) 
The Langmuir isotherm can be used to characterise the adsorption of antimalarial drugs 
onto the growing face of β-haematin in a similar manner (eq. 3). Here, the drug molecules 
are in contact with the solid surface of β-haematin at a fixed temperature and the drug 
concentrations [D] can be thought of in the same way as the pressure of the adsorbing 
reactant in the gas phase. 
  
    [ ]
      [ ]
 (3) 
To generate the equation in the context of β-haematin crystal growth in the presence of an 
inhibitor, the adsorption of drug D to binding sites S were considered in the light of 
Scheme 2 (Chapter 5), on the surface of β-haematin in a similar manner to the Langmuir 
behaviour. Arriving at the following equilibrium: 
     
     (4) 
In eq. 4, D is an inhibitor (such as CQ), S is an empty surface site where an inhibitor may 
adsorb, and is equivalent to the (1  ), DS is the filled adsorption sites and is equivalent to 
 . It is important to note that by writing this equilibrium equation, we are making an 
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inherent assumption that there is a fixed number of adsorption sites present on the surface 
of the crystal. The extent of adsorption S ( ), would be dependent on the concentration of 
the inhibiting drug [D]. Thus the adsorption process between the drug molecules [D], and 
the number of free sites (1 – ), and adsorbed sites , can be presented by a forward 
reaction governed by the rate of adsorption eq. 5: 
                      [ ]    (   ) (5) 
where N is the total number of sites available for adsorption, and ka is the adsorption rate 
constant. The reverse direction is governed by the rate of desorption eq. 6: 
                          (6) 
where kd is the desorption rate constant. At equilibrium, the rates of adsorption and 
desorption are expected to be equal:  
   [ ]    (   )         
     
  
  
 
 
(   )[ ]
 
     
 
(   )[ ]
 
Solving θ finally yields eq. 7, which is reminiscent of the Langmuir isotherm, with the 
equilibrium adsorption constant, Kads. 
  
    [ ]
      [ ]
  (7) 
The number of sites that are available for continued crystal growth is equivalent to    . 
It is reasonable to propose that any continued growth of β-haematin is then dependent on 
the number of free sites, (   ). Therefore: 
      
    [ ]
(      [ ])
 (8) 
Rearranging eq. 8 generates eq. 9: 
    
 
      [ ]
 (9) 
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The growth rate of β-haematin in the presence of a drug, zobs, (Chapter 5, Scheme 2) 
relative to its growth rate in the absence of drug (z) is proportional to the number of vacant 
binding sites. Therefore, the rate constant for the formation of β-haematin in the presence 
of an drug     , is given by eq. 10. Since, 
    
 
    , therefore 
      (   )  
 
      [ ]
 (10) 
where z is the rate constant for β-haematin formation in the absence of drug and zobs is the 
observed rate constant for β-haematin formation in the presence of drug. 
The plot of the inverse of the observed rate constant, zobs, as a function of drug 
concentration yields a linear regression, from which the values of z and Kads can be 
determined from the values of the y-intercept and slope respectively, as shown in eq.11. 
 
    
 
      [ ]
 
 
    
 
[ ]  
 
 
  (11) 
To explain the observed decrease in final yield of β-haematin formed at higher drug 
concentrations, it was necessary to incorporate a competing drug concentration-dependent 
process that would result in the irreversible precipitation of haematin, most likely as a drug 
complex (DH(s)), (Scheme 2, Chapter 5). According to this mechanism, the rate of 
depletion of haematin in solution (H(aq)) can be determined by eq. 12. 
 [ (  )]
  
      [ (  )]    [ (  )][ (  )]
 
 (12) 
Rearranging eq. 12 generates eq. 13. 
 [ (  )]
  
  [ (  )](       [ (  )]
 
) (13) 
where    is the rate constant for the irreversible precipitation of haematin brought about by 
interaction with the drug. [ (  )] (simplified as [ ] in the equations below) and [   ] are 
the respective concentrations of drug and haematin in solution, and   . It was found 
that the best agreement with the experimental results is achieved when m = 2, this value is 
assumed for the remainder of the derivation. Assuming [D(aq)] to be in large excess 
compared to haematin ( [ (  )]  [   ]  ), and therefore essentially a constant, the 
concentration of haematin remaining in solution as a function of time can be determined by 
integration, to generate eq. 14.  
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∫
 
[ (  )]
 [ (  )]   (       [ ]
 ∫   
 
 
) 
  [ (  )]    [ (  )]    
[ (  )]
[ (  )] 
  (       [ ]
 )  
[ (  )]  [ (  )]   
 (       [ ]
 )  (14) 
Since the formation of β-haematin is directly dependent on the concentration of haematin 
in solution, eq.14 is a useful expression to determine the rate of the formation of β-
haematin (eq. 15a). It follows from the corresponding integral eq. 15b of eq. 15a that the 
yield of β-haematin, [β(s)], is given by eq. 15c. 
 [ ( )]
  
     [ (  )]       [ (  )]   
 (       [ ]
 )  (15a) 
∫ [ ( )]      [ (  )] ∫  
 (       [ ]
 )   
 
 
 (15b) 
[ ( )]  
     [ (  )] 
(       [ ] )
  (       [ ]
 ) ]
 
 
 
[ ( )]  
    [ (  )] 
(       [ ] )
 
    [ (  )] 
(       [ ] )
  (       [ ]
 )  
[ ( )]  
    [ (  )] 
(       [ ] )
(    (       [ ]
 ) ) (15c) 
As written above, eq. 15c implies that the yield of β-haematin will be measured as an 
actual concentration, but in practice, the yield is determined as a fraction relative to the 
initial amount of haematin in the system (i.e. ([   ]      )) eq. 16. 
 [ ( )]  
       
(       [ ] )
(    (       [ ]
 ) ) (16) 
Acknowledging this, and substituting the expression derived above for the observed rate 
constant (eq. 10), into eq. 16, the kinetic model is reached (eq. 17). 
 [ ( )]  
    
(    [ ]        [ ] )
(   
 (
    [ ]
        [ ]
 
      [ ]
) 
) (17) 
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To take into account that the lipid (MPG) is not able to convert [   ] into a yield of 100% 
β-haematin, an additional term Y, was introduced to account for the fractional yield (0.7), 
and the overall kinetic model is reached (eq. 18). 
  ( )  
     
(    [ ]        [ ] )
{   
 (
    [ ]
        [ ]
 
      [ ]
) 
} (18) 
Eq. 18 incorporates both the adsorption of drug to the surface of β-haematin as well as the 
drug-induced precipitation of haematin, most likely as a drug complex (DH(s)). 
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“If you think you are too small to make a difference, 
try sleeping with a mosquito.” 
-Dalai Lama XIV- 
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